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Intra-abdominal hypertension (IAH) is the condition of increased intra-abdominal pressure 
(IAP) observed in severely ill or injured patients. Abdominal compartment syndrome (ACS) 
is new organ failure resulting from high IAP levels. ACS was first described in 1890 by 
Heinricius, but came more apparent in the 1990s (1, 2). Pediatric surgeons first recognized 
the syndrome after closing the abdominal wall in surgery for omphaloceles (3, 4). Later, 
following the introduction of damage control surgery and surgery for abdominal aortic 
ruptures, ACS was seen more often and therefore more commonly known (5-8). Due to 
increase of peri-operative survival in successful damage control surgery (DCS), patients 
who previously exsanguinated on the operating table now progressed to the intensive 
care units alive. Then they developed acute cardiac, respiratory, and renal failure resulting 
from increased abdominal pressure and still died as a consequence (1). The first attempts 
to treat this acute ACS aimed at abdominal decompression with removal of fluid, blood, or 
packs from the abdomen, and subsequent open abdominal treatment. Despite the direct 
decrease in IAP and initial recovery of organ function, early reports still noted high 
mortality (up to 75%) due to reperfusion injury (9). Morbidity numbers were also very 
high, for example 25% of patients treated with open abdomen develop wound 
complications (10). As the outcome of patients with ACS remained poor, the next step 
focused on prevention of ACS. Modifiable risk factors were systematically identified and 
addressed. Reduction of crystalloid resuscitation volumes, liberal and early using of the 
open abdomen for a prolonged period, goal directed correction of coagulopathy, timely 
hemorrhage control, and use of hemostatic resuscitation with tranexamic acid seemed to 
decrease ACS occurrence and mortality considerably (11-16). Whether these new 
approaches may have led to the decrease of IAH and ACS prevalence is still subject of 
debate in current literature.  
 
Definitions 
The Abdominal Compartment Society (WSACS) was established in 2004 and aimed to set 
up and improve research and management of ACS. Their evidence-based consensus 
definitions, guidelines on management, and research strategies were recommended and 
published, stating intra-bladder measurement of IAP as a standard (17). Intra-abdominal 









cavity. Most critically ill patients in the intensive care unit (ICU) have an IAP of 5-7 mmHg 
(18). For organs concealed within the abdominal cavity, the perfusion pressure was 
defined as the mean arterial pressure (MAP) minus the IAP (Abdominal Perfusion 
Pressure: APP = MAP – IAP). This indicates that as IAP increases, hemodynamic perfusion 
pressure decreases which results in organ function deterioration depending on the 
compliance of the abdominal wall (19). Intra-abdominal hypertension (IAH) was defined as 
a sustained intra-abdominal pressure of over 12 mmHg. This value was established 
arbitrarily, primarily aiming at research purposes for indicating which patients ‘intra-
abdominal pressure is increased inappropriately’. Intra-abdominal hypertension pressure 
was graded as follows: Grade I = IAP 12 to 15 mmHg; Grade II = IAP 16 to 20 mmHg; Grade 
III = IAP 21 to 25 mmHg; and Grade IV = IAP above 25 mmHg. ACS was defined for research 
purposes as IAP at more than 20 mm Hg with new organ dysfunction or failure. For clinical 
purposes, ACS is better defined as IAH-induced new organ dysfunction without a strict 
intra-abdominal pressure threshold, since no intra-abdominal pressure level can predict 
ACS in all patients. Primary IAH or ACS was defined as a condition associated with injury or 
disease in the abdominopelvic region that frequently requires early surgical or 
interventional radiological intervention. Secondary IAH or ACS refers to conditions that do 
not originate from the abdominopelvic region (17). Recurrent ACS refers to the condition 
in which ACS redevelops following previous surgical or medical treatment of ACS. Little is 
known about this rare condition of recurrent ACS and especially in which patient high 




Most epidemiologic studies regarding ACS have been performed in trauma populations, 
and reported a considerably varying prevalence. Initial reports of ACS in major trauma 
populations showed a mortality rate of more than 60% and a prevalence higher than 30% 
(9, 20-22). The largest study until now (n=706; 10 years after the first publications) 
showed a prevalence of ACS of 1% among all admission on a trauma ICU (23). Another 
study demonstrated a prevalence of 14% among 188 patients with torso injury (24). 
Presumably, the different prevalences were likely related to the different patient 
populations studied. This literature suggested that the prevalence of ACS is highest among 




loss or the resuscitation volumes given to these patients and subsequent inflammatory 
reactions. The prevalence of intra-abdominal hypertension (IAH) was less well 
characterized, mainly due to the different definitions used in literature, and the not fully 
understood clinical relevance of the condition. Since management of these severely 
injured or ill patients has developed tremendously, current prevalence and mortality 
numbers presumably decreased significantly from those stated above. The introduction of 
goal directed resuscitation and transfusion, and permissive hypotension in these patients 
directly aimed at prevention of inflammation, over-resuscitation and edema. However, 
the effects on prevalence and outcome of ACS and IAH remain unknown.  
 
Etiology and risk factors 
ACS generally occurs in critically ill patients due to variety of medical and surgical 
conditions (25). These conditions can be grouped as conditions that diminish abdominal 
wall compliance (torso trauma, major burns, BMI, abdominal surgery, and abdominal 
hernia repair), conditions that increase intra-luminal contents (ileus, gastroparesis, and 
volvulus), conditions that increase intra-abdominal content (hemorrhage, ascites, abscess, 
and intra-abdominal tumors), conditions that decrease intra-abdominal volume 
(mechanical ventilation with high pressure, retroperitoneal tumors and acute 
pancreatitis), conditions associated with capillary leakage or fluid resuscitation (acidosis, 
hypothermia, positive fluid balance, massive resuscitation and poly transfusion), and 
miscellaneous conditions (coagulopathy, increased head of bed angle, peritonitis, and 
sepsis) (24, 26-32). Most patients in the ICU are subject to at least one of these factors, 
but patients with severe trauma, burn injuries, pancreatitis, or (abdominal) sepsis have 
multiple of these risk factors. Specifically those groups are prone for IAH, ACS, and 
associated morbidity and mortality. An overview of all risk factors for IAH and ACS are 
included in the 2013 WSACS consensus (17). Most of these risk factors are not modifiable, 
but specifically over-resuscitation and uncontrolled transfusion strategies play a central 
(and iatrogenic) role in ACS development. Introduction of plasma resuscitation for severe 
burn patients and restrictive fluid resuscitation in patients with acute pancreatitis proved 
to half the prevalence of IAH and ACS, respectively (33, 34). Of all listed risk factors, it 












Intra-abdominal hypertension leads to swelling, hypoxia, and dysfunction at a cellular 
level, extensive fluid resuscitation leads to edematous and fluid-filled bowels (35). 
Decrease of venous return and deterioration of cardiac output due to effects of increasing 
IAP, triggers more fluid infusion. As a result of blood loss and dilution by (crystalloid) 
infusion, the oncotic pressure decreases. Subsequently, fluid flows into the interstitium or 
third space, an effect termed ‘third spacing’. Fluids that accumulate intra-abdominally 
increase IAP further and causes the patients’ condition to deteriorate. When this 
downwards spiral of more fluid resuscitation is not interrupted, the abdominal perfusion 
pressure will no longer be sufficient for adequate organ function and ACS emerges. 
 
Intra-abdominal hypertension has an effect on almost every organ system (36). 
Physiologic effects mainly involve the intra-abdominal organs, but pathologic effects 
extend outside the abdomen. The most common signs are increased ventilation pressures 
and decreased urinary output. However, as IAP raises high enough, multiple organ 
systems will fail and eventually death will follow. Most clinically important consequences 
of IAH are discussed in more detail below.  
 
Respiratory system 
Due to a raised diaphragm, the thoracic volume and compliance decreases. To overcome 
this, ventilation pressures become higher (resulting in barotrauma), the functional residual 
capacity decreases and ventilation–perfusion mismatch increases, resulting impaired 
oxygenation (37, 38). Also, patients with ACS are at high risk for acute respiratory distress 
syndrome (ARDS). Causality is not known, but similar diseases or injuries increase both IAP 
and the risk of ARDS. A decreased thoracoabdominal compliance is associated with 







Intra-abdominal hypertension reduces cardiac return through compression of the inferior 
vena cava and pooling of blood below the groin (40). Stroke volume is decreased by a 
raised diaphragm; contractibility is reduced through increased loading on the right 
ventricle against increased pulmonary pressures. Reduced cardiac output results in 
compensatory increases of systemic vascular resistance, which is worsened by direct 
compression of the abdominal aorta and systemic vasculature. 
 
Renal system 
Renal vein compression increases venous resistance, which impairs venous outflow (41). 
Renal artery vasoconstriction is induced by the sympathetic activity and renin-angiotensin 
systems, resulting from decreased cardiac output (42). These factors result in progressive 
reduction of urine output. 
 
Gastro-intestinal system 
Intra-abdominal pressure induced splanchnic perfusion, reduced cardiac output and 
increased splanchnic vascular resistance, results in gut ischemia and infarction (19, 43, 44). 
As a consequence, toxins, bacteria, and undigested food particles may pass the enterocyte 
layer, enter the underlying vasculature, and trigger systemic inflammatory reactions that 
may progress to multiple organ dysfunction syndrome and even death. These interstitial 
effects are thought to be the first to occur (24). A possible central role of the intestines in 
the development and outcome of IAH and ACS is studied in this thesis. 
 
Clinical presentation 
Typically, a patient with primary ACS suffers from a severe traumatic abdominal bleeding 
undergoes massive transfusion and laparotomy. After surgical hemostasis the abdominal 
wall is closed, patients are subsequently admitted to the ICU for stabilization and 
resuscitation (45, 46). Deterioration can lead to acidosis, coagulopathy and hypothermia. 
These three physiological disturbances aggravate each other independently, leading to a 
‘vicious circle of death’. This will lead to shock, intestinal edema, and increased IAP, 
especially if tight abdominal packs are left (47). When not taken back to theatre for 
decompression, ACS emerges and most of these patients die. Secondary ACS is seen in 









a result of massive bleeding outside the abdomen and a subsequent need for large volume 
resuscitation and transfusion, e.g. after a major pelvic injury (48). The resulting increase in 
IAP in these patients will lead again to the same vicious circle of death. This presentation 
of secondary ACS is also seen in patients with severe pancreatitis and burns, emphasizing 
the crucial role of fluid resuscitation in its development (49-51). 
 
Diagnostics 
The diagnosis of IAH/ACS requires measurement of IAP. Measurements should be 
performed routinely and repeatedly among high-risk patients in the ICU (17). Pressure can 
be measured directly by an intra-abdominally positioned catheter or indirectly by 
measurement of abdominal wall resistance and by using intra-gastric, intracolonic, intra-
vesical (bladder), or inferior vena cava catheters (52-54). Measurement of bladder (i.e., 
intra-vesical) pressure is the standard method to screen for IAH/ACS. It is simple and 
cheap because a standard urinary catheter can be used, it is accurate, but care must be 
taken to ensure consistent head and body positioning from one measurement to another. 
Intra-abdominal pressure is measured via the patient's Foley (bladder) catheter after 
instilling up to 25mL of sterile saline. The catheter is attached to a pressure transducer 
and the pressure is measured at end-expiration in the supine position after ensuring that 
abdominal muscle contractions are absent. The transducer should be zeroed at the level 
of the midaxillary line. Commercially available systems have also been developed to 
simplify measurement. The correlation between bladder pressure and directly measured 
IAP is strong (55). As accurate measurement of IAP requires free movement of the bladder 
wall, the bladder pressure is not reliable in the presence of intraperitoneal adhesions, 
pelvic fractures, bladder oppressive hematomas, abdominal packs, or a neurogenic 
bladder (52).  
 
For diagnosis of ACS, new organ failure has to be confirmed. No strict criteria for new 
organ failure are used. In a clinical setting, a deterioration of a patients’ condition at the 
time of peak IAP (above 20 mmHg) is enough to suspect ACS. However, it is challenging to 
distinguish whether or not new organ failure results from the increased pressure or as a 
result of the underlying condition (e.g. pancreatitis related SIRS). Abdominal 





For research purposes, scoring of new organ failure is mostly done based on the 
standardized organ failure assessment (SOFA) score (56). This scoring system is developed 
and validated for tracking a patients’ condition during ICU admission (57). The scoring 
system consists of six sub-domains for the respiratory, cardiovascular, hepatic, 
coagulation, renal, and neurological system. Every sub-domain can be scored from 0 to 4 
depending on defined clinical, laboratory, or treatment related variables. The SOFA score 
can be calculated once a day. A significant increase in one sub-score at the time of peak 
IAP (above 20 mmHg), would confirm ACS. But as individual patients have different 
capacities in overcoming the effects of IAH, no specific criterion of organ failure or cut-off 
level of IAP is sufficient for a definitive diagnose of ACS.  
 
Although not generally accepted, radiologic findings can be helpful for diagnosing of 
guiding therapy for ACS (58). A round belly sign on Computed Tomography (CT) is 
suggestive for ACS, and narrowing of upper intra-hepatic IVC (defined as IVC diameter < 
3mm on two or three consecutive CT images), and renal displacement are seen among 
patients with ACS (59). CT and ultrasound can also be helpful for the localization of fluid 
collections; guided drainage can be therapeutic as well. Plain radiographs or magnetic 
resonance imaging have no value in diagnosing or evaluating ACS.  
 
All these available diagnostics have their own value in the work up for IAH and ACS, but 
unfortunately none is indicative for short term or long term adverse outcomes. The level 
of IAP, duration of IAH, or the number of failing organs have no absolute predictive value 
for the outcome of treated or untreated IAH or ACS. Therefore, they do not provide 
definitive answers whether or not to open the abdomen. New diagnostic tools for that aim 












Evidence based treatment algorithms for IAH/ACS are available at the website of WSACS. 
These algorithms summarize the updated WSACS guidelines of 2013 (17). The most 
important features are discussed below. 
 
The first steps in management can start as soon as IAH/ACS is recognized. Determination 
of increased IAP is easy; identification that the patient has an IAP-related problem is very 
challenging. Early recognition of a problem however can improve the patients’ outcome 
significantly. The WSACS algorithm starts with non-invasive and low risk therapies. 
Whether these measures are effective depends on the patient. As IAH can rapidly develop 
into devastating ACS, a repeated evaluation of the effect of a given treatment is of key 
importance. Sequential measurement of IAP every four to six hours is advocated. 
 
If a patient has developed IAH without signs of organ failure, non-invasive or minimally 
invasive measures are feasible. Conservative treatment of IAH focuses on five points. 
Evacuation of intra-luminal content, evacuation of intra-abdominal space occupying 
lesions (for example radiologic drainage of fluid collections), improvement of abdominal 
wall compliance (sedation and relaxation), optimizing of fluid balance and optimizing 
systemic or regional perfusion (for example goal-directed resuscitation). Some of the 
newer treatments such as tissue plasminogen activator assisted evacuation of 
retroperitoneal hematoma, theophylline infusions to reduce circulating adenosine 
concentrations, octreotide for limitation of reperfusion injury, and continuous negative 
extra-abdominal pressure (CNAP) to reduce IAP, are all promising treatment options for 
specific patient populations. Future studies are warranted to confirm some of these 
findings (60). 
 
When prevention of ACS is not possible, surgical decompression of the abdomen is 
warranted, leaving the abdomen open afterwards. Although generally accepted and 
advocated by WSACS as treatment of choice, it is still associated with high morbidity, 
closure problems and high costs (61). On the other hand, the long term outcome of 







Intra-abdominal hypertension (IAH) causes tissue hypoperfusion, which may lead to multi-
organ failure, and death. The effect of decompressive laparotomy on outcomes in patients 
with abdominal compartment syndrome is not well studied. Although IAH is not a 
predictor of multi organ failure per se, mortality for patients who have progressed to ACS 
is high, ranging from 40 to 100 percent (26, 63). A prospective cohort study included 33 
adult patients who underwent decompressive laparotomy, showed an overall 28-day 
mortality of 36%, and 55% at one year (64). Thus, outcome for patients with ACS is very 
bad. Whether or not modern treatment options have resulted in lower prevalence and 
mortality remains unknown and is one of the study questions of this thesis.  
 
Prediction of IAH, ACS, and related outcome 
A large prospective cohort of patients with severe trauma identified hemoglobin 
concentration, central venous-to-arterial carbon dioxide difference (CO2 GAP), 
temperature, base deficit, administered crystalloid volume and urinary output as early 
predictors for both primary and secondary ACS (24). Clinically, primary and secondary ACS 
both have the same presentations (IAH and organ dysfunction). However, injury patterns, 
resuscitation, and causes can differ. Analogous to this, predictors of primary ACS also 
include factors indicative of damage control management, and secondary ACS has 
features of high resuscitation volumes. Although gastric mucosal acidosis (measured by 
tonometry) is a sensitive and independent predictor of ACS, this method is not used in 
clinical practice. Accurate prediction of IAH-related adverse outcomes and ACS, would be 
a final step in prevention of these complications. Nevertheless, a valid predictive tool is 
not yet available. 
  
Aim of this thesis 
The aim of this thesis is to (1) determine the current understanding and management 
strategies of IAH/ACS among surgeons, (2) determine risk factors for primary, secondary 
and recurrent ACS, (3) determine current prevalence and outcome in recent literature, 
following implementation of up to date management guidelines, and (4) identify a 











Outline of this thesis 
The first part is this thesis outlines the problem of IAH and ACS, and gives an overview of 
current clinical practice. Chapter 1 is the introduction of this thesis in which clinically 
relevant literature regarding recognition, management and outcome with IAH/ACS is 
summarized. Whether or not up to date practices for patients with these conditions were 
known or implemented is demonstrated in Chapter 2. This chapter describes the 
outcomes of a questionnaire survey among surgeons in Dutch hospitals. 
 
Part two of this thesis contains four manuscripts describing epidemiologic data of IAH/ACS 
of specified patient groups. Chapter 3 describes a retrospective study of patients who 
have undergone trauma laparotomy in a level 1 trauma center in Australia. The aim of this 
study was to identify risk factors for high-grade IAH (an IAP >20 mmHg). A comparison was 
made between characteristics of patients who developed high-grade IAH following trauma 
laparotomy versus those patients who did not. In Chapter 4, the authors determined the 
prevalence and mortality rate of ACS among severely injured patients. A systematic review 
and data pooling of all available literature was performed for this. Data of studies 
performed before and after introduction of the WSACS guidelines were compared. 
Chapter 5 describes a systematic review and meta-analysis which determined the 
prevalence and outcome of IAH and ACS among severe burn patients. This systematic 
review also provides an overview of management options for these patients as found in 
literature. In Chapter 6, data of a prospective observational study of 58 patients with 
severe burn injuries admitted to two burn centers in the Netherlands (BURNIAH study) are 
presented. The aim of this study was to determine the prevalence and outcome of IAH 
among patient’s adult patients with burn injuries ≥15% of total body surface area (TBSA). 
Also, urinary Intestinal Fatty Acid Binding Protein (I-FABP biomarker) was tested as 
potential predictor for IAH and ACS and early marker for related adverse outcomes. 
 
The third part of this thesis contains three studies that investigate the usefulness of 
potential biomarkers as predictors for IAH, ACS and related adverse outcomes. The first 
two chapters of this part describe the I-Fabulous study. This is the largest prospective 
multi-center cohort study up to date of 198 patients with two or more risk factors for 
IAH/ACS admitted to the ICU. The aim of this study was to determine the usefulness of 




adverse outcomes. Chapter 7 is the published protocol of this study. In Chapter 8, the 
outcomes of the study are presented. The outcomes of an experimental model of IAH in 
rats were describes in Chapter 9. This study aimed to determine the relation between IAP 
and respiratory parameters, hemodynamic parameters, and the development of early 
intestinal ischemia in rats. Also, serum albumin-cobalt binding ACB capacity was tested as 
early marker for IAH related intestinal ischemia. 
Part four of this thesis serves as a discussion of the chapters and summarizes most 
relevant outcomes. Chapter 10 is the general discussion with future perspectives. 
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Purpose: Intra-abdominal hypertension (IAH) and Abdominal compartment syndrome 
(ACS) are relatively rare, but severe complications. Although many advances were made in 
recent years, the recognition and management remains subject of debate. The aim of this 
study was to determine the current state of awareness, knowledge and use of evidence-
based medicine regarding IAH and ACS among Dutch surgeons. 
 
Methods: A literature-based and expert consensus survey was developed. One surgeon in 
every hospital in The Netherlands was asked to complete the online questionnaire. 
 
Results: Sixty of 87 (69 %) invited surgeons completed the questionnaire. Intra-abdominal 
pressure (IAP) was measured using intra-vesical methods by 55 (98 %) respondents. 
Diuretics (N = 38; 63 %) and laparotomy (N = 33; 55 %) were considered useful treatments 
for IAH or prevention of ACS by a majority. Only 16 (27 %) respondents used evidenced 
based (WSACS – Abdominal Compartment Society) guidelines in daily practice and 37 (62 
%) respondents are willing to do so. Although 35 (58 %) surgeons agreed that IAH is only a 
symptom, not requiring treatment. Forty-one percent of experienced respondents 
suggested that prevalence of ACS remained unchanged. Nearly all respondents (N = 59; 98 
%) believed that open abdomen management improves patient outcomes, many (N = 46; 
77 %) confirm the high complications rate of this treatment. 
 
Conclusion: The definitions of IAH and ACS and the related diagnostic and therapeutic 
challenges are relatively well known by Dutch surgeons. Despite limited use of the 
evidence-based guidelines, the willingness to do so is high. Most respondents favor open 
abdomen treatment for patients with imminent ACS, despite the high complication rates 











Abdominal compartment syndrome (ACS) is a severe, but relatively rare complication. IAH 
is more common and can proceed into ACS in some of cases. Over recent years many 
advances regarding the recognition and management of ACS have been made. 
Nonetheless, randomized controlled trials on the subject are still scarce. Current 
management of ACS is based upon the up-to-date, evidence-based recommendations 
provided by the World Society of the Abdominal Compartment Syndrome (WSACS) (1). 
The strength of these recommendations is of varying quality. As a result, the management 
of ACS is still subject of debate and differs across hospitals. 
Multiple studies have been conducted to identify the then current state of awareness, 
knowledge and use of evidence-based medicine regarding IAH and ACS. One of the most 
noticeable findings of these studies was that the awareness of IAP measurements and 
treatment options of IAH and ACS was generally low (2-9). In addition, cut-off points for 
treatment of ACS are poorly known or understood (3, 10-13). There is little agreement on 
the indications for open abdomen treatment and what type of temporary abdominal 
closure devices should be used (14-18). Most recent studies conclude that awareness 
among health care providers improved over recent years, but guidelines are still not 
uniformly applied or knowledge was inadequate (19-21). 
The most recent survey was performed in 2010. Since then, new developments, such as 
the introduction of updated WSACS guidelines in 2013, may have improved outcome. 
Quality of previous questionnaires was variable. The response rates of these 
questionnaires ranged from 26 to 90 %. Other limitations were duration of more than 2 
years and most studies were carried out by a wide variety of health care workers. Only six 
specifically focused on surgeons, yet surgeons ultimately decide whether or not to apply 
an open abdomen decompression (2-4, 8, 14, 15). No comparable surveys have been 
performed in The Netherlands. 
 
The primary aim of this study was to identify the current state of awareness, knowledge 
and use of evidence-based medicine regarding IAH and ACS among Dutch surgeons. 
Secondary aims were to identify the current annual number of ACS cases per hospital and, 






This questionnaire study was conducted and reported in accordance with the guidelines 
for survey research of Bennett, et al.(22).  
 
Ethical statement 
The current study used data that were obtained from surgeons using a survey. The 
questionnaire was anonymous. An independent officer of data and privacy protection in 
our hospital reviewed the survey procedure and confirmed that participants’ anonymity 
was protected. Since patients were not involved in the study, the institutional Medical 
Research Ethics Committee did not have to review the protocol. 
 
Questionnaire 
The questionnaire was based upon a previously published questionnaire by the WSACS 
study group (21). Key questions were adopted and response options were added to make 
them more up-to-date. The questionnaire was drafted in Dutch and pretested by a panel 
of five experts and critically appraised on relevance, completeness, and style (OJFVW, 
MHJV, RSB, DHB, and KAK). The final version of the structured questionnaire consisted of 
five parts with a total of 29 questions; one part for participant’s information and four parts 
for questions related to (1) IAP measurement, (2) IAH, (3) ACS, (4) open abdomen 
treatment and abdominal closure techniques. The full questionnaire is available in English 
(Appendix 1). 
 
Selection of respondents 
Surgical department of all Dutch hospitals with ICU facilities (N = 87) was asked to provide 
the name of the surgeon with the most ICU affinity. If a hospital had multiple locations 
with ICU facilities, only one surgeon was selected. All named surgeons were approached 
by telephone and informed about the purpose and method of the survey. Since one 
surgeon in every hospital throughout the country was selected, the targeted group of 
surgeons was presumed a representative cross-section of the care which patients in The 
Netherlands receive. Dutch surgical departments are relatively well informed and the rate 









therefore applicable for to Western European standards. For this survey, a sample size 
calculation was considered unnecessary. 
 
Distribution of survey 
The questionnaire was distributed online using LimeSurvey software [Version 2.05+, 
LimeSurvey Project Team, Carsten Schmitz (2015), LimeSurvey Project Hamburg, 
Germany]. After obtaining verbal informed consent, a link to the questionnaire with 
unique and secure access codes was sent by email. This first invitation was sent on January 
29, 2015. Reminders were sent every 2 weeks until the survey was closed on April 13, 
2015. An opt-out link was clearly marked, the questionnaire could also be sent by mail or 
email if requested. 
 
Data 
Data were stored online by a secured function of the software used. Following survey 
closure, data were downloaded to an SPSS file. Questionnaires that were completed on 
paper were entered manually into the SPSS database. Only complete data sets were 
included in the analysis. 
 
Analysis 
All data were of categorical nature and are shown as numbers with corresponding 
percentages. Descriptive analysis was performed in SPSS version 21.0 (SPSS Statistics for 
Windows, Released 2012, Armonk, New York, IBM Corporation). No comparisons were 
made with previously performed surveys since differences between questionnaires and 







Sixty surgeons completed the questionnaire (response rate: 69 %). Ten partial responses 
were excluded. Most respondents had a primary focus on trauma surgery (N = 29; 48 %) or 
oncological surgery (N = 20; 33 %) (Figure 1). The majority (N = 38; 63 %) had over 10 years 
of surgical experience and more than half of respondents worked in a general teaching 
hospital (N = 34; 57 %). 
 
Intra-abdominal pressure measurements 
Intra-abdominal pressure measurements were performed in 58 (96%) of the hospitals of 
respondents. Forty-seven (78%) respondents claimed to know the difference between IAH 
and ACS, and 57 (95%) respondents had seen at least one patient with ACS in their 
hospital. 
Fifty-five (98%) respondents use intra-vesical methods for IAP measurement. The largest 
group of respondents (N=14; 25%) measures intra-abdominal pressure three times daily 
on average (Figure 2). 
Forty-nine (88%) respondents waits with measuring of IAP until there is a clear suspicion 
for ACS and 22 (39%) respondents start measurements as soon as risk factor(s) for ACS are 
identified (Figure 3).  
 
Intra-abdominal hypertension 
Forty-two (70%) respondents claimed to use the definition of IAH as set by the WSACS 
(Table 1). Of the seven treatment options listed, only diuretics (N=38; 63%) and 
laparotomy (N=33; 55%) were considered very useful or fairly useful by the majority of 
respondents (Figure 4). Thirty-five (58%) respondents agreed to the statement that IAH is 
only a symptom and as such needs no treatment. 
 
Abdominal compartment syndrome 
For ACS, the majority of respondents (N=31, 52%) used the definition as proposed by the 










Most respondents (n=33; 55%) were not familiar with the WSACS guidelines for the 
treatment of ACS. Whereas 27 (45%) respondents were familiar with the guidelines, only 
16 (27%) actually implemented them in daily practice. Another 37 (62%) respondents plan 
to do so in the future (Table 2). A minority (n=6; 10%) disputes that the guidelines improve 
outcome of patients with ACS. Eighteen (30%) respondents answered that patients with 
ACS should be treated with surgical decompression in 76% to 100% of cases in their 
hospital (Figure 6). Another 18 (30%) indicated that this was done in 51-75% of cases.  
The vast majority of respondents considered these factors useful or had no clear opinion 
on the usefulness (Figure 7). A large group (N=26; 43%) stated that a superior indicator for 
surgical decompression would be a useful addition in to clinical practice (Table 3). 
 
The mortality rate of patients with ACS who are not treated with surgical decompression 
was estimated between 26% and 50% by 18 (30%) respondents and between 51% and 
75% by 22 (37%) respondents (Figure 8). If patients with ACS were treated with surgical 
decompression, the largest group of respondents (N=28; 47%) estimated a mortality rate 
of 10 to 25%.  
 
Open abdomen treatment and abdominal closure techniques 
Fifty-three (88%) respondents considered surgical abdominal decompression useful in the 
prevention of ACS (Table 4). However, the majority felt that ACS may not always be 
prevented.  
The respondents were asked which factors would affect their decision whether or not to 
close the abdomen after surgical decompression. Most respondents answered that an 
increase in ventilation pressures is either useful (N=36; 60%) or very useful (N=12; 20%) in 
this decision (Figure 9). In addition, tension on the abdominal wall while closing the 
abdomen, planned reoperation, application of abdominal packings, hemodynamic 
instability at closure and visceral edema were considered by the majority of respondents. 
If primary closure is not possible, several devices are available for temporary closure. 
Among the respondents, application of a Vicryl® mesh was the most popular method for 
temporary closure, chosen by 38 (63%) respondents (Table 5). Many respondents selected 
multiple methods of temporary closure, 22 (37%) respondents selected two methods and 




The largest group (n=27; 45%) of respondents prefers definitive abdominal closure in 
multiple stages (Table 6). An almost equally large group (n=26; 43%) prefers the 
component separation technique.  
Almost all respondents (n=59; 98%) believed that open abdomen management improves 
patient outcomes, although many (n=46; 77%) acknowledged a high complication rate 
associated with open abdomen management (Table 7). Only one respondent stated that 
the possible positive effects of open abdomen management do not outweigh the 











This study is the first survey detailing awareness, knowledge, and use of evidence-based 
medicine and outcome regarding intra-abdominal hypertension and abdominal 
compartment syndrome among Dutch surgeons. The definitions of the WSACS are well 
known now, but the clinical practice guidelines of this society are still waiting to be 
implemented in hospitals. Much disagreement exists today with respect to treatment and 
outcome of intra-abdominal hypertension and abdominal compartment syndrome among 
Dutch surgeons. 
 
Ninety-five percent of respondents had previously treated a patient with ACS in their 
hospital. This was in line with the 97 % reported by Tiwari, et al. (12). IAP measurements 
were regularly performed in 96 % of the participating hospitals, which was markedly 
higher than the 31–47 % reported in other surveys (4, 5). The frequency of IAP 
measurements, however, varied greatly among hospitals. In 13 (23 %) hospitals, IAP was 
measured less than once per 24 h. This frequency is rather low since IAP related morbidity 
can potentially develop or progress within a few hours (23). 
There is still no consensus on the management of IAH and ACS. Although many 
respondents believed that IAH is only a symptom which does not necessarily needs to be 
treated, several different treatment options for IAH to prevent ACS were considered 
useful. For example, the use of diuretics and laparotomy are considered valuable. The 
majority of respondents were indifferent about other treatment options or regarded them 
as useless. This indifference about IAH treatment has previously been noted by Kimball, et 
al. (2).  
Most respondents (88 %) think that surgical decompression could prevent ACS and 
improve patient outcomes. This is markedly higher than the 60 % of respondents who 
would recommend decompression laparotomy as reported by Zhou, et al.(9). Despite 
several indicators for surgical abdominal decompression were believed to be useful, 43 % 
of our respondents felt the need for a superior indicator. 
 
There is disagreement between respondents and literature regarding temporary 
abdominal closure (TAC) devices. Respondents reported to prefer mesh assisted TAC. 




(24). Definitive closure techniques ideally bring the edges of the abdominal fascia together 
primarily (primary closure). If this is not feasible, simple coverage or functional closure can 
be provided. These latter techniques are generally regarded as inferior with respect to 
patient outcome. Respondents seem to be aware of this, since they mostly preferred 
staged abdominal closure, followed by the component separation closure technique.  
The vast majority of respondents were convinced of the necessity of open abdomen 
treatment for patients with imminent ACS, even though they were aware of the high 
complication rate associated with this treatment. Apparently they estimate that benefits 
of open abdomen treatment outweigh the chance of complications. This statement is 
confirmed by the presumed mortality reduction as result of open abdomen 
decompression as demonstrated in Figure 8. The current study confirms there is a large 
support for this treatment, even though there is disagreement recent literature regarding 
the benefits of open abdominal decompression in pancreatitis patients with ACS (25, 26). 
  
 
The strength of the current study is its robust methodology. The survey was based on 
previous questionnaires, was developed by an expert group, and was repeatedly 
pretested. Surgeons were kindly, but persistently urged to participate. The online software 
enables swift responding and easy data collection. The nationwide coverage of this survey 
is also considered a strength. 
 
Taken into account the 10 incomplete responses, the response rate of 69 % was fairly 
high. This number is at the upper end of response rates of the previously performed 
surveys on IAH and ACS (range 26–90 %) (2-21).  
 
The skewed distribution of the primary focus of respondents can be regarded a limitation 
of this study, but is representative of the clinical practice in The Netherlands. The 
overrepresentation of trauma surgeons and oncological surgeons may be the result of the 
connection between these sub-specializations and intensive care medicine. It was, 
however, not the intention to approximate a cross-section of all Dutch surgeons, but 
rather of the care patients actually receive. Assuming that patients will usually be treated 
by a physician with the most relevant knowledge and experience, we are convinced that 









with the largest relevant experience and knowledge. Another shortcoming is that the 
estimation of change in ACS occurrence over the last 10 years could be subject to recall 
bias. Although this was an important question, its outcomes were likely to be inaccurate. 
For example, six respondents indicated that a decrease in ACS incidence did not occur, 
while they ticked a lower number of cases category for last year compare than for 10 
years ago (Table 2). However, this question does give insights in the perception of the 
experienced surgeon. 
 
The overall knowledge and implementation of WSACS recommendations were lower than 
expected. This may be due to the fact that the vast majority of the respondents received 
their surgical training before the WSACS guidelines were developed. ACS treatment is 
currently implemented in these training programs. The results of the current study and 
the implementation in surgical training programs should result in increased awareness in 
the future. 
 
In conclusion, the definitions of IAH and ACS and related diagnostic and therapeutic 
challenges are relatively well known among Dutch surgeons. Although use of the WSACS 
guidelines is currently limited, the willingness to do so is large. The vast majority of 
respondents are convinced of the necessity of open abdomen treatment for patients with 
imminent ACS, even though this treatment is associated with high complication rates. To 
decrease the complication rate, many respondents support the need for a superior 




Prof.dr. Roelf S. Breederveld (trauma surgeon, Rode Kruis Ziekenhuis, Beverwijk, The 
Netherlands), Dr. Desiree H. Burger (surgeon-intensivist, St. Elisabeth Ziekenhuis, Tilburg, 
The Netherlands), and Dr. Karel A. Kolkman (trauma surgeon, R Rijnstate Ziekenhuis, 
Arnhem, The Netherlands) are acknowledged for their assistance and efforts as expert in 




Figure 1. Primary focus of respondents 
 
Primary focus of respondents is arranged on the y-axis from highest to lowest frequency. 




Figure 2. Number of IAP measurements performed daily in the individual patient 
 










Figure 3. Percentage of patients in which IAP measurements are performed more or less 
routinely (patients with or after a/an:) 
 
Percentages of all respondents are shown in the bars. 
 
 
Table 1. Used definition for IAH (not ACS)  
  N % 
An IAP of ≥ 12 mmHg, as stated by the WSACS 42 70 
An IAP of > 18 mmHg 1 2 
An IAP of > 20 mmHg 1 2 
Ongoing or increasing IAP at multiple measurements  1 2 




Figure 4. Usefulness of treatments for IAH in order to prevent ACS 
 
Therapy options are arranged from highest to lowest summed percentage of very useful 
and fairly useful. Percentages of all respondents are shown in the bars. 
 
Figure 5. Definition used for ACS (not IAH, an IAP of:) 
 









Table 2. Implementation of WSACS guidelines and recommendations for treatment of 
Abdominal Compartment Syndrome 
 
  N % 
This guideline is used 16 27 
This guideline is not used but implementation is favored in the near future 37 62 
This guideline is not used because it presumably does not improve the outcome of 
patients 6 10 




Figure 6. Number of ACS patients per hospital, treated with a surgical abdominal 
decompression 
 




Figure 7. Usefulness of factors in deciding for surgical abdominal decompression (in 
addition to intra-abdominal pressure) 
 
Factors are arranged from highest to lowest summed percentage of very useful and fairly 
useful. Percentages of all respondents are shown in the bars. 
 
Table 3. Need for superior indicators of abdominal decompression (for example a serum 
marker of hypo-perfusion of abdominal organs)  
 N % 
Yes, there is a need for superior indicators 26 43 
I do not know / no opinion 26 43 











Figure 8. Estimated mortality rate among patients with ACS 
 
Percentages of all respondents are shown in the bars. 
 
Table 4. Open abdominal treatment prevents ACS 
  N % 
Yes, always 16 27 
Yes, but not always 37 62 
I am not sure 6 10 





Figure 9. Usefulness of factors in deciding not to close the abdomen after surgical 
decompression 
 
Factors are arranged from highest to lowest summed percentage of very useful and fairly 
useful. Percentages of all respondents are shown in the bars. 
 
Table 5. Used temporary abdominal closure method or devices  
 N % 
Mesh placement (Vicryl®)  38 63 
Bogota / silo bag 28 47 
Abdominal VAC 14 23 
Vacuum pack  14 23 
Only closure of the fascia 3 5 
Closure of the skin (with surgical clamps) 3 5 
Closing of the skin with thick suture 1 2 
Regular gauze cover 1 2 










Table 6. Used definitive abdominal closure method 
 N % 
Staged closure of the abdomen 27 45 
Component separation technique 26 43 
Absorbable mesh 22 37 
Complete closure of fascia and skin 21 35 
Only closure of the fascia 20 33 
Non-absorbable mesh 17 28 
ABRA system 12 20 
Only closure of the skin 5 8 
Delayed hernia 1 2 
Dual mesh 1 2 
Try to prevent non-resorbable materials 1 2 





Table 7. Reply to statement: “Open abdomen treatment improves the outcome of 
patients with ACS” 
  N % 
Agree 13 22 
Agree, but open abdomen treatment is associated with many complications 46 77 
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ABSTRACT 
Background: Abdominal Compartment Syndrome (ACS) is an uncommon but deleterious 
complication after trauma laparotomy. Early recognition of patients at risk of developing 
ACS is crucial for their outcome. The aim of this study was to compare the characteristics 
of patients who developed high-grade intra-abdominal hypertension (IAH) (i.e., grade III or 
IV; intra-abdominal pressure, IAP >20 mmHg) following an injury-related laparotomy 
versus those who did not (i.e., IAP ≤20 mmHg). 
Methods: A retrospective analysis of consecutive trauma patients admitted to a level 1 
trauma center in Australia between January 1, 1995 and January 31, 2010 was performed. 
A comparison was made between characteristics of patients who developed high-grade 
IAH following trauma laparotomy versus those who did not. 
Results: A total of 567 patients (median age 31 years) were included in this study. Of these 
patients 10.2% (58/567) developed high-grade IAH of which 51.7% (30/58) developed ACS. 
Patients with high-grade IAH were older (p<0.001), had a higher Injury Severity Score 
(p<0.001), larger base deficit (p<0.001) and lower temperature at admission (p=0.011). In 
the first 24 hours of admission, patients with high-grade IAH received larger volumes of 
crystalloids (p<0.001), larger volumes of colloids (p<0.001) and more units of packed red 
blood cells (p<0.001). Following surgery prolonged prothrombin (p<0.001) and partial 
thromboplastin times (p<0.001) were seen. The patients with high-grade IAH suffered 
higher mortality rates (25.9% (15/58) vs. 12.2% (62/509); p=0.012). 
Conclusion: Of all patients who underwent a trauma laparotomy, 10.2% developed high-
grade IAH, which increases the risk of mortality. Patients with acidosis, coagulopathy, and 
hypothermia were especially at risk. In these patients, the abdomen should be left open 
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INTRODUCTION 
Trauma is the leading cause of death in people aged 1 to 44 years and exsanguination is a 
common cause of death (1). Such active bleeding focus is frequently located intra-
abdominally (2). In patients presenting to hospital following severe injury, hemodynamic 
instability or acute abdominal findings can mandate laparotomy. Laparotomy in this 
setting may be lifesaving.  
Despite improved survival following laparotomy, patients are still at risk of developing 
abdominal compartment syndrome (ACS) (3, 4). ACS is a syndrome of intra-abdominal 
hypertension (IAH) with new onset or worsening organ failure. The World Society of the 
Abdominal Compartment Syndrome (WSACS) defines ACS as an intra-abdominal pressure 
(IAP) >20 mmHg with clinical signs of new organ failure, such as renal failure or increasing 
ventilation difficulties (5, 6). ACS is termed primary when it originates from intra-
abdominal pathology, secondary when originating from an extra-abdominal source and 
tertiary or recurrent when ACS occurs in an already decompressed abdomen (7). WSACS 
defines IAH as an IAP ≥12 mmHg and introduced an IAH grading system for increasing 
severity with grades from I to IV (8). Grade I (IAP 12-15 mmHg) and II (IAP 16-20 mmHg) 
are referred to as low-grade IAH and Grade III (IAP 21-25 mmHg) and IV (IAP> 25 mmHg) 
are referred to as high-grade IAH. IAH and ACS result from decreased abdominal wall 
compliance and/or increased intra-abdominal volumes (fluid, edema).  
ACS in isolation is generally treated through medical means or by decompressing the 
abdomen. The resulting laparostomy can be kept open for several days to a week using a 
temporary abdominal closure technique (TAC) (9). Surgeons can consider using TAC 
following trauma laparotomy when a patient is likely to develop IAH or ACS. However, a 
prolonged open abdomen is associated with higher morbidity including intra-abdominal 
infections, sepsis, anastomotic leakage, intestinal fistulae and sepsis (10-13). Knowledge of 
specific risk factors for IAH or ACS following trauma laparotomy may help the surgeon to 
mitigate these risks and improve outcomes. The aim of this study was to compare 
characteristics of patients who developed high-grade IAH following trauma laparotomy 
versus those patients who did not.
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METHODS 
A retrospective analysis was performed on trauma patients who underwent trauma 
laparotomy in a level I trauma center in Australia. This trauma center serves over 1 million 
inhabitants and admits more than 350 trauma patients annually with an injury severity 
score (ISS) greater than 15 (14). Data of admitted trauma patients were prospectively 
collected by trained trauma nurse coordinators (15). This registry has been recording more 
than 154 different variables for seriously injured patients, and has done so since 1994. 
Consecutive trauma patients who underwent trauma laparotomy within 24 hours of 
admission between January 1, 1995 and January 31, 2010 were included. Trauma registry 
data were collected as was information from clinical notes. This study was approved by 
the hospital’s Human Research Ethics Committee.  
Data collection included patient demographics, IAP’s, information on organ function and 
diagnosis of ACS, abdominal decompression, ISS, shock, mechanism of injury, temperature 
on admission, lactate, base deficit, pH, hemoglobin level, resuscitation fluid(s), 
resuscitation volume, survival, and ICU/hospital lengths of stay. IAH and ACS were defined 
in accordance with the WSACS guidelines (6). Data were complete, unless specified 
differently in the Table footnotes. 
Data were analyzed using SPSS version 16 (SPSS Inc. Released 2007. SPSS for Windows, 
Version 16.0. Chicago, SPSS Inc.). Youden index was analysed using MedCalc version 
14.10.2 (MedCalc Software, Ostend, Belgium). Inspecting frequency histograms and Q-Q 
plots revealed that the majority of continuous variables deviated from a standard normal 
distribution. Therefore, all continuous variables were regarded as non-normal and are 
shown as median values with first and third quartiles. Differences between patients with 
versus without high-grade IAH were tested using a Mann-Whitney U-test (continuous 
variable), a Fisher’s exact test or Chi-squared test (categorical variables). Binary logistic 
regression analysis was performed in order to determine the strength of the association 
between covariates (independent variables) and the IAH grade (dependent variable; high-
grade versus no high-grade IAH). Odds Ratios are presented with 95% confidence 
intervals. The Hosmer-Lemeshow test statistic (Chi-squared value) with corresponding p-
value is given as measure of model calibration, and the area under the Receiver Operating 
Characteristic (ROC) curve is provided as measure of discriminatory power. The Youden 
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between the ROC curve and the diagonal line, was calculated in order to determine at 
which value of the evaluated variable the sum of sensitivity and specificity had the highest 
value. The Youden index was shown with its 95% confidence interval following 
bootstrapping (1,000 replicates and 900 random-number seeds). For continuous variables 







Over a 16-year period 583 trauma patients presented to the emergency department and 
underwent trauma laparotomy. Of these patients, 16 underwent trauma laparotomy more 
than 24 hours following admission or were pregnant and therefore were not included in 
the study. 
 
Baseline characteristics of the 567 included patients are shown in Table 1. Patients had a 
median age of 31 years, the majority of these patients were male, two-thirds sustained 
blunt injury and less than half had circulatory shock (defined by SBP < 90 mmHg) at the 
time of presentation to the emergency department. Of the included patients 10.2% 
(58/567) developed an IAP >20 mmHg, of which 51.7% (30/58) developed ACS. In order to 
compare characteristics and potential risk factors for ACS following trauma laparotomy, 
patients were divided into two separate groups; patients with an IAP ≤20mmHg (no high-
grade IAH, N=509) and patients with an IAP >20 mmHg (high-grade IAH, N=58). The 
patients with high-grade IAH following trauma laparotomy were older (p<0.001), had a 
higher injury severity score (ISS; (p<0.001) and were more frequently in circulatory shock 
at presentation (p<0.001). Blunt abdominal trauma mechanisms were relatively more 
frequently seen in the high-grade IAH group than penetrating trauma mechanisms 
(p=0.012). Of the baseline characteristics investigated, higher age, higher ISS, being 
presented in circulatory shock, or having sustained blunt trauma increased the odds of 
developing a high-grade IAH (Odds Ratio, OR, 1.05, 1.03, 4.51, and 2.38, respectively). 
 
Of the 567 laparotomies performed, immediate abdominal closure was undertaken in 479 
(84.5%) patients; the abdomen was not immediately closed in 80 patients. The remaining 
8 patients died during surgery or the data set could not be completed (Figure 1). Following 
immediate abdominal closure, 7.1% (34/479) developed high-grade IAH, of which 41.2% 
(14/34) developed ACS. In the group where the abdomen was not closed immediately, 
30.0% (24/80) developed high-grade IAH, of this group 62.5% (15/24) still developed ACS 
either before or after delayed abdominal closure. In 20.8% (5/24) of patients who did not 
have immediate abdominal closure and developed high-grade IAH, delayed primary 
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Confidence Interval, CI 38-96%), which was substantially more than the 31.6% of patients 
(6/19; 95% CI 15-54%) in whom early delayed primary closure was possible (p=0.150). 
A total of 57 re-laparotomies were performed in the 479 patients in whom the abdomen 
was directly closed; 38 in the group without high-grade IAH (8.5%; 38/445) and 19 in the 
high-grade IAH group (55.9%; 19/34). No significant association was found with mortality; 
mortality rates were 12.3 % (7/57) in patients who had a re-laparotomy versus 7.3% 
(31/422) in patients who did not (p=0.300). 
Physiologic and fluid resuscitation parameters were identified as possible risk factors for 
high-grade IAH by determining values of these parameters at admission and 
approximately 6 hours after surgery (Table 2). Patients who developed high-grade IAH 
following trauma laparotomy more frequently presented with hypothermia (p=0.011) and 
acidosis as demonstrated by a lower pH (p<0.001), higher levels of lactate (p=0.013), and a 
larger base deficit (p<0.001) than those in whom IAP remained ≤20mmHg. Following 
laparotomy, these differences remained, except for hypothermia. On the other hand 
coagulopathy, expressed as a prolonged Prothrombin Time (PT) (p<0.001) or Partial 
Thromboplastin Time (PTT) (p<0.001), was seen following trauma laparotomy in patients 
with high-grade IAH. Logistic regression analysis showed that hypothermia at admission 
(OR 0.74) and presence of acidosis and coagulopathy (PTT) at six hours after trauma 
laparotomy (OR 0.05 and 1.01, respectively) significantly increased the odds of developing 
high-grade IAH. 
Patients with high-grade IAH following laparotomy received larger volumes of 
resuscitation fluid in the emergency department (p=0.001) and during the first 24 hours 
following admission (p<0.001) compared to patients without high-grade IAH (Table 3). 
Even though this was mainly due to crystalloid volumes administered in the first 24 hours 
of admission (6.0L vs. 4.2L; p<0.001), patients also received larger volumes of colloid 
resuscitation in the first 24 hours of admission (2.5 vs. 1.5L, p<0.001). Patients with high-
grade IAH also received more blood transfusions (17 vs. 2 units of packed red cells, 
p<0.001). The total resuscitation volume as well as the volume of crystalloids and colloids 





Patients with high-grade IAH following trauma laparotomy had worse outcomes than 
patients without high-grade IAH with a higher mortality rate (25.9% (15/58) vs. 12.2% 
(62/509); p=0.012), a longer median ICU length of stay (15 days vs. 1 day; p<0.001), and a 
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DISCUSSION 
This analysis demonstrates associations between the development of high-grade IAH 
following trauma laparotomy and presence of acidosis, coagulopathy, and hypothermia. 
Coagulopathy is often associated with acidosis and hypothermia and these factors 
combined are associated with injury severity (ISS) (16). More severely injured patients 
often require larger volumes of resuscitation fluids which is a known risk factor for IAH 
(17). Moreover, a direct relation between acidosis (univariate analysis), hypothermia 
(multivariable analysis) and IAH has been confirmed (18, 19). 
Acidosis, coagulopathy, and hypothermia could not be confirmed as independent risk 
factors for high-grade IAH by multivariable analysis. Nevertheless, it does suggest that the 
typical patient, who gets a damage control laparotomy, is also at risk for high-grade IAH. 
Leaving the abdomen open after a damage control laparotomy and delaying abdominal 
closure until coagulopathy, acidosis and hypothermia are corrected seems to be a good 
strategy.  
Patients arriving to the emergency department in circulatory shock were twice as likely to 
develop high-grade IAH following trauma laparotomy. Crystalloid fluid resuscitation is a 
common first choice in emergency departments, but excessive use of it is a known risk 
factor for ACS (20). In this study, crystalloid resuscitation volumes were significantly higher 
in patients with high-grade IAH following trauma laparotomy. This is in concordance with 
the view that excessive crystalloid use is a risk factor for ACS following trauma laparotomy 
too. Over the studied period, no trend was observed in used volumes of crystalloid 
resuscitation fluid. High-grade IAH patients also received significantly larger colloid 
resuscitation volumes, total resuscitation volumes and more units of packed red blood 
cells over the first 24 hours following admission. More recently, a benefit for colloid 
resuscitation (including hydroxyethyl starches; HES) over crystalloid resuscitation with 
respect to days free from mechanical ventilation, vasopressor therapy and 90-day 
mortality has been suggested (21). Two other studies have advocated against the use of 
HES-based resuscitation, as HES-based resuscitation was associated with higher 90-day 
mortality rates in sepsis patients and an increased need for renal-replacement therapy in 
an ICU population (22, 23). Our analysis could not confirm a benefit for colloid 
resuscitation with respect to the development of high-grade IAH. 
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In the data presented, there are increased mortality rates associated with IAH grade and 
the use of open abdomen treatment. Mortality was highest in patients in whom delayed 
primary abdominal closure was not possible (80%; 4 out of 5). Inability to close the 
abdomen is known to be related to high morbidity and mortality (24). The presented data 
show significantly higher mortality following inability to close the abdomen than in 
patients in whom delayed abdominal closure was possible. Although the populations were 
too small in this analysis to attain statistical significance, it may suggest that open 
abdomen is an unfavourable condition. Moreover, open abdomen does not necessarily 
prevent ACS from occurring. In the 24 patients that developed high-grade IAH after open 
abdomen treatment, 15 patients still developed ACS. ACS developed during open 
abdomen treatment in seven of these 15 patients (46.7%) and after abdominal closure it 
developed in six patients (6/15; 40.0%). For the remaining two patients, it is unknown at 
what moment exactly the ACS was diagnosed. 
The results of the current study indicated a lower mortality in patients with an open 
abdomen without high-grade IAH (14.7%; 5/34) than in patients with a closed abdomen 
and high-grade IAH (37.5%; 21/56; p=0.034). This is likely attributable to a more severe 
injury in the former group. Although the patients with an open abdomen without high-
grade IAH were significantly younger (median age 33 vs. 52 years; p=0.001), they were 
more frequently in circulatory shock at presentation (83.9% (47/56) versus 58.8% (20/34); 
p=0.018) and had a higher median ISS (38 versus 29; p=0.048) than patient with a closed 
abdomen and high-grade IAH. Resuscitation (volume and composition), acidosis, 
coagulopathy, and hypothermia were not statistically significantly different between these 
two groups (data not shown). 
Severely injured patients and patients in circulatory shock in whom trauma laparotomy is 
performed for blunt abdominal injury and who subsequently develop coagulopathy, 
hypothermia, or acidosis are at risk for ACS. These patients may benefit from open 
abdomen treatment, even though this treatment is associated with high morbidity and 
mortality (25, 26). Recently developed (vacuum assisted) temporary abdominal closure 
devices seem to improve patient outcome (27). Nevertheless, open abdomen treatment 
should be avoided when the development of high-grade IAH is unlikely. When open 
abdomen treatment is applied, abdominal closure should be aimed at as soon as possible 





Identifying patients at risk for high-grade IAH following trauma laparotomy 65
Our study possesses several limitations. Given that ACS is a relative rare finding, patients 
who only developed high-grade IAH were interpreted as patients with a high risk for 
developing ACS. As mentioned, the number of patients who actually developed ACS was 
low. Even though ACS is relatively rare, its impact on patient outcome is very large, 
therefore early recognition of patients at risk is of developing ACS is important. Another 
limitation is the retrospective design of this study. Even though a retrospective design is 
unfavourable, it made inclusion of large patient numbers possible. The large population of 
patients that underwent trauma laparotomy is the main novelty of this study, it concerns 
the largest series published until now. Lastly, none of the identified characteristics of 
patients at risk for ACS could be confirmed with multivariable analysis. The multivariable 
analysis was hampered by the extent of redundancy and co-linearity between the 
covariates. This makes interpreting the findings more difficult. For example, the high 
mortality in patients in whom delayed abdominal closure was not possible, may also be a 
result of selection bias and injury severity. Larger (prospective) studies are needed to 
quantify the relative contribution of the demonstrated characteristics to the overall risk of 
high-grade IAH in patients following trauma laparotomy. 
In conclusion, patients in need of a damage control laparotomy who develop acidosis, 
coagulopathy, and hypothermia, are at risk of IAH and ACS. At the time of trauma 
laparotomy in patients with these ACS risk factors, temporary abdominal closure with 

















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4: Mortality, length of stay at ICU and hospital separated for the groups with an 




IAP ≤ 20 
(N=509) 
IAP > 20 
(N=58) 
P-value 
Mortality 77 (13.6%) 62 (12.2%) 15 (25.9%) 0.012A 
LOS ICU (days) 2 (0 - 6) 1 (0 - 4) 15 (8 - 27) <0.001 
LOS Hospital (days) 10 (6 - 20) 9 (6 - 17) 44 (15 - 65) <0.001 
IAP, Intra-Abdominal Pressure (mmHg); LOS, Length of Stay. 
Data are shown as median with the P25 - P75 between brackets or as number with the 
percentage between brackets.  
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ABSTRACT 
Background: Abdominal Compartment Syndrome (ACS) in severely injured patients is 
associated with high morbidity and mortality. Many efforts have been made to improve 
outcome of patients with ACS. A treatment algorithm for ACS patients was introduced on 
January 1, 2005 by the World Society of the Abdominal Compartment Syndrome (WSACS). 
The aim of this study was to estimate prevalence and mortality of ACS among severely 
injured patients, and to compare these before and after January 1, 2005 using a 
systematic literature review and meta-analysis. 
Method: Databases of Embase, Medline (OvidSP), Web-of-science, CINAHL, CENTRAL, 
PubMed publisher and Google Scholar were searched for terms related to severely injured 
patients and ACS. Original studies reporting ACS in trauma patients were considered 
eligible. Data on study design, population, definitions, and outcomes were extracted. 
Estimates of overall prevalence and mortality of ACS among severely injured patients were 
calculated using inversed variance weighting assuming a random effects model. Tests for 
heterogeneity were applied. 
Results: A total of 81 publications were included. The overall prevalence of ACS among 
severely injured patients was 4.5% (95% Confidence Interval, CI, 3.5-5.7%; N= 33,455). 
Prevalence among severely injured patients admitted to the ICU was 1.1% (95% CI: 0.6-
1.7%; N= 6,985), 2.8% (95% CI: 1.6-4.4%; N= 3,803) among patients with visceral injuries, 
and 5.0% (95% CI: 2.8-7.7%; N= 4,200) among patients who underwent trauma 
laparotomy. The overall mortality rate among severely injured patients with ACS was 
48.3% (95% CI, 41.5-55.2%; N= 967). Whereas prevalence has decreased by 1.5% 
(p=0.016) since January 1, 2005, an effect on mortality could not be shown. 
Conclusion: The pooled prevalence of ACS among severely injured patients is 4.5%. The 
pooled mortality rate of these patients is 48.3%. Modern trauma resuscitation and 
introduction of evidence-based treatment algorithms resulted in decreased prevalence of 











Abdominal compartment syndrome (ACS) is a serious complication in severely injured 
patients. ACS was initially recognized as a typical complication among trauma populations, 
although it is also described in many other critically ill patient groups. It is a result of major 
tissue injury, traumatic shock and massive fluid resuscitation, with or without abdominal 
injury or abdominal surgery. The diagnosis of ACS is confirmed if the intra-abdominal 
pressure (IAP) exceeds 20 mmHg (i.e., high grade intra-abdominal hypertension; IAH) in 
combination with splanchnic hypoperfusion and subsequent organ dysfunction. ACS is 
associated with a high risk of mortality; the full blown syndrome without decompression is 
uniformly lethal (1-4). 
Efforts during the past decades to improve the outcome of severely injured patients 
include the introduction of damage control surgery, damage control resuscitation, and the 
development of vacuum assisted temporary abdominal closure devices (TAC). Although 
aimed at improving outcome after trauma, these developments may also have changed 
the risk and outcome of post injury ACS (5). The World Society of the Abdominal 
Compartment Syndrome (WSACS) critically reviewed literature regarding these 
developments and subsequently introduced the Consensus Statements and 
Recommendations using the GRADE methodology. These statements serve as guidelines 
for the treatment of patients at risk for IAH/ACS and were first implemented on January 1, 
2005 (but published in 2006) (6). An updated version of these guidelines provides 
physicians with easy-to-use treatment algorithms (7).  
The application of these algorithms has resulted in a decrease of ACS mortality in a mixed 
population of trauma and non-trauma patients (8). It is however unclear to what extent 
these developments have affected the ACS prevalence and ACS mortality among severely 
injured patients. The aim of this study was to determine the prevalence and mortality rate 
of ACS among severely injured patients, and to assess to what extent developments 






This systematic literature review was conducted and reported according to the standards 
set out in Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) 
(9). The protocol was predefined, but is not available online. 
 
Ethics statement 
The current study used secondary data, extracted from readily available literature; 
therefore, obtaining research ethics approval was not necessary. 
 
Search Strategy 
Databases of Embase, Medline (OvidSP), Web-of-science, Cumulative Index to Nursing and 
Allied Health Literature (CINAHL), Cochrane Central Register of Controlled Trials 
(CENTRAL), PubMed publisher and Google Scholar were searched from database inception 
until February 15, 2015. Searched items consisted of terms related to injury and terms 
related to abdominal compartment syndrome (Table 1). Reference lists of review articles 
and eligible studies were reviewed for additional studies that may have been missed. 
 
Manuscript selection and eligibility criteria 
Titles and abstracts were screened independently by two reviewers (SGS and RAV) for 
presence of trauma populations. Inconsistencies were resolved by discussion and 
consensus. Studies were included if they met the following inclusion criteria: 1) design: 
original reports with primary data; 2) population: presence of injured patients, and 3) 
outcome: description of ACS prevalence or ACS mortality numbers or data from which 
prevalence or mortality rates among injured patients could be calculated. No language 
criterion was used. Studies were excluded if no full text version was available after 
contacting corresponding authors. Also, studies restricted to thermally injured patients 
were excluded, as a systematic review on prevalence and outcome of IAH and ACS among 
severely burned patients is already available (10). No specific definitions for injured 
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Scientific Level of Evidence 
Study classification according to Mahid et al. and the prospective- and retrospective 
nature of the studies were collected in order to assess the type and level of evidence of 
publications; randomized controlled trials (RCTs), cohort studies, and case series were 
found to be eligible (11). The patient groups of RCTs were taken together, the pooled 
study population was considered one cohort over which prevalence or mortality rate was 
calculated.  
Risk of bias assessment 
Two reviewers (SGS and EMMVL) independently assessed the methodological quality of 
the studies using the MINORs (Methodological Index for Non-Randomized Studies) scale 
(12). The MINORs scale yields a maximum score of 16 for non-comparative cohort studies 
and a maximum of 24 for comparative cohort studies. 
Data collection process and data items 
Data extraction was done independently in duplicate by three reviewers (SGS, OJFVW and 
AVVB) using a standardized data sheet. Discordance was resolved by the reviewers 
rechecking their extracted data until data sheets corresponded. The following data were 
extracted for each publication: name of first author, publication year, years the inclusion 
period started and ended, population size (N), type of population, age of population, 
mean or median injury severity score (ISS), definition used for ACS, number of ACS 
patients (or ACS rate), and mortality rate of ACS patients. Publications using the same 
patient database in overlapping periods were identified. Only data from 1) the largest or 
2) most recent cohorts were used.
Data synthesis and statistical analysis 
ACS prevalence and mortality rates were computed for each study; they were transformed 
using a double arcsine transformation in order to ensure normal distribution (13). Next, 
the transformed rates and 95% confidence intervals were transformed back to prevalence 
and mortality rate estimates. Forest plots were constructed with 95% confidence interval 
for all studies to show the variation in ACS prevalence and mortality in severely injured 
patients across the included studies.  
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The Cochrane Chi-squared (χ2) Q-test was applied in order to test for heterogeneity 
(significance set at p < 0.10), and the I2 statistic was calculated in order to quantify the 
degree of between-study heterogeneity. This defines the variability percentage in effect 
estimates that is due to heterogeneity rather than to chance (14, 15). An I2 statistic 
greater than 40% was considered to represent significant heterogeneity. 
Data were pooled using a random-effects model for binomial data (DerSimonian–Laird) 
(16). A random-effects model was planned a priori, due to the degree of anticipated 
heterogeneity among the eligible studies. If significant heterogeneity was present, 
subgroup analyses were planned. Patients were categorized based on the source 
population, being ‘severely injured patients admitted to the ICU’, ‘patients with visceral 
injuries’ and ‘patients who had undergone emergent trauma laparotomy’. These groups 
are not unique, as overlap to a certain degree is likely. For example, patients in the trauma 
laparotomy group may very well be admitted to the ICU, and vice versa. 
For the secondary analysis the populations were divided into two groups, using January 1, 
2005 (the date of first introduction of the WSACS guideline) as cut-off date (8). The first 
groups consisted of studies that stopped enrolling before January 1, 2005, and the second 
group started enrolling after this date. Studies without specified enrolment period as well 
as studies with enrolment periods that included this date were excluded from this sub-
analysis. Differences in ACS prevalence and mortality rates between the two time periods 
were tested using an unpaired Student’s t test. A p-value below 0.05 was considered 
statistically significant. 
Analyses was performed using MetaXL software (Version 2.2; Epigear International Pty 
Ltd, Australia; 2011-2015). Student’s t test was calculated using the GraphPad QuickCalcs 












The search yielded 5,899 publications. After eliminating duplicates, 3,755 publications 
remained. These were reviewed for inclusion and exclusion criteria, and reference lists of 
reviews and eligible studies were examined for additional publications. A total of 80 
publications was included in this analysis, including three randomized controlled trials, 12 
prospective cohort studies, 40 retrospective cohort studies, and 25 case series (Figure 1) 
(1, 2, 8, 17-94).  
The within-study quality according to the MINORS score ranged from 1 to 13 points out of 
a maximum of 16 points. The mean score was 7 points. Extracted data of included 
publications are listed in (Table 2) 
The search identified no systematic reviews or meta-analysis regarding prevalence and 
mortality rate of ACS among injured patients. Only one previously published literature 
review listed prevalence and outcome of ACS among trauma patients in 2009. This study, 
however, did not describe a systematic search method (95). One publication reported 
sufficient data to calculate annual prevalence between 2002 and 2007 (8). The annual 
prevalences of this publication were pooled in a group before January 1, 2005 and a group 
after that date.  
 
Prevalence of ACS in severely injured patients 
The prevalence of ACS for 33,455 severely injured patients in 60 publications ranged from 
0.0% to 36.4% (Figure 2). Prevalence of studies that finished enrolling patients before 
January 1, 2005 ranged from 0.5% to 36.4% (pooled value of 5.2%; 95% CI 3.7-7.0%; I2 
95%; 17,689 patients; 33 publications). Prevalence reported after that date ranged from 
0.0% to 28.0% (pooled value of 3.7%; 95% CI 1.7-6.4%; I2 90%; 4,752 patients; 12 
publications; Table 3).  
Given the large heterogeneity, subgroup analyses were performed (Figure 3). For severely 
injured patients admitted to the ICU, the prevalence ranged from 0.0% to 5.3% (6,985 
patients; 8 publications). The reported prevalence before January 1, 2005 ranged from 
0.5% to 1.3% (pooled value of 1.0%, 95% CI 0.7-1.3%; I2 27%; 6,678 patients; 6 
publications). Only one study (81 patients) was found for the second period and contained 




For patients with visceral injuries, ACS prevalence ranged from 0.2% to 20.0% (3,803; 18 
publications). Prevalence ranged from 1.0% to 20.0% (pooled value 4.3%; 95% CI 1.6-8.1%; 
I2 78%; 892 patients; 8 publications) before January 1, 2005. The only study after January 
1, 2005 reported an ACS prevalence of 11.1% (9 patients).  
For patients who underwent trauma laparotomy, the ACS prevalence ranged from 0.9% to 
36.4% (4,200 patients; 11 publications). The prevalence before January 1, 2005 ranged 
from 0.9% to 36.4% (pooled value 5.4; 95% CI 2.3-9.7%; I2 93%; 2,058 patients; 8 
publications). Two studies after January 1, 2005 reported ACS prevalence of 2.3% and 
13.2%, respectively.  
 
Mortality of severely injured patients with ACS  
The mortality for 967 severely injured patients with ACS in 42 publications ranged from 
0.0% to 100.0% (Table 4). The mortality reported before January 1, 2005 ranged from 
0.0% to 100.0% (pooled value 47.1%; 95% CI 39.3-54.9%; I2 64%; 484 patients; 28 
publications). After that date, mortality ranged from 0.0% to 100.0% (pooled value 53.1%; 
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DISCUSSION 
The overall prevalence of ACS among trauma patients ranged from 0.0% to 36.4% with a 
pooled prevalence of 5.2% and 3.7% before and after January, 2005, respectively. The 
mortality ranged from 0.0% to 100.0% with a pooled value of 47.1% before and 53.1% 
after January 1, 2005. These values should be interpreted with care given the large 
statistical and clinical heterogeneity. Therefore, no causal relation with improved trauma 
care and the introduction of the Consensus Statements and Recommendations by the 
WSACS can be concluded.  
The ACS prevalence was lowest in a general trauma ICU population and highest in patients 
who underwent a trauma laparotomy. This was not surprising. Damage control surgery 
keeps the most severely shocked patients alive with a packed abdomen with or without 
cross-clamping, increasing the risk of massive intestinal edema and reperfusion injury. 
 (5). The current systematic review has certain limitations resulting from the inherent 
biases of the included studies. As stated above, the findings should be interpreted with 
caution. The studies had different study designs (i.e., RCT, longitudinal cohort study, or 
case series), diverse populations, and used different definitions of ACS. It is unclear to 
what extent this has biased the pooled values. It may also explain the large between-study 
heterogeneity and outlines the need for more rigorous and uniform definitions in future 
studies. Assuming that the WSACS guidelines are effective, it is notable that its use is not 
frequently described in included publications. Even definitions of ACS are still not 
uniformly applied in modern literature (83).  
The current systematic review has certain limitations resulting from the inherent biases of 
the included studies. As stated above, the findings should be interpreted with caution. The 
studies had different study designs (i.e., RCT, longitudinal cohort study, or case series), 
diverse populations, and used different definitions of ACS. It is unclear to what extent this 
has biased the pooled values. It may also explain the large between-study heterogeneity 
and outlines the need for more rigorous and uniform definitions in future studies. 
Assuming that the WSACS guidelines are effective, it is notable that its use is not 
frequently described in included publications. Even definitions of ACS are still not 
uniformly applied in modern literature.  
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In conclusion, the overall prevalence of ACS ranged from 0.0% to 36.4% and the mortality 
ranged from 0.0% to 100.0%. Future studies are needed to measure the effect of 
improved trauma care and effectiveness of the WSACS Consensus Statements.  
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Table 1: Search strategy 
 
Database Query Hits Unique 
Embase ('abdominal compartment syndrome'/exp OR 'intraabdominal 
hypertension'/exp OR 'abdominal pressure'/exp OR ('compartment 
syndrome'/exp AND ('abdominal injury'/exp OR 'abdominal disease'/exp 
OR 'abdomen'/exp)) OR 'abdominal hypertension'/exp OR 'abdominal 
decompression'/exp OR 'lower body negative pressure'/exp OR 
(((abdomin* OR intraabdomin*) NEXT/1 (compartment* OR hypertens* 
OR pressure* OR decompressi*)) OR 'visceral edema' OR 'visceral 
oedema')) AND (injury/exp OR traumatology/exp OR 'emergency 
ward'/exp OR 'emergency medicine'/exp OR emergency/exp OR 
'emergency surgery'/exp OR 'emergency health service'/exp OR 
'emergency treatment'/exp OR (injur* OR wound* OR trauma* OR 





('abdominal compartment syndrome'/exp OR 'intraabdominal 
hypertension'/exp OR 'abdominal pressure'/exp OR ('compartment 
syndrome'/exp AND ('abdominal injury'/exp OR 'abdominal disease'/exp 
OR 'abdomen'/exp)) OR 'abdominal hypertension'/exp OR 'abdominal 
decompression'/exp OR 'lower body negative pressure'/exp OR 
(((abdomin* OR intraabdomin*) NEXT/1 (compartment* OR hypertens* 
OR pressure* OR decompressi*)) OR 'visceral edema' OR 'visceral 
oedema')) AND (injury/exp OR traumatology/exp OR 'emergency 
ward'/exp OR 'emergency medicine'/exp OR emergency/exp OR 
'emergency surgery'/exp OR 'emergency health service'/exp OR 
'emergency treatment'/exp OR (injur* OR wound* OR trauma* OR 





TS=(((((abdomin* OR intraabdomin*) NEAR/1 (compartment* OR 
hypertens* OR pressure* OR decompressi*)) OR "visceral edema" OR 
"visceral oedema")) AND ((injur* OR wound* OR trauma* OR penetrat* 
OR emergen*)) NOT ((animal* OR porcine OR swine OR pig OR rat OR 
mouse OR mice OR rats OR murine OR dog OR dogs OR rabbit* OR 
horse* OR equin* OR cat OR cats OR cow OR cows OR bovine) NOT 
(human* OR patient*)))  
 
1,330 569 
CINAHL (MH "Abdominal Compartment Syndrome+" OR (MH "Compartment 
Syndromes+" AND (MH "Abdominal Injuries+" OR MH abdomen+)) OR 
(((abdomin* OR intraabdomin*) N1 (compartment* OR hypertens* OR 
pressure* OR decompressi*)) OR "visceral edema" OR "visceral 
oedema")) AND (MH "Wounds and Injuries+" OR MH Traumatology+ OR 
MH "Emergency Medical Services+" OR MH "emergency medicine+" OR 
MH emergencies+ OR MH "Emergency Treatment (Non-Cinahl)+" OR 
(injur* OR wound* OR trauma* OR penetrat* OR emergen*)) NOT (MH 
animals+ NOT MH humans+) 
 
297 79 
CENTRAL ((((abdomin* OR intraabdomin*) NEXT/1 (compartment* OR hypertens* 
OR pressure* OR decompressi*)) OR 'visceral edema' OR 'visceral 







(Intra-Abdominal Hypertension[mh] OR (Compartment Syndromes[mh] 
AND (Abdominal Injuries[mh] OR abdomen[mh])) OR intraabdominal 
compartment*[tiab] OR intra abdominal compartment*[tiab] OR 
intraabdominal hypertens*[tiab] OR intra abdominal hypertens*[tiab] 
OR intraabdominal pressure*[tiab] OR intra abdominal pressure*[tiab] 
OR "visceral edema"[tiab] OR "visceral oedema"[tiab]) AND ("Wounds 
and Injuries"[mh] OR injuries[sh] OR Traumatology[mh] OR Emergency 
Medical Services[mh] OR emergency medicine[mh] OR emergencies[mh] 
OR Emergency Treatment[mh] OR (injur*[tiab] OR wound*[tiab] OR 
trauma*[tiab] OR penetrat*[tiab] OR emergen*[tiab])) NOT 












Reference lists  9 9 
Total 5,899 3,755 
#First 200 hits. 
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I2, I2-statistic for study heterogeneity; Prev, Prevalence; Q, Cochrans Q-statistic for study 
heterogeneity, 95% CI, 95% Confidence Interval 
Studies are listen based upon publication year on the y-axis on the left hand side. 
Prevalence is shown on the x-axis as fraction. The individual study prevalence and 
corresponding 95% Confidence Intervals and study weight as used in the pooled analysis 
are listen on the y-axis on the right hand side. 
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Figure 2: Forest plot of prevalence of ACS among severely injured patients before (A) 
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Studies are listed based upon publication year on the y-axis on the left hand side. 
Prevalence is shown on the x-axis as fraction. The individual study prevalence and 
corresponding 95% confidence intervals and study weight as used in the pooled analysis 
are listed on the y-axis on the right hand side. 
I2, I2 statistic for study heterogeneity; Prev, prevalence; Q, Cochran's Q-statistic for study 




Figure 3: Forest plot of ACS mortality among severely injured patients before (A) and 
after (B) January 1, 2005.  
 
Studies are listed based upon publication year on the y-axis at the left hand side. Mortality 
rate is shown at the x-axis as fraction. The individual study mortality and corresponding 
95% confidence intervals and study weight as used in the pooled analysis are listed on the 
y-axis at the right hand side.  
I2, I2 statistic for study heterogeneity; Prev, prevalence of mortality; Q, Cochran's Q-





Prevalence and outcome of ACS in trauma patients; a systematic review 97
REFERENCES 
1. Beck R, Halberthal M, Zonis Z, Shoshani G, Hayari L, Bar-Joseph G. Abdominal
compartment syndrome in children. Pediatric critical care medicine : a journal of
the Society of Critical Care Medicine and the World Federation of Pediatric
Intensive and Critical Care Societies. 2001;2(1):51-6.
2. Khan S, Verma AK, Ahmad SM, Ahmad R. Analyzing intra-abdominal pressures
and outcomes in patients undergoing emergency laparotomy. Journal of
emergencies, trauma, and shock. 2010;3(4):318-25.
3. Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF. Abdominal
perfusion pressure: a superior parameter in the assessment of intra-abdominal
hypertension. J Trauma. 2000;49(4):621-6; discussion 6-7.
4. Hirshberg A, Wall MJ, Jr., Mattox KL. Planned reoperation for trauma: a two year
experience with 124 consecutive patients. J. Trauma. 1994;37(3):365-9.
5. Balogh ZJ, Lumsdaine W, Moore EE, Moore FA. Postinjury abdominal
compartment syndrome: From recognition to prevention. Lancet.
2014;384(9952):1466-75.
6. Malbrain ML, Cheatham ML, Kirkpatrick A, Sugrue M, Parr M, De Waele J, et al.
Results from the International Conference of Experts on Intra-abdominal
Hypertension and Abdominal Compartment Syndrome. I. Definitions. Intensive
Care Med. 2006;32(11):1722-32.
7. Kirkpatrick AW, Roberts DJ, De Waele J, Jaeschke R, Malbrain MLNG, De
Keulenaer B, et al. Intra-abdominal hypertension and the abdominal
compartment syndrome: Updated consensus definitions and clinical practice
guidelines from the World Society of the Abdominal Compartment Syndrome.
Intensive Care Med. 2013;39(7):1190-206.
8. Cheatham ML, Safcsak K. Is the evolving management of intra-abdominal
hypertension and abdominal compartment syndrome improving survival? Critical
Care Medicine. 2010;38(2):402-7.
98 CHAPTER 4
9. Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP, et al. The
PRISMA statement for reporting systematic reviews and meta-analyses of studies
that evaluate health care interventions: explanation and elaboration. PLoS
medicine. 2009;6(7):e1000100.
10. Strang SG, Van Lieshout EM, Breederveld RS, Van Waes OJ. A systematic review
on intra-abdominal pressure in severely burned patients. Burns. 2014;40(1):9-16.
11. Mahid SS, Hornung CA, Minor KS, Turina M, Galandiuk S. Systematic reviews and
meta-analysis for the surgeon scientist. Br J Surg. 2006;93(11):1315-24.
12. Slim K, Nini E, Forestier D, Kwiatkowski F, Panis Y, Chipponi J. Methodological
index for non-randomized studies (minors): development and validation of a new
instrument. ANZ J Surg. 2003;73(9):712-6.
13. Freeman MF, Tukey JW. Transformations related to the angular and the square
root. The Annals of Mathematical Statistics. 1950;21(4):607-11.
14. Cochran WG. The combination of estimates from different experiments.
Biometrics. 1954;10(1):101-29.
15. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Statistics
in medicine. 2002;21(11):1539-58.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled clinical trials.
1986;7(3):177-88.
17. Smith PC, Tweddell JS, Bessey PQ. Alternative approaches to abdominal wound
closure in severely injured patients with massive visceral edema. The Journal of
trauma. 1992;32(1):16-20.
18. Morris JA, Jr., Eddy VA, Blinman TA, Rutherford EJ, Sharp KW. The staged
celiotomy for trauma. Issues in unpacking and reconstruction. Annals of Surgery.
1993;217(5):576-84; discussion 84-6.
19. Bender JS, Bailey CE, Saxe JM. The technique of visceral packing: recommended
management of difficult fascial closure in trauma patients. Journal of Trauma …. 
1994. 
20. Widergren JT, Battistella FD, Holcroft JW. The open abdomen: treatment for
intra-abdominal compartment syndrome. 1994.
21. Howdieshell TR, Yeh KA, Hawkins ML, Cue JI, Ledgerwood AM. Temporary
abdominal wall closure in trauma patients: Indications, technique, and results.










22. Torrie J, Hill AA, Streat S. Staged abdominal repair in critical illness. Anaest 
Intensive Care. 1996;24(3):368-74. 
23. Eddy V, Nunn C, Morris JA, Jr. Abdominal compartment syndrome. The Nashville 
experience. The Surgical clinics of North America. 1997;77(4):801-12. 
24. Mayberry JC, Mullins RJ, Crass RA, Trunkey DD. Prevention of abdominal 
compartment syndrome by absorbable mesh prosthesis closure. Archives of 
surgery (Chicago, Ill: 1960). 1997;132(9):957-61; discussion 61-2. 
25. Meldrum DR, Moore FA, Moore EE, Franciose RJ, Sauaia A, Burch JM. Prospective 
characterization and selective management of the abdominal compartment 
syndrome. American Journal of Surgery. 1997;174(6):667-72; discussion 72-3. 
26. Behrman SW, Bertken KA, Stefanacci HA, Parks SN. Breakdown of intestinal repair 
after laparotomy for trauma: incidence, risk factors, and strategies for 
prevention. The Journal of trauma. 1998;45(2):227-31; discusion 31-3. 
27. Chang MC, Miller PR, D'Agostino R, Jr., Meredith JW. Effects of abdominal 
decompression on cardiopulmonary function and visceral perfusion in patients 
with intra-abdominal hypertension. The Journal of trauma. 1998;44(3):440-5. 
28. Ivatury RR, Porter JM, Simon RJ, Islam S, John R, Stahl WM. Intra-abdominal 
hypertension after life-threatening penetrating abdominal trauma: prophylaxis, 
incidence, and clinical relevance to gastric mucosal pH and abdominal 
compartment syndrome. The Journal of trauma. 1998;44(6):1016-21; discussion 
21-3. 
29. Cheatham ML, Safcsak K, Block EF, Nelson LD. Preload assessment in patients 
with an open abdomen. The Journal of trauma. 1999;46(1):16-22. 
30. Letoublon C, Lachachi F, Arvieux C, Lavagne P, Amroun H, Delannoy P, et al. 
Current treatment of closed injuries of the liver: benefits and pitfalls. Chirurgie; 
memoires de l'Academie de chirurgie. 1999;124(1):20-30. 
31. Maxwell RA, Fabian TC, Croce MA, Davis KA. Secondary abdominal compartment 
syndrome: an underappreciated manifestation of severe hemorrhagic shock. The 
Journal of trauma. 1999;47(6):995-9. 
32. Barker DE, Kaufman HJ, Smith LA, Ciraulo DL, Richart CL, Burns RP. Vacuum pack 
technique of temporary abdominal closure: a 7-year experience with 112 
patients. The Journal of trauma. 2000;48(2):201-6; discussion 6-7. 
100 CHAPTER 4
33. Cheatham ML, White MW, Sagraves SG, Johnson JL, Block EF. Abdominal
perfusion pressure: a superior parameter in the assessment of intra-abdominal
hypertension. The Journal of trauma. 2000;49(4):621-6; discussion 6-7.
34. Ertel W, Oberholzer A, Platz A, Stocker R, Trentz O. Incidence and clinical pattern
of the abdominal compartment syndrome after "damage-control" laparotomy in
311 patients with severe abdominal and/or pelvic trauma. Critical Care Medicine.
2000;28(6):1747-53.
35. Kopelman T, Harris C, Miller R, Arrillaga A. Abdominal compartment syndrome in
patients with isolated extraperitoneal injuries. The Journal of trauma.
2000;49(4):744-7; discussion 7-9.
36. Paunescu V, Popescu C. Acute abdominal compartment syndrome in
politraumatised patients. Proceedings Eurosurgery 2000. 40128 Bologna:
Medimond S R L; 2000. p. 295-7.
37. Chen RJ, Fang JF, Chen MF. Intra-abdominal pressure monitoring as a guideline in
the nonoperative management of blunt hepatic trauma. The Journal of trauma.
2001;51(1):44-50.
38. Garner GB, Ware DN, Cocanour CS, Duke JH, McKinley BA, Kozar RA, et al.
Vacuum-assisted wound closure provides early fascial reapproximation in trauma
patients with open abdomens. American Journal of Surgery. 2001;182(6):630-8.
39. Raeburn CD, Moore EE, Biffl WL, Johnson JL, Meldrum DR, Offner PJ, et al. The
abdominal compartment syndrome is a morbid complication of postinjury
damage control surgery. American Journal of Surgery. 2001;182(6):542-6.
40. Tremblay LN, Feliciano DV, Schmidt J, Cava RA, Tchorz KM, Ingram WL, et al. Skin
only or silo closure in the critically ill patient with an open abdomen. American
Journal of Surgery. 2001;182(6):670-5.
41. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Holcomb JB, Ware DN, et al.
Secondary abdominal compartment syndrome is an elusive early complication of
traumatic shock resuscitation. American Journal of Surgery. 2002;184(6):538-43;
discussion 43-4.
42. Gracias VH, Braslow B, Johnson J, Pryor J, Gupta R, Reilly P, et al. Abdominal






Prevalence and outcome of ACS in trauma patients; a systematic review 101
43. Hong JJ, Cohn SM, Perez JM, Dolich MO, Brown M, McKenney MG. Prospective
study of the incidence and outcome of intra-abdominal hypertension and the
abdominal compartment syndrome. The British journal of surgery.
2002;89(5):591-6.
44. Miller PR, Thompson JT, Faler BJ, Meredith JW, Chang MC. Late fascial closure in
lieu of ventral hernia: the next step in open abdomen management. The Journal
of trauma. 2002;53(5):843-9.
45. Arvieux C, Cardin N, Chiche L, Bachellier P, Falcon D, Letoublon C, et al. Damage
control laparotomy for haemorragic abdominal trauma. A retrospective
multicentric study about 109 cases. Annales De Chirurgie. 2003;128(3):150-8.
46. Balogh Z, McKinley BA, Cocanour CS, Kozar RA, Cox CS, Moore FA. Patients with
impending abdominal compartment syndrome do not respond to early volume
loading. American Journal of Surgery. 2003;186(6):602-7; discussion 7-8.
47. Gao JM, Du DY, Zhao XJ, Liu GL, Yang J, Zhao SH, et al. Liver trauma: Experience in
348 cases. World Journal of Surgery. 2003;27(6):703-8.
48. Goldman R, Zilkoski M, Mullins R, Mayberry J, Deveney C, Trunkey D. Delayed
celiotomy for the treatment of bile leak, compartment syndrome, and other
hazards of nonoperative management of blunt liver injury. American Journal of
Surgery. 2003;185(5):492-7.
49. Mayberry JC, Welker KJ, Goldman RK, Mullins RJ. Mechanism of acute ascites
formation after trauma resuscitation. Archives of surgery (Chicago, Ill: 1960).
2003;138(7):773-6.
50. Mohr AM, Lavery RF, Barone A, Bahramipour P, Magnotti LJ, Osband AJ, et al.
Angiographic embolization for liver injuries: low mortality, high morbidity. The
Journal of trauma. 2003;55(6):1077-81; discussion 81-2.
51. Velmahos GC, Toutouzas K, Radin R, Chan L, Rhee P, Tillou A, et al. High success
with nonoperative management of blunt hepatic trauma: the liver is a sturdy
organ. Archives of surgery (Chicago, Ill: 1960). 2003;138(5):475-80; discussion 80-
1.
52. Cothren CC, Moore EE, Ciesla DJ, Johnson JL, Moore JB, Haenel JB, et al.
Postinjury abdominal compartment syndrome does not preclude early enteral




53. Miller PR, Meredith JW, Johnson JC, Chang MC. Prospective evaluation of 
vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate 
is substantially reduced. Annals of Surgery. 2004;239(5):608-14; discussion 14-6. 
54. Pleva L, Sir M, Mayzlik J. Abdominal compartment syndrome in polytrauma. 
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, 
Czechoslovakia. 2004;148(1):81-4. 
55. Stone PA, Hass SM, Flaherty SK, DeLuca JA, Lucente FC, Kusminsky RE. Vacuum-
assisted fascial closure for patients with abdominal trauma. Journal of Trauma - 
Injury, Infection and Critical Care. 2004;57(5):1082-6. 
56. Britt RC, Gannon T, Collins JN, Cole FJ, Weireter LJ, Britt LD. Secondary abdominal 
compartment syndrome: risk factors and outcomes. The American surgeon. 
2005;71(11):982-5. 
57. Miller RS, Morris JA, Jr., Diaz JJ, Jr., Herring MB, May AK. Complications after 344 
damage-control open celiotomies. The Journal of trauma. 2005;59(6):1365-71; 
discussion 71-4. 
58. Prince RA, Hoffman CJ, Scanlan RM, Mayberry JC. The distinct and secondary 
harmful effect of pelvic and extremity injury on the outcome of laparotomy for 
trauma. The Journal of surgical research. 2005;124(1):3-8. 
59. Rodas EB, Malhotra AK, Chhitwal R, Aboutanos MB, Duane TM, Ivatury RR. 
Hyperacute abdominal compartment syndrome: an unrecognized complication of 
massive intraoperative resuscitation for extra-abdominal injuries. The American 
surgeon. 2005;71(11):977-81. 
60. Kozar RA, Moore FA, Cothren CC, Moore EE, Sena M, Bulger EM, et al. Risk factors 
for hepatic morbidity following nonoperative management: Multicenter study. 
Arch Surg. 2006;141(5):451-9. 
61. Reed SF, Britt RC, Collins J, Weireter L, Cole F, Britt LD. Aggressive surveillance 
and early catheter-directed therapy in the management of intra-abdominal 
hypertension. The Journal of trauma. 2006;61(6):1359-63; discussion 63-5. 
62. Nicol AJ, Hommes M, Primrose R, Navsaria PH, Krige JEJ. Packing for control of 
hemorrhage in major liver trauma. World Journal of Surgery. 2007;31(3):569-74. 
63. Scalea TM, Bochicchio GV, Habashi N, McCunn M, Shih D, McQuillan K, et al. 





Prevalence and outcome of ACS in trauma patients; a systematic review 103
brain injury: multiple compartment syndrome. J TRAUMA. 2007;62(3):647-56; 
discussion 56. 
64. Dissanaike S, Pham T, Shalhub S, Warner K, Hennessy L, Moore EE, et al. Effect of
Immediate Enteral Feeding on Trauma Patients with an Open Abdomen:
Protection from Nosocomial Infections. Journal of the American College of
Surgeons. 2008;207(5):690-7.
65. Letoublon C, Chen Y, Arvieux C, Voirin D, Morra I, Broux C, et al. Delayed
celiotomy or laparoscopy as part of the nonoperative management of blunt
hepatic trauma. World J Surg. 2008;32(6):1189-93.
66. Madigan MC, Kemp CD, Johnson JC, Cotton BA. Secondary abdominal
compartment syndrome after severe extremity injury: are early, aggressive fluid
resuscitation strategies to blame? The Journal of trauma. 2008;64(2):280-5.
67. Parsak CK, Seydaoglu G, Sakman G, Acarturk TO, Karakoc E, Hanta I, et al.
Abdominal compartment syndrome: current problems and new strategies. World
Journal of Surgery. 2008;32(1):13-9.
68. Wei B, Hemmila MR, Arbabi S, Taheri PA, Wahl WL. Angioembolization reduces
operative intervention for blunt splenic injury. Journal of Trauma - Injury,
Infection and Critical Care. 2008;64(6):1472-7.
69. Cotton BA, Au BK, Nunez TC, Gunter OL, Robertson AM, Young PP. Predefined
massive transfusion protocols are associated with a reduction in organ failure and
postinjury complications. The Journal of trauma. 2009;66(1):41-8; discussion 8-9.
70. Koss W, Ho HC, Yu M, Edwards K, Ghows M, Tan A, et al. Preventing loss of
domain: a management strategy for closure of the "open abdomen" during the
initial hospitalization. Journal of Surgical Education. 2009;66(2):89-95.
71. Nellensteijn D, Porte RJ, Van Zuuren W, Ten Duis HJ, Hulscher JBF. Paediatric
blunt liver trauma in a Dutch level 1 trauma center. European Journal of Pediatric
Surgery. 2009;19(6):358-61.
72. Duchesne JC, Howell MP, Eriksen C, Wahl GM, Rennie KV, Hastings PE, et al. Linea
alba fasciotomy: a novel alternative in trauma patients with secondary abdominal




73. Balogh ZJ, Martin A, van Wessem KP, King KL, Mackay P, Havill K. Mission to 
eliminate postinjury abdominal compartment syndrome. Archives of surgery 
(Chicago, Ill: 1960). 2011;146(8):938-43. 
74. Giladi AM, Dossett LA, Fleming SB, Abumrad NN, Cotton BA. High-dose 
antioxidant administration is associated with a reduction in post-injury 
complications in critically ill trauma patients. Injury. 2011;42(1):78-82. 
75. James MFM, Michell WL, Joubert IA, Nicol AJ, Navsaria PH, Gillespie RS. 
Resuscitation with hydroxyethyl starch improves renal function and lactate 
clearance in penetrating trauma in a randomized controlled study: the FIRST trial 
(Fluids in Resuscitation of Severe Trauma). British Journal of Anaesthesia. 
2011;107(5):693-702. 
76. Parks NA, Davis JW, Forman D, Lemaster D. Observation for nonoperative 
management of blunt liver injuries: How long is long enough? Journal of Trauma - 
Injury, Infection and Critical Care. 2011;70(3):626-9. 
77. Saltzherr TP, Van Der Vlies CH, Van Lienden KP, Beenen LFM, Ponsen KJ, Van Gulik 
TM, et al. Improved outcomes in the non-operative management of liver injuries. 
HPB. 2011;13(5):350-5. 
78. Shekhei RA, Heydari M, Shahbazi S. Comparison of intra-abdominal pressure 
measurement and physical exam for diagnosis of surgery indication in patients 
with abdominal compartment syndrome due to blunt trauma. Journal of Kerman 
University of Medical Sciences. 2011;18(3):271-8. 
79. Al-Sharif A, Thakur V, Al-Farsi S, Singh RN, Kornecki A, Seabrook JA, et al. 
Resuscitation volume in paediatric non-haemorrhagic blunt trauma. Injury-
International Journal of the Care of the Injured. 2012;43(12):2078-82. 
80. Ding LA, Niu DG, Shao CC, Cheng HG. Laparostomy for treating severe abdominal 
infection and truma - 39 cases report and literature review. Journal of 
gastroenterology and hepatology. 2012;27(Journal Article):295. 
81. Harrell BR, Melander S. Identifying the association among risk factors and 
mortality in trauma patients with intra-abdominal hypertension and abdominal 
compartment syndrome. Journal of trauma nursing : the official journal of the 






Prevalence and outcome of ACS in trauma patients; a systematic review 105
82. Maung AA, Schuster KM, Kaplan LJ, Ditillo MF, Piper GL, Maerz LL, et al.
Compared to conventional ventilation, airway pressure release ventilation may
increase ventilator days in trauma patients. The journal of trauma and acute care
surgery. 2012;73(2):507-10.
83. Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG, et al.
Crystalloid to packed red blood cell transfusion ratio in the massively transfused
patient: when a little goes a long way. The journal of trauma and acute care
surgery. 2012;72(4):892-8.
84. Ordonez CA, Badiel M, Pino LF, Salamea JC, Loaiza JH, Parra MW, et al. Damage
control resuscitation: Early decision strategies in abdominal gunshot wounds
using an easy "aBCD" mnemonic. Journal of Trauma and Acute Care Surgery.
2012;73(5):1074-8.
85. Pando E, Ferrer J, Burrel M, Gobbo GDD, Barrufet M, Real MI, et al. Evaluation of
the efficacy of angioembolization in the management of severe liver trauma.
Hospital clinic barcelona case studies. HPB. 2012;14:530.
86. Ali SR, Mohammad H, Sara S. Evaluation of the relationship between pelvic
fracture and abdominal compartment syndrome in traumatic patients. Journal of
emergencies, trauma, and shock. 2013;6(3):176-9.
87. Divarci E, Ergun O, Karapinar B, Yalaz M, Celik A. Can increased intra-abdominal
pressure (IAP) be treated more effectively with intravesical pressure
measurement in high-risk patients? Ulusal travma ve acil cerrahi dergisi = Turkish
journal of trauma & emergency surgery : TJTES. 2013;19(6):559-63.
88. Fiard G, Terrier N, Sengel C, Chodez M, Descotes JL, Rambeaud JJ, et al.
Indications, successes and complications of arterial embolization in renal trauma.
Eur Urol Suppl. 2013;12(1):e564.
89. Guidry C, DellaVope J, Simms E, Heaney JB, Guice J, McSwain Jr N, et al. Impact of
inverse ratios on patients with exsanguinating vascular injuries: Should more be
the new paradigm? Journal of Trauma and Acute Care Surgery. 2013;74(2):403-
10.
106 CHAPTER 4
90. Kasotakis G, Sideris A, Yang Y, De Moya M, Alam H, King DR, et al. Aggressive early
crystalloid resuscitation adversely affects outcomes in adult blunt trauma
patients: An analysis of the Glue Grant database. Journal of Trauma and Acute
Care Surgery. 2013;74(5):1215-22.
91. Mahmood I, Mahmood S, Parchani A, Kumar S, El-Menyar A, Zarour A, et al. Intra-
abdominal hypertension in the current era of modern trauma resuscitation. Anz
Journal of Surgery. 2013(Journal Article).
92. Rencuzogullari A, Yalav O, Dalci K, Eray IC, Parsak CK, Seydaoglu G. Comparison of
early surgical alternatives in the management of open abdomen: A randomized
controlled study. European Surgical Research. 2013;50(Journal Article):155.
93. Asfar S, Khoursheed M, Al-Saleh M, Alfawaz AA, Farghaly MM, Nur AM.
Management of liver trauma in Kuwait. Medical Principles and Practice.
2014;23(2):160-6.
94. Joseph B, Zangbar B, Pandit V, Vercruysse G, Aziz H, Kulvatunyou N, et al. The
conjoint effect of reduced crystalloid administration and decreased damage-
control laparotomy use in the development of abdominal compartment
syndrome. The journal of trauma and acute care surgery. 2014;76(2):457-61.
95. Balogh ZJ, Van Wessem K, Yoshino O, Moore FA. Postinjury abdominal
compartment syndrome: Are we winning the battle? World J Surg.
2009;33(6):1134-41.
Chapter 5
A systematic review on intra-abdominal 
pressure in severely burned patients
B U R N S .  
2 0 1 4  F E B ; 4 0 ( 1 ) : 9 - 1 6 .  
S T E V E N  G .  S T R A N G
E S T H E R  M . M .  V A N  L I E S H O U T
R O E L F  S .  B R E E D E R V E L D
O S C A R  J . F .  V A N  W A E S
P A R T  I I  -  E P I D E M I O L O G Y
108 CHAPTER 5
ABSTRACT 
Objective: Intra-abdominal hypertension (IAH) and abdominal compartment syndrome 
(ACS) are complications that may occur in severe burn patients. Evidenced based medicine 
for these patients is in its early development. The aim of this study was to provide an 
overview of literature regarding IAH and ACS in severe burn patients. 
Methods: A systematic search was performed in Cochrane Central Register of Controlled 
Trials, PubMed, Embase, Web of Science and CINAHL on October 1, 2012. These databases 
were searched on ‘burn’, ‘intra-abdominal hypertension’, ‘abdominal compartment 
syndrome’, synonyms and abbreviations. Studies reporting original data on mortality, 
abdominal decompression or abdominal pressure related complications were included. 
Results: Fifty publications met the criteria, reporting 1616 patients. The prevalence of ACS 
and IAH in severe burn patients is 4.1-16.6 % and 64.7-74.5%, respectively. The mean 
mortality rate for ACS in burn patients is 74.8%. The use of plasma and hypertonic lactated 
resuscitation may prevent IAH or ACS. Despite colloids decrease resuscitation volume 
needs, no benefit in preventing IAH was proven. Escharotomy, peritoneal catheter 
drainage, and decompression laparotomy are effective intra-abdominal pressure (IAP) 
diminishing treatments in burn patients. Markers for IAP-related organ damage might be 
superior to IAP measurement itself. 
Conclusion: ACS and IAH are frequently seen devastating complications in already severely 
injured burn patients. Prevention is challenging but can be achieved by improving fluid 
resuscitation strategies. Surgical decompression measures are effective and often 
unavoidable. Timing is essential since decompression should prevent progression to ACS 
rather than limit its effects. Prognosis of ACS remains poor, but options for care 
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INTRODUCTION 
Severely injured burn patients are at risk for elevated intra-abdominal pressure (IAP). The 
World Society of Abdominal Compartment Syndrome (WSACS) defines burn injury as an 
independent risk factor for abdominal compartment syndrome (ACS). ACS is a syndrome 
of new organ failure resulting from a sustained or repeated IAP >20 mmHg (1). A sustained 
or repeated IAP ≥12 mmHg without signs of organ failure is termed Intra-Abdominal 
Hypertension (IAH). IAH and ACS are detrimental complications in the critically ill, even 
more in severely burned patients. However, evidenced based medicine for these severely 
injured patients is still in its early development. 
Greenhalgh et al. were the first to describe the occurrence and effects of elevated IAP 
among four cases of burn injury in children in 1994 (2). In a prospective analysis of 30 
severe burn patients, they demonstrated that an IAP ≥30 mmHg is associated with a 3 to 4 
times increased sepsis and mortality rates. This publication initiated an increase of 
awareness of IAP-related complications and its devastating effects. It took until 1999 
before Ivy et al. (3) reported on intra-abdominal hypertension (IAH) and abdominal 
compartment syndrome (ACS) in adult burn patients. IAH and ACS are diagnosed using 
various IAP measuring techniques, measurements can be continuous and direct or indirect 
intra-vesical; this last method is included in the guidelines of WSACS and is accurate in 
burn patients as well (4-6) 
IAH and ACS result from large fluid resuscitation volumes in combination with severe 
systemic inflammatory response syndrome (SIRS) (7). Both resuscitation volume and SIRS 
are dependent of the burn injury severity (8). Even though the most commonly used 
Parkland-Baxter formula states a use of 4mL/kg/% of (burned) total body surface area 
(TBSA), larger volumes are often given (9, 10). This may lead to a phenomenon called ‘fluid 
creep’ which gives rise to excessive edema formation and ‘third spacing’ of the fluid 
excess (11). This is swift process; intra-abdominal edema and ascites leading to IAH can 
emerge within only a few hours after sustaining the burn injury (12). SIRS in these patients 
becomes a self-perpetuating process caused by accumulation of pro-inflammatory 
cytokines in the resulting ascites fluid (13). 
The second main factor that leads to IAH in burn patients are compliance decreasing burns 
of the abdominal or thoracic wall. The compliance curve of a healthy human abdomen 
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shows it can easily contain 3L extra volume without a significant increase in IAP (14). 
When local burn injury is present, the abdominal volume capacity is smaller. Truncal burn 
and increased intra-abdominal volume can raise IAP independently, but when an 
inauspicious combination of these conditions occurs, patients can deteriorate fast. In that 
case, IAP can be relieved rapidly by longitudinal skin incision (escharotomy) of the truncal 
burns or eschars (15, 16). 
ACS related new organ failure typically presents itself as oliguria or ventilation difficulties. 
They result from the body’s inability to compensate and overcome the intra-abdominal 
pressures which gives rise to tissue ischemia. Compensatory ability is strongly patient 
dependent, therefore measuring IAP alone is not sufficient in determining the patient’s 
threat. Abdominal perfusion pressure (APP) defined as the mean arterial pressure (MAP) 
minus the IAP, is more suitable measurement (1, 17). To restore adequate perfusion 
pressures in ACS patients, decompression is needed. Early ACS recognition is of decisive 
importance for prompting such a decompression. Even when early recognition is achieved, 
ACS has a poor prognosis. Mortality rates of 44% up to 100% are reported for burn 
patients with ACS (18, 19). 
Even though IAP-related complications in severe burn patients are dangerous, they occur 
quite common. Prevention of IAH and ACS should receive high priority in severe burn 
patients. Unfortunately resuscitation of burn patients with respect to IAH and ACS is based 
on limited evidence (9, 20, 21). In order to identify the treatment elements that improve 
outcome for these patients, a concise overview of available evidence is needed. The aim 
of this systematic review was to provide a detailed overview of literature regarding 
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METHODS 
A systematic search was conducted in Cochrane Central Register of Controlled Trials, 
PubMed, Embase, Web of Science and CINAHL on October 1, 2012. Databases were 
searched for the following terms: “burn” and synonyms combined with “abdominal 
compartment syndrome” or “intra-abdominal hypertension” and synonyms or 
abbreviations (Table 1). Reference lists of all manuscripts were reviewed to identify 
additional literature. Articles were screened on [title] and [abstract] for the exclusion 
criteria; no burn in combination with IAH or ACS, reviews, comments, animal studies, and 
questionnaire surveys. When no full-text was available after several attempts and when a 
double population was suspected, manuscripts were excluded too. The remaining articles 
were screened in full text and included when original patient data were present. No 
language criterion was used. 
The level of evidence was determined according to Mahid et al. (22). Data regarding risk 
factors, diagnosis, treatment and outcome of these studies were extracted; conclusions of 
individual studies are discussed. 
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RESULTS 
The primary search resulted in 500 hits. After applying the inclusion and exclusion criteria, 
50 manuscripts remained (Figure 1); 21 case-reports or case series and 29 cohort studies. 
Especially the first publications used a variety of definitions and cut points for intra-
abdominal hypertension and abdominal compartment syndrome. Since WSACS stated 
unambiguous definitions for IAH and ACS in 2006, literature became more uniform and 
comparable (1). The heterogeneity in study populations and collected data and the lack of 
details on the IAP measurement techniques across studies made pooled analysis 
impossible. 
Prevalence 
By approximation, IAH prevalence according to WSACS guidelines (≥12 mmHg) is 64.7-
74.5% among patients with ≥20% of TBSA burned or having inhalation injury (Table 2). The 
prevalence of ACS among patients with ≥15% TBSA burned ranged from 4.1% to 16.6% 
(Table 3). Seven of nine manuscripts reported ACS rates between 4% and 16.6 % 
independent of their variety in cutoff burn size.  
Outcome 
In 21 case reports and series, a mortality rate of 50% among 58 burn ACS patients was 
seen (2, 3, 5, 12, 16, 23-38) (Table 4). Nine cohort studies (N=132 total) report mortality 
rates between 44%-100%, with a weighted average of 74.8% (18, 19, 39-45) (Table 5). No 











Several obvious risk factors for ACS in burn patients exist. Decreased abdominal wall 
compliance (caused by local burns) is generally considered to contribute to the 
development of IAH. However, truncal burns are not a prerequisite per se for IAH in burn 
patients (3). Resuscitation volume is the second risk factor for IAH. A small prospective 
case series of nine patients showed that fluid resuscitation volume of 0.25L/kg in the early 
post burn period resulted in an IAP of 24.4 mmHg (27). Exceeding this volume (also 
described as ‘Ivy score’), is a suggested independent risk factor for developing IAH/ACS. 
Oda et al. noted that a resuscitation volume larger 0.3L/kg in the first 24h post burn were 
at risk for ACS (46). 
Greenhalgh et al. described sepsis, oliguria, hypoventilation and hypotension as specific 
signs for IAH or ACS, apart from sepsis evidence was insufficient to determine whether 
these risk factors are independent (1, 2). Additionally, injury severity (in % TBSA burned), 
seems linearly associated with ACS incidence (47). A burn size of ≥40% TBSA proved to be 
an independent risk factor for ACS (25). Electrical etiology of burn injury is another 
possible risk factor; in a matched case control study the ACS prevalence in electrical burns 
patients was 4% vs. 1.5% in thermally injured patients (48). Nonetheless sample size was 
too small to reach statistical significance. The last risk factor is skeletal immaturity; in a 
retrospective study of 1014 patients, six out of 10 cases that developed ACS (mean TBSA 
burned 72%) were non-adults with a mean age of six years (41). 
 
Resuscitation 
Large volumes of resuscitation fluid are needed to maintain appropriate hemodynamics in 
severely burned patients. However, excessive fluid resuscitation may increase the IAP 
level in burn patients (2, 3, 27). Similarly, pediatric burn patient prove to be at risk for 
excessive chylous ascites accumulation as a result of large resuscitation fluid volumes 
leading to ACS (35). A multivariable linear regression analysis of 72 burn patients (mean 
TBSA burned 44.5%), showed percentage TBSA burned, age, weight, and intubation before 
admission to a burn center to significantly influence fluid requirements in the first 24 
hours after burn injury (49). 
Implementation of standardized military volume limiting burn resuscitation guidelines 
resulted in a decrease of a composite endpoint of ACS and mortality (50). Decreasing 
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resuscitation volume of the Parkland formula from 4 to 3 ml/kg/%TBSA is proposed in a 
case report of a pediatric burn patient who developed ACS and died as a result of ‘fluid 
creep’ (36). The use of a modified Brooke formula (2ml/kg/%TBSA) proved to be a good 
alternative as well (51). A statistically significant reduction of resuscitation volumes 
(p=0.005) and peak IAP (p=0.0001) was achieved by using plasma instead of crystalloid 
resuscitation fluid (52). In a randomized trial, a statistically significantly lower resuscitation 
volume (p<0.01) and IAP after 24h (p<0.05) was demonstrated in severe burn patients 
without inhalation injury after resuscitation with hypertonic lactated saline (HLS) 
compared lactated Ringer’s (53). Using colloids to reduce resuscitation volumes was not 
associated with worse outcome in burn patients when compared with the standard 
Parkland formula (54). 
Decompression laparotomy 
Decompression laparotomy is the most used and accepted abdominal decompressive 
measure. Even in children this is an adequate therapy without specified adverse effects 
(19). Although indications for decompression laparotomy are usually straight forward, 
some nuances can be made. Since burn patients have already lost the protective barrier of 
normal skin, there is diversion in opinion whether decompression laparotomy might 
induce unacceptable morbidity. Although hemodynamic parameters in burn patients 
rapidly improve after decompression laparotomy, it does not decrease rates of acute lung 
injury and multi organ dysfunction syndrome (MODS) (55). Acute lung injury and multi 
organ dysfunction syndrome may be more severe after decompression laparotomy than 
before (p<0.05 and p<0.01, respectively) and more severe than in similar severely injured 
burn patients without IAH (p<0.05 and p<0.05, respectively). Similarly, open abdominal 
decompression is associated with higher mortality rates among patients aged 80 years or 
older (81%) than among younger patients (30-50%) (56). If possible, surgeons should 
consider avoiding decompression laparotomy in fragile patient categories. 
Alternative IAP lowering techniques which can be applied prior to decompression 
laparotomy include escharotomy of circumferential abdominal burn wounds, 
percutaneous catheter decompression, bowel care, nasogastric tube decompression, 
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Escharotomy 
When large burns of the trunk are present, abdominal and thoracic wall escharotomy is 
the appropriate early decompressive measure. Thoracoabdominal escharotomy is mostly 
performed in a standardized pattern; an incision in the anterior axillary line bilaterally, one 
along the lower margin of the rib cage and two symmetric longitudinal cuts at the anterior 
abdomen. A small cohort study proved abdominal escharotomy to decrease mean bladder 
pressure significantly in low grade IAH (p<0.001) (16). Another 8-patients cohort study 
demonstrated that escharotomy statistical significantly reduces IAP from 38 to 19 mmHg 
(p<0.01) and results in a direct improvement of cardiovascular parameters in high grades 
of IAH (57). Patients of both studies presented themselves within 2-6 hours after burn 
injury and developed IAH requiring decompressive escharotomy within 24 hours after the 
injury. This endorses the need for early IAP measurement in standard burn care, especially 
when burn injury of the trunk is present. 
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Percutaneous catheter decompression 
IAH in burn patients can occur as a result of accumulation of ascites and bowel edema. 
Percutaneous catheter decompression decompresses the abdomen by releasing the 
ascites without influencing the edema. When ascites is present, placement of a peritoneal 
dialysis catheter or angiocatheter (depending on patient size) and leaving it sutured in 
place is generally sufficient. In a small study, this minimally invasive measure decreased 
the IAP by 14 mmHg, with a rapid improve in hemodynamic parameters (26). A 13-patient 
cohort study concluded percutaneous catheter decompression to be effective in patients 
with <80% TBSA burned with concomitant inhalation injury. More severely injured 
patients required decompression laparotomy and died (44). The effectiveness of 
percutaneous catheter decompression with respect to abdominal perfusion pressure 
(APP) was confirmed in a case report (32). Lastly, a retrospective case-control study 
determined percutaneous catheter decompression to be a safe decompression alternative 
(43). Nonetheless, when no signs of ascites are present, this technique is obsolete. 
Peritoneal catheter decompression is indicated when escharotomy has failed (40), beware 
of non-functioning catheters.  
Temporary abdominal closure 
When faced with an open abdomen after decompression laparotomy, the question raises 
how to close it. Closing an open abdomen is especially difficult in patients with abdominal 
burns. In order to prevent complications of the open abdomen, temporary abdominal 
closure device can be used. Temporary abdominal closure devices again cause additional 
damage to the already injured abdominal wall and are associated with infectious 
complications such as abscess and fistula formation. In a six-patient cohort study, four 
burn patients died of sepsis with MODS after applying a vacuum-assisted TAC (42). 
To bridge the period unto definitive abdominal closure, visceral coverage should be 
preferred over vacuum assisted temporary abdominal closure devices until proven to be 
safe in burn patients. The possibility for early partial abdominal closure should be regularly 
assessed in order to prevent persistent dehiscence. The component separation technique 
of Ramirez is a primary closure technique which does not use foreign materials (34, 58). In 
a series of burn patients with ACS, two patients survived more than 30 days after 
abdominal closure with this technique (34). No intra-abdominal abscess and entero-
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The danger for ACS remains after temporal abdominal closure (23). Recurrent or tertiary 
ACS endorses the need for continued IAP monitoring after temporary closure 
Management 
IAH in burn patients is frequently a result of large resuscitation volumes, but this may lead 
to other complications such as acute ischemic optic neuropathy as well (33). This ‘fluid 
creep’ is a dangerous condition of which IAH (and ACS) is only a single expression. Acute 
kidney injury, a possible complication of IAH/ACS, does not help in draining this volume 
overload. Acute kidney injury is found in 40% of severely burned patients with ACS, and is 
associated with 50% mortality rate (59). Burn patients with AKI require dialysis, which is 
associated with high mortality rates as well. Renal deterioration in burn patients can be 
reduced by diminishing the use of nephro-toxic medication (60). If IAH emerges, one 
should be aware of this other severe non-surgical or systemic complications. These 
complex multi-system complications require a multi-disciplinary approach, in which 
intensivists, surgeons, anesthesiologists, and nutritionists can play a crucial role in patient 
survival (37, 61, 62).
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DISCUSSION 
This systematic review listed best literature regarding prevalence, treatment and outcome 
of IAH and ACS in severe burn patients, and provides more clarity regarding occurrence 
and mortality of ACS in burn patients. There are several shortcomings of the individual 
reports, the most obvious being the limited level of scientific evidence. Moreover, most 
papers do not mention clearly whether the diagnosis IAH was made based upon a one 
time “peak” measurement or on repeated sequential measurements. Nevertheless, some 
amendments can be made for this review as well. For example, the broad range of interest 
of this search aims at most important findings of the available literature regarding IAP-
related complications in severe burn patients. Subsequently, minor details were not 
mentioned in this report. Much literature is available regarding burn care or ACS and IAH, 
but little and often poor evidence is found on the combination of conditions. More 
research is needed to decrease IAP related morbidity and mortality. A promising clue for 
this can be found in the following. Even though a large increase in use in abdominal 
decompressions is seen, no decrease in laparotomies for IAH related non-occlusive 
intestinal ischemia was seen over recent years (45). This ischemia induces massive 
inflammatory response which creates a vicious circle which indirectly leads to the 
development of ACS. Tools for early recognition of IAP related splanchnic ischemia are not 






A systematic review on IAP in severely burned patients 119
CONCLUSION 
Abdominal compartments syndrome and especially intra-abdominal hypertension are 
frequently seen devastating complications in the already severely injured burn patients. 
IAH prevalence is 64.7-74.5% among patients with ≥20% TBSA burned or with inhalation 
injury. ACS is seen in 4.1-16.6% of patients with ≥15% of TBSA burned. IAH or ACS can be 
prevented by decreasing resuscitation volume. Strict monitoring of urine output or 
hemodynamic parameters to prevent ‘fluid creep’ is of great importance. Using the 
modified Brooke formula, plasma, hypertonic lactated or colloid resuscitation is preferred 
over crystalloid use, especially in more severely injured, older and heavier patients 
intubated prior to admission on a burn unit.  
Truncal burns in ACS patients require immediate escharotomy and should be followed by 
increasingly invasive decompression measures if no relieve is achieved. Timing of 
decompression is essential since it should rather prevent progression to abdominal 
compartment syndrome than limiting its effects.  
Prognosis of abdominal compartments syndrome is very poor with a mean mortality rate 
of 74.8%. IAH/ACS-burn patient outcome can be further improved by superior 
resuscitation regimes, better understanding of the inflammatory response after burn 
injury and tools for early recognition of splanchnic ischemia. 
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Table 1: Search query 
(burn OR burns OR burning OR burnings OR burned OR burnt OR scald OR scalds OR 
scalding OR scorch OR scorching OR singe OR singed OR blaze OR blazed OR “blast 
injury” OR “blast injuries”) AND (“abdominal compartment syndrome” OR ACS OR 
“abdominal compartment syndromes” OR “abdominal compartmental syndrome” OR 
“abdominal compartmental syndromes” OR “abdominal hypertension” OR “intra-
abdominal hypertension” OR “IAH” OR “intra abdominal hypertension” OR “abdominal 
pressure” OR “intra-abdominal pressure” OR “intra abdominal pressure” OR “IAP”) 
122 CHAPTER 5
Table 2: Prevalence of IAH among burn patients 
Author LOE Burn cutoff IAH cutoff N= Prevalence 
Oda et al. (2006) (53)  2 ≥40% TBSA ≥22mmHg* 36 36%* 
Sanchez et al. (2009) (63)  5 Mech. Vent. ≥12mmHg 33 64.7% 
Malbrain et al (2010) (64) 3 Mech. Vent. ≥12mmHg 55 74.5% 
*WSACS stated IAH cutoff pressure at 12 mmHg, therefore this number is of less
relevance. 
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Table 3: Prevalence of ACS among burn patients 
Author LOE Cutoff point N= Prevalence 
Hobson et al. (2002) (41) 3 ‘Acute burn’ 1014 1% 
Markel et al (2009) (47) 3 ‘Acute burn’ 51 1.8% 
Oda et al (2006) (46) 3 ≥40% TBSA 48 16.6% 
Ennis et al (2008) (50) 3 ≥30% TBSA 118 11% 
Mosier et al (2011) (61) 3 ≥20% TBSA 153 4.6% 
Klein et al (2007) (49) 3 ≥20% TBSA 72 4.2% 
Yenikomshian et al (2011) (62) 3 ≥20% TBSA 50 8% 
Cartotto et al (2010) (18) 3 ≥15% TBSA 194 4.1% 
Dulhunty et al (2008) (54) 3 ≥15% TBSA 80 16% 
Seven of nine cohort studies reported ACS prevalence of 4.1-16 % among patients burned 
≥15% TBSA 
TBSA, Total Body Surface Area burned; LOE, Level Of Evidence according to Mahid et al 
(22)
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Table 4: Mortality of severe burn patients with ACS in case descriptions 
Author N Mortality 
Greenhalgh et al (1994) (2) 4 3 (75%) 
Ivy et al (1999) (3) 3 3 (100%) 
Ivy et al (2000)(27) 10 2 (20%) 
Mayes et al (2000) (31) 2 1 (50%) 
Corcos et al (2001) (26) 3 2 (67%) 
Wilson et al (2001) (38) 1 0 (0%) 
Blinderman et al (2002) (24) 1 1 (100%) 
Tsoutsos et al (2003) (16) 10 4 (40%) 
Pirson et al (2004) (33) 1 0 (0%) 
Britt et al (2005) (25) 4 4 (100%) 
Rodas et al (2005) (12) 1 0 (0%) 
Ball et al (2006) (23) 1 0 (0%) 
Jensen et al (2006) (28) 3 2 (67%) 
Levis et al (2006) (30) 4 3 (75%) 
Parra et al (2006) (32) 1 0 (0%) 
Muangman et al (2007) (5) N/A 
Poulakidis et al (2009) (34) 3 2 (67%) 
Thamm et al (2009) (37) 1 0 (0%) 
Lamb et al (2010) (29) N/A 
Rogers et al (2010) (36) 1 1 (100%) 
Rocourt et al (2011) (35) 2 0 (0%) 
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Table 5: Mortality of severe burn patients with ACS in cohort studies 
Author LOE N Mortality 
Hobson et al (2002) (41) 3 10 6 (60%) 
Latenser et al (2002) (44) 5 4 4 (100%) 
Hershberger et al (2007) (40) 5 25 22 (88%) 
Chung JY et al (2007) (39) 5 9 5 (56%) 
O’Mara et al (2007) (19) 5 16 7 (44%) 
Latenser et al (2008) (43) 4 9 4 (44%) 
Keremati et al (2008) (42) 5 6 4 (67%) 
Cartotto et al (2010) (18) 3 8 8 (100%) 
Van Niekerk et al (2010) (45) 3 45 39 (87%) 
Total 132 74.8% 
LOE, level of evidence according to Mahid et al (22) 
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Background: Intra-abdominal hypertension (IAH) and abdominal compartment syndrome 
(ACS) have detrimental effects on all organ systems and are associated with increased 
morbidity and mortality in critically ill patients admitted to an intensive care unit. Intra-
bladder measurement of the intra-abdominal pressure (IAP) is currently the gold standard. 
However, IAH is not always indicative of intestinal ischemia, which is an early and rapidly 
developing complication. Sensitive biomarkers for intestinal ischemia are needed to be 
able to intervene before damage becomes irreversible. Gut wall integrity loss, including 
epithelial cell disruption and tight junctions breakdown, is an early event in intestinal 
damage. Intestinal Fatty Acid Binding Protein (I-FABP) is excreted in urine and blood 
specifically from damaged intestinal epithelial cells. Claudin-3 is a specific protein which is 
excreted in urine following disruption of intercellular tight junctions. This study aims to 
investigate if I-FABP and Claudin-3 can be used as a diagnostic tool for identifying patients 
at risk for IAP-related complications. 
 
Methods/Design: In a multicenter, prospective cohort study 200 adult patients admitted 
to the intensive care unit with at least two risk factors for IAH as defined by the World 
Society of the Abdominal Compartment Syndrome (WSACS) will be included. Patients in 
whom an intra-bladder IAP measurement is contra-indicated or impossible and patients 
with inflammatory bowel diseases that may affect I-FABP levels will be excluded. The IAP 
will be measured using an intra-bladder technique. During the subsequent 72 hours, the 
IAP measurement will be repeated every six hours. At these time points, a urine and 
serum sample will be collected for measurement of I-FABP and Claudin-3 levels. Clinical 
outcome of patients during their stay at the intensive care unit will be monitored using the 
Sequential Organ Failure Assessment (SOFA) score. 
 
Discussion: Successful completion of this trial will provide evidence on the eventual role of 
the biomarkers I-FABP and Claudin-3 in predicting the risk of IAP-associated adverse 
outcome. This may aid early (surgical) intervention. 
 











Patients undergoing major surgery or sustaining severe trauma are at risk of developing 
morbidity and mortality from postoperative or posttraumatic systemic inflammatory 
response syndrome, sepsis and multiple organ dysfunction. The development of such 
potentially lethal complications in otherwise healthy patients is poorly understood. Data 
from a prospective multicenter epidemiological study showed that intra-abdominal 
hypertension (IAH) is associated with increased morbidity and mortality rates in critically 
ill patients admitted to an intensive care unit (ICU) (1,2). Therefore, early identification of 
patients at risk for IAH-related morbidity and mortality can be potentially lifesaving. 
 
Intra-abdominal pressure and intra-abdominal hypertension 
Compliance of the abdominal wall together with the abdominal content determines the 
intra-abdominal pressure (IAP) level. Under physiologic situations, the IAP level is below 
12 mmHg. Increased pressure in the abdomen is known as intra-abdominal hypertension 
(IAH). This is defined as a sustained IAP ≥12 mmHg (3). IAH results in reduced blood flow 
to most organs, with consequent dysfunction of the cardiovascular, respiratory, renal, 
gastrointestinal, and central nervous systems. An IAP >20 mmHg in combination with new 
organ dysfunction is indicative of an abdominal compartment syndrome (ACS). The 
ultimate treatment of ACS is a decompressive laparotomy. Risk factors for ACS include 
leakage of an aneurysm of the abdominal aorta, closing the abdomen under pressure after 
abdominal surgery, damage control laparotomy, hyper-hydration during hypovolemic 
shock, pancreatitis, and pulmonary contusion. These risk factors may apply to a majority 
of patients in the ICU. The mortality risk in patients with ACS may be as high as 80% (1). 
The current gold standard measurement tool as put forward by the World Society of the 
Abdominal Compartment Syndrome (WSACS; www.wsacs.org) is an intra-bladder pressure 
measurement. This is a simple, minimally invasive method, and the results are 
immediately available (3). From a clinical perspective, however, the IAP level does not 
always represent the presence of intestinal ischemia and as such is not a perfect indicator 
for clinical outcome nor surgical therapy. Sensitive biomarkers indicative of early (i.e., 
reversible) organ dysfunction are therefore needed as additional diagnostic tool. The 
combination of increased IAP and a biomarker level that represents organ damage would 






Biomarkers released upon loss of small intestinal integrity 
Evidence is accumulating that the intestines play a central role in the origin of 
postoperative and posttraumatic sequelae (4-6). Enterocyte damage and tight junction 
loss can be triggered by IAH, and both result in loss of intestinal integrity. As a 
consequence, toxins, bacteria, and undigested food particles may pass the enterocyte 
layer, enter the underlying vasculature, and trigger systemic inflammatory reactions that 
may progress to multiple organ dysfunction syndrome and even death. Peptides released 
upon enterocyte damage (e.g., Intestinal Fatty Acid Binding protein; I-FABP) or tight 
junction loss (e.g., Claudin-3) are potentially ideal biomarkers that will help identify 
patients with early IAH-induced intestinal damage. 
I-FABP is a small (14–15 kDa) protein that is exclusively present in mature enterocytes of 
the small and large intestine. It is released into the circulation upon enterocyte membrane 
integrity loss and rapidly excreted into the urine (half-life 11 minutes). Elevated I-FABP 
levels have been found in plasma, serum, and urine in patients with intestinal ischemia, 
celiac disease, systemic inflammatory response syndrome and necrotizing enterocolitis (7-
15). I-FABP levels can be measured sensitively in plasma, serum, and urine using an 
enzyme-linked immunosorbent assay (ELISA) (7, 8). 
Claudins are small (22 kDa) tight junction proteins (4,16-19). Especially Claudin-3 is 
expressed in high quantities solely in the intestine (18). The amount of Claudin-3 in the 
intestine decreases after tight junction integrity loss (17). Breakdown of tight junctions by 
loss of Claudins (as measured on Western blots in urine) is an early event in intestinal 
damage, resulting in intestinal barrier loss (20). 
The main aim of the current study is to investigate if urinary levels of I-FABP can be used 
as a diagnostic tool for identifying patients at risk for IAP-related complications. Secondary 
aims are to determine the same for serum levels of I-FABP and for urinary and serum 










METHODS / DESIGN 
 
Study design and setting 
Multicenter prospective observational study of 200 patients admitted to the ICU of 
Erasmus MC, University Medical Center Rotterdam (Rotterdam, The Netherlands) or 
Radboud University Medical Center Nijmegen (Nijmegen, The Netherlands), who are at 
risk for developing IAH or ACS according to the definitions of the World Society of the 
Abdominal Compartment Syndrome (3). Since it was suggested that patients who have 
undergone liver transplantation should also be screened for IAH (21, 22), liver 
transplantation has been added to the list of risk factors. The study is registered at the 
Netherlands Trial Register (NTR4638). 
 
Study population and eligibility criteria 
All adult patients admitted to the ICU who have at least two risk factors for developing IAH 
or ACS according to the WSACS will be eligible for inclusion (3). 
Patients meeting the following inclusion criteria will be eligible for enrolment: 
1. Patients with at least two risk factors putting them at risk for IAH or ACS as agreed by 
the WSACS. Risk factors may be present already at admission, but also patients 
developing risk factors during ICU stay will be eligible from that moment onwards; 
2. Age 18 or older, with no upper age limit; 
3. Signed informed consent by patient or proxy. 
If any of the following criteria applies, patients will be excluded: 
1. Patients in whom intra-bladder pressure measurement is contra-indicated. This 
includes patients with bladder trauma or hematuria; 
2. Patients in whom intra-bladder pressure measurements are not reliable due to intra-
peritoneal adhesions, bladder oppressive pelvic hematoma, abdominal packs in situ, 
(previous) bladder tumor or previous bladder removal; 
3. Patients with any inflammatory bowel disease that may affect I-FABP levels. 
Exclusion of a patient because of enrolment in another ongoing drug or surgical 







Patients with increased pressure determined by the intra-bladder pressure measurements 
will be treated in compliance with the algorithms for patient management as developed 
by the WSACS (www.wsacs.org/algorithms.php) (3). The IAH Assessment Algorithm 
describes all risk factors that every patient should be screened for upon intensive care unit 
admission and upon clinical deterioration leading to new organ dysfunction. The intra-
bladder pressure will be measured in patients with two or more risk factors for IAH or ACS 
or in patients who have undergone a liver transplantation. Patients who do not have two 
or more risk factors at baseline but develop new risk factors during their ICU admission 
will be followed from that moment onwards. The reason for this is that the occurrence of 
IAH during intensive care stay is known to be an independent predictor for mortality, 
whereas presence of IAH at intensive care admission is not (23). Patients should be 
enrolled as soon as possible, but at least within 48 hours after meeting the eligibility 
criteria. The IAH/ACS Management Algorithm provides a decision tree for the follow-up of 
patients related to the IAP level. The IAH/ACS Medical Management Algorithm provides a 
stepwise approach of actions to be taken for achieving IAP pressure relief. In short, ICU 
management will be provided by the attending physicians and may consist of, among 
others, balanced intravenous fluid administration, correction of hypovolemia, electrolyte 
disturbances and/or anemia and analgesics. 
 
Outcome measures 
I-FABP levels will serve as primary outcome measure. Urinary and serum concentrations of 
I-FABP will be analyzed in duplicate using a highly specific, commercially available enzyme-
linked immunosorbent assay (ELISA) that selectively detects human I-FABP (HyCult 
Biotechnology, Uden, The Netherlands). The ELISA will be performed following the 
supplier’s protocol. I-FABP levels in urine will be adjusted to urinary creatinine levels. 
Claudin-3 levels will serve as secondary outcome measure. Urinary levels of Claudin-3 will 
be analyzed in duplicate either by ELISA (if available at time of analysis) or by Western 
blotting. Claudin-3 levels in urine will be adjusted to urinary creatinine levels. If analyzed 
from Western blots, equal amounts of each sample (adjusted to urinary creatinine levels) 
will be separated by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-









primary antibody to Claudin-3 (Rabbit anti-claudin-3 (34–1700), Zymed Laboratories, San 
Francisco, CA). After incubation with goat anti rabbit HRP-conjugated secondary antibody 
(Jackson, West Grove, PA), a signal will be detected by supersignal west pico 
chemiluminescence substrate (Pierce, Etten-Leur, the Netherlands). Band intensities for 
each sample will be semi-quantitatively analyzed using Quantity One (Biorad, Hercules, 
CA). This is a straightforward approach for semi-quantitative assessment of protein levels. 
Urinary creatinine levels in the collected samples will be determined at the Clinical 
Chemistry department. The occurrence of (increasing) organ dysfunction will be based 
upon the SOFA score. 
 
Baseline, disease and treatment-related data 
In addition to the outcome variables mentioned above, the following data will be 
collected: 
 






Disease-related variables at admission: 
• Reason of admission to the ICU (i.e., type of disease or injury and type of intervention) 
• Serum lactate concentration at baseline (sodium fluoride tube) 
• IAP level at baseline 
• Urinary creatinine level at baseline (sediment tube) 
• Acute Physiology and Chronic Health Evaluation II (APACHE II) score at baseline; this is a 
validated and commonly applied severity of disease classification system (24). An 
integer score ranging from 0 to 71 is computed based upon 12 routine physiological 
measurements with a higher score implying a more severe disease and a higher risk of 
death. 




standardized scoring metrics was developed in 2005 as an improved version of the 
APACHE II. The previously used set of equations were re-evaluated and improved 
where needed. The most important change involved the new categorization of disease 
groups (25). 
• Simplified Acute Physiology Score II (SAPS II) at baseline; this score was designed to 
measure the severity of disease for patients admitted to Intensive care units aged 15 or 
more (26). The SAPS II score is calculated from 12 routine physiological measurements 
during the first 24 hours of ICU admission, information about previous health status 
and some information obtained at admission. The computed score has a range from 0 
to 163 points and a predicted mortality between 0% and 100%. Higher scores imply a 
more severe disease and a higher risk of death. 
• Sequential Organ Failure Assessment (SOFA) score at baseline; this score is a validated 
and commonly used score to track a patient’s status during the stay in an ICU. The SOFA 
score is a scoring system to determine the extent of a person’s organ function or rate of 
failure (27-31). The score is based upon six different scores, one each for the 
respiratory system (i.e., PaO2/FiO2 ratio), the cardiovascular system (i.e., mean arterial 
pressure and vasopressor requirement), the hepatic system (i.e., bilirubin level), the 
coagulation system (i.e., platelet count), the renal system (i.e., creatinine level or urine 
output), and the neurological system (i.e., Glasgow Coma Score). For each of these 
systems, a maximum of four points can be attributed. SOFA scores are determined on a 
daily basis during ICU admission. 
 
Treatment-related variables: 
• Medication use 
• Interventions performed (i.e., type and number of interventions) 
• Sequential Organ Failure Assessment (SOFA) score on day 1 to 4 (or until ICU discharge 
or death). 
• Length of stay in the ICU 











Sample size calculation 
In order to reliably calculate correlation coefficients for the association between IAP, I-
FABP and Claudin-3 levels, at least 75 patients with IAH are needed. Malbrain et al. 
showed in a multicenter study that in a general ICU population, the prevalence of IAH (i.e., 
IAP > 12 mmHg) and ACS (i.e., IAP > 20 mmHg with concomitant new organ dysfunction) 
was 32%, and 4%, respectively (23). Since we will only follow-up on patients with a 
minimum of two IAH/ACS risk factors, the percentage of enrolled patients that will 
develop IAH or ACS will be higher, and is likely to exceed 40% (unpublished data). 
Therefore, enrolling a total population of 200 patients will be sufficient to ascertain 
availability of 80 patients with IAH. 
This will also be sufficient to compare I-FABP levels in patients with physiologic IAP levels 
with patients that developed IAH with adequate statistical power. Based upon data 
provided by Kanda et al. we expect that mean I-FABP levels will be 20.0 ± 10.0 ng/mL 
(range 0–100 ng/mL) in patients without IAH (32). In patients with IAH, the I-FABP levels 
will be higher (≥20 ng/mL). An overall population of 200 patients (consisting of 120 
controls and 80 patients with IAH) will be sufficient to detect a 0.5 SD increase to 30.0 ± 
12.5 ng/mL in I-FABP level in patients with IAH (two-sided test with an α level of 0.05) with 
>90% statistical power. 
 
Recruitment and consent 
Upon identification of two IAH risk factors, treatment should be initiated in compliance 
with international guidelines of the WSACS. This implies that the baseline IAP 
measurement and the first urine sample may have been collected prior to obtaining 
informed consent from the patient or his/her legal representative. Eligible persons 
admitted to the ICU who are at risk for developing IAH will be informed about the trial and 
asked for consent at the ICU. If patients are unconscious or otherwise not able to sign 
informed consent, their legal representative will be informed about the trial and asked to 
sign informed consent on behalf of the patient. Upon recovery the patient will be asked to 
sign final consent. The patient and their legal representative will receive information and a 
consent form from the attending physician, the clinical investigator or a research assistant. 
If a patient or his/her legal representative decides not to sign informed consent, data and 







In patient with ≥2 risk factors for IAH or ACS, the intra-abdominal pressure will be 
measured using an intra-bladder technique. The modified Kron technique described by 
Cheatham and Safcsak (33) will be applied for measuring IAP. In the current study, 20 mL 
of saline will be used in order to comply with the current recommendations of the WSACS. 
For the IAP measurement, a Foley catheter will be disconnected and a 3-way-valve will be 
inserted to create a continuous connection to a pressure transducer (DTXPlusTM PRESS PA, 
reference No 686496; Argon Critical Care Systems, Singapore). For every single 
measurement the valve connecting the urinary drainage bag is closed and 20 mL of saline 
is instilled. The mid-axillary line will be used as reference. During the first 72 hours after 
enrolment, IAP measurement will be repeated every six hours (Table 1). At those time 
points (including baseline), the following samples will be collected: 
 
Table 1: Schedule of enrolment, interventions, and assessments 
 Study period 
 Enrolment * Measurement ** Close-out 
TIMEPOINT <T0 T0 to T72 ICU discharge 
ENROLMENT:    
Eligibility screen X   
Informed Consent X   
ASSESSMENTS:    
Baseline variables X   
Disease-related variables X   
IAP measurement  X  
Blood sample  X  
Urine sample  X  
I-FABP measurement  X  
Claudin-3 measurement  X  
Creatinine measurement  X  









SOFA score  X  
Adverse events  X X 
Length of ICU stay  X X 
Mortality during ICU stay  X X 
Secondary interventions  X X 
* Patients are considered eligible as soon as two IAH risk factors are present. This can 
either be at ICU admission or later on during ICU stay. 
**Patients are followed until 72 hours or until discharge from the ICU, whichever comes 
first. Measurements are performed every six hours. 
1) Urine samples for measurement of I-FABP, Claudin-3 and creatinine levels: A single 
fresh specimen of urine will be collected from the urinary bladder catheter that is 
already in situ. Samples will be kept on ice and then frozen at −80°C in aliquots within 
two hours of collection. 
2) Blood samples for measurement of serum I-FABP levels (NB: this only applies to 
patients enrolled at Erasmus MC, Rotterdam, the Netherlands): A single blood sample 
(10 mL) will be drawn from the arterial line that is already in situ. Blood will be collected 
in pre-chilled vacutainer containing EDTA as anticoagulent (BD Vacutainer, Becton 
Dickinson Diagnostics, Aalst, Belgium) and kept on ice. Blood will be centrifuged at 4°C, 
4000x g for 15 minutes. Serum will be stored in aliquots at −80°C within 2 hours until 
analysis. 
The reason for following up on patients during the first 72 hours after enrollment is based 
upon our observation (unpublished data) that over 95% of patients that deteriorate 
clinically due to increased IAP will do so during the 12–24 hours. In order not to miss any 
patients that may deteriorate somewhat later (e.g., due to leak at the surgical site), we 
have set the time frame at 72 hours. 
In order to assess if levels of I-FABP or Claudine-3 can be used as a prognostic marker for 
intestinal ischemia-related morbidity it is necessary to also collect clinical data of patients 
during their entire stay at the ICU. These data will be extracted from the ICU patient data 
management system (PDMS), where they are stored as part of clinical routine. This will be 
done using the APACHE II, APACHE IV, SAPS II and SOFA score, which will be collected 
routinely for any patient admitted to the ICU. Follow-up in the ICU will include a daily 




other ancillary tests as required. The attending physicians will record complications and 




Most variables will be collected as part of standard of care and are routinely recorded in 
electronic patients records. The intra-abdominal pressure will be measured by the ward 
nurse and recorded in the PDMS system and on case record forms (CRF). This CRF contains 
no patient identifiers. Urine and serum samples will be collected, processed and frozen at 
−80°C by the researchers or a research nurse. I-FABP and Claudin-3 levels will be 
measured by the researcher (SGS) and results will be recorded in the CRF. CRFs are stored 
and secured at the hospital where the patient is included. 
Data management 
Research data will be stored in a database (SPSS), and will be handled confidentially and 
anonymously. Research data that can be traced to individual patients can only be viewed 
by authorized personnel. These persons are the members of the research team, members 
of the health care inspection, and members of the Medical Ethics Committee Erasmus MC. 
The handling of personal data will be in compliance with the Dutch Data Protection Act 
and the privacy regulation of the Erasmus MC. 
Research data will be stored under a code number. Only the code number will be used for 
study documentation, progress reports and publications. The principal investigator and 
research assistant are the only persons with the information linking individual persons to 
study code numbers. Patient data and materials will be stored for a maximum of 15 years 
after the end of the study. Patients need to consent with this, and if not, their materials 
will be disposed of upon termination of the study. 
 
Statistical analysis 
Data will be analyzed at the end of the study using the Statistical Package for the Social 
Sciences (SPSS) version 21 or higher (SPSS, Chicago, Ill., USA) and will be reported 
following the STrengthening the Reporting of OBservational studies in Epidemiology 
(STROBE) guidelines. No interim analysis will be done. Normality of continuous data will be 
assessed by the Shapiro Wilk tests and by inspecting the frequency distributions 









Descriptive analysis will be performed in order to report baseline characteristics (intrinsic 
variables and disease-related variables) and outcome measures of the entire cohort as 
well as for the group of patients that develop IAH (IAH group; IAP of 12 mmHg or higher 
on two separate recordings) versus those that do not (control group). For continuous data 
mean and SD (parametric data) or medians and percentiles (non-parametric data) will be 
calculated and reported. For categorical data, numbers and frequencies will be calculated 
and reported for the entire cohort and for the IAH and the control group separately. 
Univariate analysis will be performed in order to test the difference in the primary and 
secondary outcome measures between the IAH group and the control group. Continuous 
data such as the I-FABP level (primary outcome) of the Claudin-3 level (secondary 
outcome) will be tested using a Student’s T-test (parametric data) or a Mann Whitney U-
test (non-parametric data). Chi-squared analysis will be used for statistical testing of 
categorical data such as the number of secondary interventions. A p-value <0.05 will be 
taken as threshold of statistical significance. Depending upon the number of patients 
within the cohort of the study that develop ACS and the mortality rate, similar tests will be 
used to compare data for those who developed ACS (or those who died) versus those who 
did not. The patient cohort to be included will be heterogeneous by nature, as IAH and 
ACS risk factors will differ between patients. If it is possible to identify subgroups of 
patients (e.g., liver transplant patients) subgroup analyses may be performed. P-values 
<0.05 will be taken as threshold of statistical significance. 
The prognostic role of the I-FABP and Claudin-3 on development of IAH, ACS, (increasing) 
organ dysfunction (based upon SOFA increase) or mortality will be assessed. This analysis 
will be performed with Stata software, version 10.0 or higher (StatCorp LP, College 
Station, TX, USA), using the generalized linear latent and mixed model (GLLAMM) 
framework. Herein, the binary outcome IAH (or new organ dysfunction or ACS or 
mortality) will be used as dependent variable, and the level of I-FABP or Claudin-3 will be 
included in the model as time-dependent variable. Patient ID will be included as clustering 
variable as up to 13 measurements per patient will be available. Additional covariates such 
as age, gender, number of IAH risk factors, and BM will be entered into the model in order 
to evaluate their effect on the relation between biomarker level and outcome. Random 
intercept and slope will be considered. Results will be expressed as Odds Ratios with their 






No data monitoring committee has been established as this study is not an interventional 
study and all data are either recorded in patient files (i.e., all clinical data including 
baseline, disease-related and treatment-related variables) as part of standard of care, or 
are generated electronically (i.e., ELISA results and laboratory tests). A random sample of 
at least 10% of all data will be double checked by a member of the research team in order 
to check the quality of the data entry into the database. The only exception to this will be 
the primary outcome, for which 100% of data will be checked. 
 
Ethical considerations 
The study will be conducted according to the principles of the Declaration of Helsinki (64th 
World Medical Association General Assembly, Fortaleza, October 2013). This study has 
been given a waiver by the medical research ethics committee (MREC) Erasmus MC, 
University Medical Center Rotterdam (Rotterdam, The Netherlands; reference number 
MEC-2011-016) and by the local hospital board in the participating center (Radboud 
University Medical Center, Nijmegen, The Netherlands). Following review of the protocol 
(version 1.0, dd December 13, 2010), the MREC concluded that this study is not subject to 
the Medical Research Involving Human Subjects Act (WMO, in Dutch “Wet Medisch-
wetenschappelijk Onderzoek met mensen”). They concluded that the study is a 
medical/scientific research, but no patients are subjected to procedures or are required to 
follow rules of behavior. Consequently, the statutory obligation to provide insurance for 
subjects participating in medical research (article 7, subsection 6 of the WMO and Medical 
Research (Human Subjects) Compulsory Insurance Decree of 23 June 2003) was also 
waived. The reason for this dispensation is that participation in this study is without risks. 




Research data can be presented or publicized in agreement with the clinical investigator 
and project leaders only. No research data that can be traced to individual persons will be 










Every year, approximately 80,000 patients are admitted to an ICU in the Netherlands (34). 
Specific groups of patients such as those who underwent major surgery (e.g., vascular or 
intestinal surgery) or who sustained severe trauma are at risk of developing morbidity and 
mortality from postoperative or posttraumatic systemic inflammatory response syndrome, 
sepsis and multiple organ dysfunction. The development of such potentially lethal 
complications in relatively healthy surgical or trauma patients is poorly understood. 
Evidence is accumulating that intra-abdominal hypertension plays a central role in the 
origin of such postoperative and posttraumatic sequelae. An increased intra-abdominal 
pressure level is currently the best indicator of intra-abdominal complications. However, 
the IAP level does not always represent the presence or absence of organ dysfunction, 
substantial intra-abdominal damage may be present already prior to the development of 
IAH and ACS. There is a distinctive need for a non-invasive early-onset diagnostic test and 
biomarkers. The main aim of the current study is to test if urinary I-FABP or Claudine-3 
levels can be used as diagnostic tool for identifying patients at risk for IAP-related 
complications. This marker can then be used in order to take the necessary clinical 
measures (e.g., decompressive laparotomy) before the IAP has reached the level of 
irreversible damage to vital organs. This may prevent serious morbidity or even death in a 
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ACS, Abdominal compartment syndrome; APACHE II, Acute physiology and chronic health 
evaluation II; APACHE IV, Acute physiology and chronic health evaluation IV; ELISA, 
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Objective: Critically ill patients are at risk for intra-abdominal hypertension (IAH) and 
related complications such as organ failure, abdominal compartment syndrome (ACS), and 
death. This study aimed to determine the value of urinary and serum intestinal fatty acid 
binding protein (I-FABP) levels as early marker for IAH-associated complications. 
 
Methods: A prospective observational study was conducted in two academic institutional 
mixed medical-surgical ICUs in the Netherlands. Adult patients admitted to the ICU with 
two or more risk factors for IAH (198) were included. Urinary and serum I-FABP and intra-
abdominal pressure (IAP) were measured every six hours during 72 hours.  
 
Results: Fifteen (8%) patients developed ACS and 74 (37%) developed new organ failure. I-
FABP and IAP were positively correlated. Patients who developed ACS had higher median 
baseline levels of urinary I-FABP (235(P25-P75 85-1747)µg/g creat) than patients with IAH 
who did not develop ACS (87(P25-P75 33-246)µg/g, p=0.037). With an odds ratio of 1.00, 
neither urinary nor serum I-FABP indicated increased risk for developing new organ failure 
or ACS. 
 
Conclusions: While statistical differences between groups were observed, I-FABP levels 
have no value in the early identification of individual patients at risk for IAH-related 














Increased pressure in the abdomen, known as intra-abdominal hypertension (IAH), plays 
an important role in the development of complications in critically ill patients (1). 
Increased pressure in the abdomen, known as intra-abdominal hypertension (IAH), plays 
an important role in the development of complications in critically ill patients (2). 
Untreated, ACS is associated with high morbidity and mortality rates (3). The ultimate 
treatment of IAH is a decompressive laparotomy.  
Risk factors for IAH and subsequent ACS include massive bleeding (e.g. from a ruptured 
aneurysm of the abdominal aorta or trauma), a severe inflammatory state resulting in 
edema and ascites (e.g after abdominal surgery, hyper-hydration to treat hypovolemic 
shock or pancreatitis). These risk factors may apply to a relevant percentage of the 
patients admitted in the ICU. In case ACS develops, the associated mortality risk may be as 
high as 80% (4). Early identification of patients at risk for ACS and IAH-related 
complications might improve outcome. The current gold standard, as put forward by the 
World Society of the Abdominal Compartment Syndrome (WSACS; www.wsacs.org), 
requires intra-bladder pressure measurements (2). This is a simple and cheap technique, 
yielding immediate results. However, the level of IAP alone is neither a reliable indicator 
for clinical outcome, nor does it indicate when surgical therapy should be considered as 
clinical decision-making also involves other parameters (5, 6). In this context, intestinal 
fatty acid binding protein (I-FABP) may be of interest. 
 
In this context, intestinal fatty acid binding protein (I-FABP) may be of interest. I-FABP is a 
peptide exclusively present in mature enterocytes that is released into the circulation 
upon enterocyte damage and is rapidly excreted into the urine (7). Elevated levels of I-
FABP have been found in urine and serum of patients with intestinal ischemia, celiac 
disease, systemic inflammatory response syndrome, necrotizing enterocolitis and 
increasing norepinephrine infusion rate (8-16). This suggests that intestinal ischemia with 
subsequent enterocyte damage is an early and rapidly developing complication of IAH. 
Since it is also assumed that early decompression improves outcome, I-FABP is a potential 
and specific biomarker to identify such patients in a reversible phase. Consequently, I-
FABP and other biomarkers are considered promising for the early identification of intra-




the need for, and timing of decompressive measures to relieve the abdominal pressure 
(17).  
The main aim of the current study was to determine the value of serum or urinary levels 










MATERIALS AND METHODS 
This prospective, observational study was conducted in two academic hospitals in The 
Netherlands. The study was approved by the Medical Research Ethics Committee (MREC) 
in the principal study hospital (reference number MEC-2011-016) and by the local hospital 
board in the participating center (reference number MEC-2013-076). The study is 
registered at the Netherlands Trial Register (NTR4638). Signed informed consent by 
patient or proxy was obtained. The study protocol has been published previously (18). 
 
Patients 
Adult patients (18 years or older) admitted to the ICU between April 18, 2011 and March 
20, 2015, with at least two risk factors for IAH were eligible (2). Liver transplantation was 
added as a risk factor, as post-transplantation patients also appear to be at risk for 
developing IAH (19, 20). Patients were enrolled as soon as possible, maximally within 48 
hours after meeting the eligibility criteria. Patients in whom intra-bladder pressure 
measurement was contra-indicated or unreliable, and patients with inflammatory bowel 
disease that might affect I-FABP levels were excluded from the study. 
 
Treatment 
Treatment was initiated in compliance with international guidelines of the WSACS (2). The 
IAH/ACS Management Algorithm provides a decision tree for the follow-up of patients 
related to the IAP level.  
Sample collection 
During the first 72 hours after enrolment, urine (and blood in a subgroup of 129 patients 
of one hospital) was sampled every six hours. One hospital was not able to process blood 
samples for this study. Urine samples were kept on ice and then frozen at −80°C within 
two hours after collection. Blood was centrifuged at 4°C, 4000g for 15 minutes and stored 
at −80°C until further analysis. 
 
Data collection 
Patient characteristics, ICU admission diagnosis, baseline serum lactate concentrations, 
urinary creatinine levels at baseline, Simplified Acute Physiology Score (SAPS) II, 
Sequential Organ Failure Assessment score (SOFA, on day 1 to 4) and Acute Physiology and 




Urinary and serum concentrations of I-FABP were analyzed in duplicate using a highly 
specific, commercially available enzyme-linked immunosorbent assay (ELISA) that 
selectively detects human I-FABP (HyCult Biotechnology, Uden, The Netherlands). I-FABP 
levels in urine were adjusted to urinary creatinine levels in order to correct for renal 
function. Analysis of claudine-3 levels as was planned for accourding to the protocol, was 
not feasible due to financial reasons. Intra-abdominal pressure was measured using an 
intra-bladder technique according to Kron et al. (2) with an instilling volume of 20 mL of 
sodium chloride 0.9% solution, also every 6 hours during the first 72 hours after 
enrolment. Complications (New organ failure, ACS and death), as well as any (secondary) 
intervention performed such as decompression laparotomy, were recorded. The 
monitoring of occurrence and extent of new organ failure was based upon change in SOFA 
score. New organ failure was diagnosed if the score in one of six SOFA subdomains 
increased to ≥3, compared with the day before. Furthermore, mortality during 72 hours of 
follow-up was registered. 
 
Statistical analysis  
A sample size calculation based on previous studies of IAH and I-FABP indicated that an 
overall population of 200 patients (anticipated to consist of approximately 120 patients 
without elevated abdominal pressure and 80 patients with IAH) would need to be enrolled 
in order to detect a 0.5 SD increase in I-FABP level in patients with IAH (two-sided test 
with an α level of 0.05) with >90% statistical power (21, 22). 
Statistical analyses were performed using IBM SPSS statistics 22 (IBM, Armonk, NY, USA). 
ROC analysis and calculation of the Youden index associated criterions were performed 
with MedCalc Statistical Software version 17.4 (MedCalc Software bvba, Ostend, Belgium; 
http://www.medcalc.org; 2017). P-values in plots were calculated with Kruskal-Wallis tests 
using GraphPad Prism version 5.03 (GraphPad for Windows, GraphPad Software, La Jolla 
California USA, www.graphpad.com).  
Normality of continuous data was assessed by the Shapiro Wilk test. Homogeneity of 
variances was tested using the Levene’s test. Parametric data are presented as mean and 
standard deviation (SD) and were compared by means of Student t test, non-parametric 
data were presented by median and quartiles and were compared using Mann-Whitney U-
test or Kruskal-Wallis test with Mann-Whitney post-hoc test for pairwise comparisons. 









Linear mixed-effect model was used to determine the correlation between I-FABP levels 
and IAP. For this later analysis, restricted maximum likelihood method was used, random 
intercept and slope were considered. Gender, age, BMI, APACHE II at baseline, lactate, 
mean arterial pressure, and time from baseline measurement were entered as covariates 
into the model to evaluate their effect on the correlation between I-FABP level and IAP. 
For determining the predictive value of I-FABP on peak IAP and ACS, repeated 
measurements of the biomarker were realigned and recoded T=0 for the moment peak 
IAP or ACS occurred. Median (P25-P75) I-FABP levels were plotted separately for patients 
with the outcome of interest and control patients. For comparison with the non-ACS 
control group, the median time point at which ACS occurred in the ACS group was also 
used as T=0 for the non-ACS patients.  
Prognostic role of repeated I-FABP on development of IAH, ACS or new organ failure was 
assessed using a generalized linear mixed model (GLMM) framework with binomial logit 
link. The binary outcomes of IAH (IAH versus no IAH; and vice versa for new organ failure 
or ACS) were used as dependent variable. Patient ID was used as a clustering variable as 
up to 13 measurements per patient were available. BMI, age, gender, time from baseline 
measurement, APACHE score, associated mean arterial pressure, and lactate levels were 
entered as covariate into the model to evaluate their effect on the relation between I-
FABP level and outcome. Data points which occurred after the event of interest were left 
out of this analysis. Random intercept and slope were considered. Results were expressed 
as odds ratios with corresponding 95% confidence interval and p-values.  
Given the low number of new events (IAH, ACS, or mortality), a preliminary confounder 
model was developed using new organ failure as dependent variable. The variables 
gender, BMI, baseline serum lactate concentration, Simplified SAPS II, APACHE II, and 
abdominal status (no IAH/IAH/ACS) were added as covariates. In a final model, the mean 
and maximum I-FABP level across all measurements as well as the area under the curve of 
I-FABP level was also added as covariate. The optimal regression model was developed 






From a total of 200 included patients, two patients were excluded from analysis as 
informed consent was withdrawn (Figure 1). No patients were lost to follow-up. Clinical 
baseline characteristics of 198 included patients are shown in Table 1. BMI, SAPS II score, 
lactate levels, and positive end-expiratory pressure at ICU admission were significantly 
higher in patients who developed IAH than in patients who did not. Patients had a median 
number of 4 (P25-P75 3-6) risk factors for IAH. Of 118 patients who developed IAH, 90 
(76%) already had IAH at baseline. Fifteen (8%) of the 198 patients were diagnosed with 
abdominal compartment syndrome of which 12 (80%) already at baseline. The median 
time-point of development of ACS was T=0 (P25-P75 0-0). Two patients underwent 
decompressive laparotomy, one of these patients had intestinal ischemia and underwent 
a colonic resection. Eighteen (9%) patients died in the ICU during the study. Urinary and 
serum I-FABP levels over time in patients with or without IAH, organ failure, or abdominal 
compartment syndrome are shown in Figure 2. 
 
Group-based analyses of urinary and serum I-FABP levels related to IAP, IAH, ACS, and 
organ failure 
 
The baseline levels of urinary and serum I-FABP were not significantly different between 
patients with or without IAH (Figure 3). Median baseline levels of urinary I-FABP were 
higher in patients who developed ACS (235 (P25-P75 85-1747) µg/g creat) than in patients 
with IAH who did not develop ACS (87 (P25-P75 33-246) µg/g, p=0.037, Figure 3A). Also, 
they were higher than in patients without new organ failure and IAP>20 mmHg;90 (P25-
P75 25-202) µg/g creat, p=0.035, Figure 3B). No differences in baseline levels of serum I-
FABP were found between patients with and without IAH, neither in patients with ACS and 
patients with new organ failure without IAP>20 mmHg (Figures 3C and D).  
Multi-level correlation over the complete follow-up period showed that urinary I-FABP 
levels and IAP were positively and linearly correlated in unadjusted and adjusted models 
(Table 2). Serum I-FABP levels did not correlate with IAP.  
 












No significant peaks in serum or urinary I-FABP levels prior to the peak value of IAP could 
be demonstrated (Figure 4). Only median urinary I-FABP levels were significantly, but not 
clinically relevantly, higher in the patients with IAH vs. patients without IAH, only at T-12 
(84.5 µg/g creat vs. 41.2 µg/g creat respectively, p=0.04).  
 
Abdominal compartment syndrome:  
Median serum I-FABP levels were 3432 (P25 – P75 189-6839) ng/L in patients with ACS at 
time of ACS occurrence (T0), compared with 602 (P25 – P75174-1631) in patients that did 
not develop ACS (p=0.2; Figure 5). I-FABP measurements before ACS developed, were only 
available in 2 patients. The calculation of receiver operator characteristics (ROC) was 
performed on I-FABP values from the moment ACS had already emerged (Table 3). I-FABP 
showed no discriminatory ability on the development of ACS. The area under the ROC 
curve (AUC) of urinary I-FABP was 0.62 (95% CI 0.55–0.69, p = 0.13) with a sensitivity of 
64.3% (95% CI 35.1- 87.2%) and a specificity of 59.3% (95% CI 51.7-66.6%). Serum I-FABP 
AUC was 0.75 (95% CI 0.67-0.83) with a sensitivity of 66.7% (95% CI 22.3-95.7%) and 
specificity of 92.5% (95% CI 86.2-96.5%). Since no predictive value on ACS was found, 





Analyses of repeated urinary and serum I-FABP levels related to IAP, IAH, ACS, and organ 
failure 
 
Unadjusted generalized linear mixed model analysis demonstrated no statistically 
significant predictive value of repeated I-FABP measurements on the development of IAH, 
new organ failure or ACS on a patient level (Table 4). The odds ratio of urinary I-FABP in 
predicting ACS was 1.00 (95% CI 1.00-1.00, p=0.07), and 1.00 (95% CI 1.00-1.00, P=0.69) 
for serum I-FABP. Adjusting for covariates did not improve any of the prediction models in 
this study. Both the preliminary and final logistic regression models did not demonstrate a 
significant value of I-FABP measurement on the onset of new organ failure on a patient 
level (data not shown). Both in the unadjusted and adjusted analyses, the p-value for the 
mean I-FABP level, maximum I-FABP level, and area under the I-FABP curve were larger 











The present study represents the largest cohort on I-FABP related to abdominal pressure 
and complications in ICU patients. Although I -FABP levels are statistically different 
between the groups of patients with IAH/ACS and those without, urinary and serum I-
FABP levels have no relevant value in the early identification of patients at risk for IAH-
related complications on an individual patient level. Intestinal ischemia or mucosal 
disruption (as measured by I-FABP) are no early signs of IAH-related complications. 
 
These findings are in contrast with the limited available literature on this subject. 
Diagnostic values of urinary and serum I-FABP levels have been investigated previously in 
specific subgroups of patients. Several studies suggest that I-FABP may be useful as 
marker for the diagnosis of intestinal ischemia in patients with acute abdominal pain or 
after aortic surgery (23-25). A meta-analysis of 1,246 patients confirmed that I-FABP may 
be useful in diagnosing intestinal ischemia (26). However, included studies were small and 
heterogeneous, group differences were not corrected for, and in some studies no histo-
pathological examination was performed. This could have led to overestimation of the 
diagnostic value of I-FABP in the detection of intestinal ischemia. Indeed, experimental 
models showed that intestinal ischemia could only be detected in pigs with abdominal 
pressures above 20-25 mmHg and became more apparent at 30-40 mmHg (27, 28). 
Translation to human circumstances is difficult, but this may suggest that intestinal 
ischemia only occurs when ACS already occurred. Data from the current study cannot 
confirm this. An animal study exposing animals to increasing IAP and evaluating both I-
FABP levels and ischemia would be needed. I-FABP was measured in critically ill ICU 
patients with risk factors for IAH. Increased I-FABP levels were found in the small group of 
patients with ACS. A larger group of patients is needed for confirmation and to provide a 
meaning for this finding. I-FABP levels were not only elevated in patients with IAH, ACS, or 
new organ failure, but also in patients without these conditions. Among these patients, 
peak serum I-FABP levels were even four to nine fold higher than in control groups of 
other studies that used the same ELISA kit (24, 25). The control groups in previous studies 
consisted of healthy controls, patients with acute abdominal pain due to other conditions 
such as bowel obstruction, appendicitis, coprostasis or diverticulitis, or patients with an 




suffer from more severe conditions that already increase I-FABP. Nevertheless, from a 
clinical point of view, ICU patients with risk factors for IAH represent the correct control 
group.  
 
This study has several limitations. First, 237 patients were excluded for logistical reasons, 
it’s unclear (but ulnlikely) whether this has lead to a selection bias. Second, the rate of ACS 
in the present study in patients with risk factors for IAH was 8%. This is not completely in 
line with recently reported rates of ACS of 3-6% among general population of adult ICU 
patients not selected for the presence of risk factors (6, 29). Aggressive medical and 
minimally invasive therapies to avoid sustained IAH or ACS in our patient cohort may 
account for this relatively low rate of ACS. Since few patients developed ACS and 80% (12 
out of 15) of patients had already developed ACS at baseline measurement, it was not 
possible to demonstrate a peak in I-FABP values prior to development of ACS. The latter 
also applied for the 76% of patients that had already developed IAH at baseline. In 
general, the relatively low number of patients with newly developed IAH or ACS during 
follow-up has limited the statistical analysis and made the study underpowered for 
analysis of newly developed ACS. Third, our study illustrates that IAH and ACS develop 
very rapidly. As a consequence, many patients had already developed IAH or ACS before 
informed consent was obtained. As a result, many relevant patho-physiologic changes 
prior to the actual onset of IAH or ACS, were missed. Given the short half-life of I-FABP, an 
increase in I-FABP prior to onset of IAH or ACS may also have been mist. Fourth, it was 
difficult to assess the endpoint ‘new organ failure’. WSACS defined ACS as an IAP >20 
mmHg that is associated with new organ failure (2). The most applied and objective 
assessment for the presence of organ failure is the SOFA score. This score is calculated 
only once a day, all other time varying outcomes where measured 4 times a day. 
Therefore, it was impossible to accurately determine at what time organ failure actually 
occurred, related to the other measurements. This affected the moment ACS was 
diagnosed in the present study. Moreover, inherent to the observational nature of our 
study, it remains unclear to what extent and how new organ failure can be attributed to 
IAP. Fifth, a study design with repeated measurements every six hours (i.e. with an 
overnight measurement) resulted in missing measurements. Given the rapid development 
of IAH and ACS, a peak in abdominal pressure or I-FABP levels can easily be missed in the 









minimized by mixed model analysis. As a last limitation, blood could only be collected at 





A relevant diagnostic value of I-FABP levels for identifying individual patients at risk for 
intra-abdominal pressure related complications could not be demonstrated. Therefore, I-
FABP should be re-analysed in a study that includes patients in who IAP has not exceeded 
20 mmHg yet. Until then, it should not be used for early detection of IAH related 





Figure 1: Flowchart 
 
* Logistical reasons included unavailability of proxy to provide consent within the 










Table 1: Baseline characteristics and overview of risk factors at enrolment for patients 
with versus without intra-abdominal hypertension 
  All IAH No IAH P-value 
  N=198 N=118 N=80   
Age (years) 62 (51 - 70) 64 (53 - 71) 60 (49 - 69) 0.145 
BMI (kg/m2) 25 (23 - 29) 27 (24 - 31) 24 (22 - 28) 0.001 
APACHE II score 21 (17 - 25) 22 (17 - 27) 21 (16 - 24) 0.105 
SAPS II score 44 (30 - 57) 50 (37 - 61) 35 (24 - 50) <0.001 
SOFA score 8 (6 - 11) 9 (6 - 12) 8 (5 - 11) 0.158 
Mean arterial pressure (mmHg) 80 (72 - 90) 81 (72 - 95) 80 (73 - 87) 0.406 
IAP (mmHg) 11 (7 - 15) 14 (12 - 17) 6 (4 - 8) <0.001 
Mechanical ventilation (intubated) 138 (69.7%) 94 (79.7%) 44 (55.0%) <0.001 
PEEP (mmHg) 8 (6 - 10) 10 (8 - 12) 6 (5 - 10) <0.001 
Lactate at admission (mmol/L) 1.9 (1.3 - 3.3) 2.2 (1.5 - 3.4) 1.6 (1.2 - 2.3) 0.020 
Risk factors, n 4 (3 - 6) 5 (4 - 6) 4 (3 - 5) 0.086 
PEEP (any level) 149 (75.3%) 94 (79.7%) 55 (68.8%) 0.094 
Coagulopathy  131 (66.2%) 76 (64.4%) 55 (68.8%) 0.545 
Abdominal surgery 127 (64.1%) 71 (60.2%) 56 (70.0%) 0.176 
Sepsis 67 (33.8%) 50 (42.4%) 17 (21.3%) 0.002 
Massive resuscitation (>5L) 66 (33.3%) 39 (33.1%) 27 (33.8%) 1.000 
Oliguria 62 (31.3%) 44 (37.3%) 18 (22.5%) 0.030 
Cirrhosis 45 (22.7%) 17 (14.4%) 28 (35.0%) 0.001 
BMI>30 40 (20.2%) 30 (25.4%) 10 (12.5%) 0.031 
Massive transfusion(protocol started) 35 (17.7%) 19 (16.4%) 16 (20.0%) 0.571 
Pancreatitis or peritonitis 35 (17.7%) 26 (22.0%) 9 (11.3%) 0.059 
Hemo/pneumoperitoneum 27 (13.6%) 20 (16.9%) 7 (8.8%) 0.139 
Liver transplantation 26 (13.1%) 7 (5.9%) 19 (23.8%) <0.001 
Acidosis pH<7.35) 24 (12.1%) 18 (15.3%) 6 (7.5%) 0.123 
Trauma 20 (10.1%) 13 (11.0%) 7 (8.8%) 0.641 
Damage control surgery 20 (10.1%) 13 (11.0%) 7 (8.8%) 0.641 
Ileus 19 (9.6%) 16 (13.6%) 3 (3.8%) 0.026 
Abdominal wall reconstruction 5 (2.5%) 4 (3.4%) 1 (1.3%) 0.650 
Prone position 4 (2.0%) 4 (3.4%) 0 (0.0%) 0.149 
Hypothermia (T<35°C) 0 (0.0%) 0 (0.0%) 0 (0.0%) N.D. 
 
Data are presented as number with corresponding percentage (%) or median (P25 - P75). P-
values were calculated using a Mann Whitney U-test or Fisher exact test. None of the 




body mass index; IAH, intra-abdominal hypertension; IAP, intra-abdominal pressure; N.D., 
not determined; PEEP, positive end expiratory pressure; SAPS, Simplified Acute Physiology 











Figure 2: Change in urinary (A, C, E) and serum (B, D, F) I-FABP levels over time in 
patients with or without intra-abdominal hypertension (A, B), organ failure (C, D), or 
abdominal compartment sydrome (E, F) 
 
Data are represented as median with P25-P75.  
ACS, abdominal compartment syndrome; creat, creatinine; IAH, intra-abdominal 






























































































































































































































































































































































































































































Figure 3: I-FABP levels at baseline in patients admitted to the ICU with at least 2 risk 
factors for intra-abdominal hypertension. 
 
Data are represented as median with P25-P75.  
ACS, abdominal compartment syndrome; creat, creatinine; IAH, intra-abdominal 







Figure 4: Time course of median (P25-P75) levels of I-FABP before and after peak values of 
IAP. 0 Denotes the peak value of IAP. (A) Urinary I-FABP levels. (B) Serum I-FABP levels.  
 
Data are represented as median with P25-P75. * Indicates statistically significant difference, 
tested using Kruskal-Wallis tests. 
IAH, intra-abdominal hypertension; IAP, intra-abdominal pressure; I-FABP, intestinal fatty 











Figure 5: Time course of median levels of I-FABP before and after ACS. 0 denotes the 
moment of ACS. (A) Urinary I-FABP. (B) Serum I-FABP.  
 
Data are represented as median with P25-P75. No statistically significant differences were 
found, using Kruskal-Wallis tests.  














































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table 4 – Prognostic role of urinary and serum I-FABP levels on development of intra-
abdominal hypertension, abdominal compartment syndrome and organ failure 
Data were analyzed using a generalized linear mixed model. The OR is shown with 95% 
confidence interval within brackets. 
Adjusting for covariates did not significantly improve any of the models; therefore, 
adjusted analysis is not shown. 
ACS, abdominal compartment syndrome; CI, confidence interval; creat, creatinine; IAH, 
intra-abdominal hypertension; I-FABP, intestinal fatty acid binding protein; OR, odds ratio. 
  
 Event Unadjusted analysis 
All patients  N OR (95% CI) P 
Urinary I-FABP (µg/g creat) IAH 818 1.000 (1.000-1.001) 0.266 
 ACS 710 1.000 (1.000-1.001) 0.066 
 Organ failure 694 1.000 (1.000-1.001) 0.178 
Serum I-FABP (ng/L) IAH 652 1.000 (1.000-1.000) 0.339 
 ACS 568 1.000 (1.000-1.000) 0.686 
 Organ failure 561 1.000 (1.000-1.000) 0.576 
Patients with IAH     
Urinary I-FABP (µg/g creat) ACS 218 1.000 (1.000-1.001) 0.115 
 Organ failure 212 1.000 (1.000-1.001) 0.359 
Serum I-FABP (ng/L) ACS 123 1.000 (1.000-1.000) 0.733 
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GENERAL DISCUSSION 
In this chapter, the results of the studies described in this thesis are discussed and put into 
perspective, and it elaborates how results fit in the already existing knowledge on the 
topic. Finally, implications of the current study findings are outlined and suggestions for 
future research are made. 
Although up to date WSACS guidelines regarding management of IAH and ACS were not 
uniformly known and implemented in Dutch surgical practices (Chapter 2), they were 
considerably better used than the global average (1). This is possibly due to the structure 
of Dutch surgical training and the international scientific orientation of Dutch clinicians. 
The well available knowledge may have resulted in a more aggressive ACS treatment and 
more frequent use of surgical abdominal decompression in the Netherlands when 
compared with responses of previous surveys carried out elsewhere (2). However, Dutch 
surgeons seemed to favour mesh assisted techniques for temporary abdominal closure 
(TAC) following decompressive laparotomy while vacuum assisted techniques are 
advocated by the recently published WSES guidelines for open abdomen treatment (3, 4). 
Open abdomens were relatively frequent used in the Netherlands, despite that earlier 
literature showed that the disadvantages of that treatment outweigh the benefits among 
some patient categories (5). Today however, it is more widely accepted that the long term 
outcomes of open abdomen treatment are not that debilitating and life altering as 
thought before (6).  
Epidemiology 
A direct relation between acidosis, hypothermia, resuscitation fluid volume and IAH 
(Chapter 3) has been described before (7-9). However, the demonstrated association 
between coagulopathy and high grade IAH was not. Also, a previously presumed benefit 
for colloid resuscitation (including hydroxyethyl starches; HES) over crystalloid 
resuscitation was not supported by the data from this study and is now not longer 
advocated in recent literature (10-12). The study also showed that an open abdomen does 
not necessarily prevent ACS from re-occurring. Although not many cases were described 
before in literature, recurrent ACS was recognized before (13). The presented study was 











abdominal injury. These identified characteristics of patients who developed recurrent 
ACS might help clinicians to prevent, recognize and treat this syndrome timely. 
 
The study presented in Chapter 4 did not confirm a decrease in ACS prevalence and 
related mortality among trauma patients after introduction of WSACS guidelines. This is 
unexpected, but should be put in perspective. The methodology of a systematic review is 
the best available tool for determining long term trends in these epidemiologic features, 
but it is still far from ideal. Different study designs of included studies (i.e., RCT, 
longitudinal cohort study, or case series), heterogeneous populations, different definitions 
of ACS used and a possible reporting bias obviously influenced the results of this study. A 
long term uniform data registry would be more suitable for that aim. Such a data registry 
which includes IAP or IAH and ACS occurrence is not available to our knowledge. The data 
presented in the chapter did however emphasize that ACS prevalence was highest in 
patients who had undergone a trauma laparotomy. This finding is in line with the 
previously noted increase in ACS prevalence after introduction of damage control surgery. 
Until now it remained unclear whether this increase is influenced by a parallel increase in 
survival of patients that would otherwise have died before ACS would become imminent 
(14). Despite the methodological shortcomings, the study showed that the supposed 
elimination of post-injury ACS by Balogh et al., has not yet become reality.  
 
Chapter 5 showed that prevalence of IAH and ACS among severe burn patients was very 
high with 64.7-74.5% and 4.1-16.6%, respectively. The demonstrated mortality rate of 
patients with ACS (74.8%) was even more striking. These numbers indicate that there is 
still much room for improvement of care for such patients. As an obvious first step, we 
would recommend that the definitions for IAH and ACS as set by WSACS are used 
uniformly in studies and publications. It was remarkable however that even in more recent 
literature, this was not the case.  
The described study furthermore provided an overview of the best available literature 
regarding prevalence, treatment and outcome of IAH and ACS in severe burn patients. This 
could be seen as a starting point for further research. Most importantly, it concluded that 




important than the measurement of IAP or APP itself. These tools however were not 
available yet (15, 16). 
 
A prospective multicenter study among severe burn patients as presented in Chapter 6 
showed a lower IAH prevalence (53%) than demonstrated in the previous chapter. 
However, this was consistent with a recent African study reporting an IAH-prevalence of 
58% among severe burn patients (17). The absence of ACS cases in this chapter contrasted 
literature. A reduction in prevalence of IAH and ACS was confirmed in other studies and 
was mainly attributed to modern restrained resuscitation regimes (18, 19). This 
explanation seems logically given the secondary ACS etiology of over-resuscitation which 
is usually seen in severe burn patients (with and without truncal burns influencing 
abdominal wall compliance).  
In an attempt to provide for a marker for IAH related adverse outcomes, this chapter 
showed that the promising biomarker of urinary I -FABP had no significant diagnostic or 
predictive value for that aim in this population (20-23).  
 
Markers for adverse outcome 
A study that aimed to provide a potent predictor for IAH related adverse outcome in a 
general ICU population was described in Chapters7 and 8. The population studied showed 
a prevalence of ACS of 8% which was higher than in previous studies (24, 25). This was 
likely due to the fact that included patients were selected for having at least two risk 
factors for IAH as other studies did not. The study again showed that promising urinary 
and serum I-FABP levels had no relevant value in the early identification of patients at risk 
for IAH-related adverse outcome (20-23). Interestingly, the peak serum I-FABP levels 
among included patients without IAH were four to nine fold higher than in control groups 
of these studies (using the same ELISA kit). The control groups in these studies consisted 
of healthy controls, patients with acute abdominal pain due to other conditions such as 
bowel obstruction, appendicitis, coprostasis or diverticulitis, or patients with an 
uncomplicated course after aortic surgery. Since ICU patients in the I-Fabulous Study 
(Chapter 8) likely suffered from more severe conditions that might have already increased 
I-FABP levels, these false-positive patients (with elevated I-FABP, but no IAH or ACS) might 
explain why the results of the current study contrast those found in literature. This does 











a marker remains in a time in which ACS is becoming a rarer diagnosis. Especially when 
less experienced physicians have to decide whether or not imminent ACS should be 
surgically decompressed.  
 
As opposed to previous literature, an increase in IAP did not result in significant ischemic 
complications within the first three hours as measured by serum albumin-cobalt binding 
(ACB) assay and histopathology in an animal model (Chapter 9) (26). These results 
however may support the WSACS theory that the effects of percutaneous catheter 
decompression (PCD) can be awaited for a period of three to four hours before 
decompressive laparotomy is initiated (27). Despite the nature of this pilot study of only 
25 rats, it showed that even in relatively low levels of increased IAP (below 20 mmHg) 
without obvious organ failure, hemodynamic and respiratory failure already occur. 
Unfortunately, the results of the study were not encouraging enough to perform larger 








Although prevalences of IAH, ACS and related adverse outcome have already decreased 
significantly, outcome could possibly be further improved by better implementation of 
evidence based treatment algorithms, improved knowledge of the implication of IAH 
related conditions, novel methods for recognition of IAH and related adverse outcomes 
and uniform registration. These four points are discussed in more detail below.  
 
Implementation  
Although the ACS development after vascular surgery or among patients with pancreatitis 
is increasingly well understood, further implementation of evidence based treatment 
algorithms to prevent ACS would most likely also benefit severely injured patients (30). 
The diversity of acute general surgical conditions with different timeframes and 
presentations of IAH related adverse outcomes also need additional systematic research 
(31, 32). For patients with post-operative abdominal sepsis, large abdominal wall surgery 
such as bilateral Ramirez or transverse abdominis muscle release (TAR) procedures, or 
non-operatively managed patients with (traumatic) intra-abdominal hemorrhage, it now is 
unclear whether IAH-related adverse effects play a relevant role in their outcome. 
Whether IAH is a relevant determinant for these patients or if they benefit from the 
treatment algorithms does not necessarily need to be studied in prospective research. For 
that aim IAPs are easily measured and added as a variable in other future surgical and ICU 
studies.  
 
Clinical implication of IAP  
IAH (without organ failure) is common on ICUs, but its clinical significance is unknown. 
Intra-abdominal hypertension without ACS has no direct clinical implications, but in 
combination with pre-existing impaired renal or pulmonary function the syndrome is 
harmful as a result of impaired compensatory reserve. The role of IAH in the outcome of 
these patients is not well established and should be further studied. Given the very 
specific patient group, it seems difficult to set up new prospective research for this, 
certainly considering how little patients would actually be helped with the results of such 
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from databases and retrospectively compare the results. Again, uniform handling of 
internationally accepted (WSACS) definitions is of hallmark importance for this. 
Recognition 
ACS is not frequently seen in modern time of damage control resuscitation and permissive 
hypotension. This may well be the result of systematic identification of modifiable risk 
factors, and subsequent change of management of severely ill and injured patients at the 
emergency room, theatre and ICU. The recent published prevalence of 0–2% of post-injury 
ACS is valid only for the highest performing trauma centers (28). In those hospitals, multi-
disciplinary state of the art approach with physicians familiar with the risk of ACS is known 
to be effective (29). The global average prevalence and outcomes of these patients 
however, are likely to be much worse. The importance of ACS surveillance with IAP 
monitoring of patients with risk factors for IAH and ACS remains unchanged. 
As early recognition is of importance for the outcome of ACS, the need for markers for IAH 
related adverse outcome remains. In a time in which ACS is becoming a more rare 
diagnosis, it can help less experienced physicians to decide whether or not imminent ACS 
should be surgically decompressed. Intestinal fatty acid binding protein and to a lesser 
extent albumin cobalt binding capacity, proved not to be adequate for that aim.  
(1) Similar to the way I-FABP is a marker for intestinal mucosa damage, Claudine-3 is a
marker for tight-junction decay of the same epithelium. Since this is a rapid process that 
occurs with mild ischemia, possibly it is a specific and suitable marker for this purpose 
(33).  
(2) To a lesser extent, D-lactate might be interesting as such a marker. D-lactate is a
marker for intestinal ischemia and has also been associated with increasing IAP. Essays for 
that marker are already in use in many hospitals and therefore are a low-threshold 
alternative.  
(3) More recently, 'mitochondrial Ca2+ uptake 1' (MICU1, the key protein regulating the
oxidative process in de gut) has also been proposed to as such a marker (34). Leng et al, 
detected changes in the expression of MICU1 during the development of increased 
intestinal permeability in rats with IAH. Their results indicated that MICU1-related 




intestinal barriers. This marker could serve as a marker for IAH related adverse outcome, 
but might also hold promise for preventing the progression of IAH to gut-derived sepsis by 
MICU1-targeted treatment. However, for this marker it first must be made plausible that it 
could be cost-effective, because at first sight this appears to be a problem. 
Nevertheless, the potential of these three new proposed markers for early recognition of 
IAH related adverse outcome, deserves further exploration. In a time where IAH related 
adverse outcomes become more rare, these markers might hold important promise for 
adequate and timely therapy in case of the rare situation of imminent ACS.  
 
Registration 
The progress that has already been made in preventing IAH and ACS and improving the 
outcome of patients with these syndromes, suggest that it is no longer feasible or 
necessary to set up large prospective studies for severe burn patients with IAH or ACS as 
primary endpoint. In the Netherlands the mandatory National Intensive Care Evaluation 
(NICE) registration is an easier way to collect data on organ failure. This registration 
includes 80.000 patients annually in all Dutch ICU’s and started in 1996. For burn patients, 
registering the SOFA score is apparently not mandatory. Our proposal would be to do this 
nationally and internationally. Each ICU study among serious burn patients would then 
only have to record IAP measurements (in a standardized way, and preferably all from the 
same percentage of TBSA) as variables. It is not unlikely that organ failure in these patients 
is more often associated with IAH than assumed. In that case, it would be considerable to 
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P A R T  I V  -  Discussion
Chapter 11




Chapter 1 is the introduction of this thesis. It gives an overview of definitions, 
epidemiology, etiology, risk factors, physiology, clinical presentation, diagnostics, 
management, and outcome of intra-abdominal hypertension (IAH) and abdominal 
compartment syndrome (ACS). Furthermore, a number of knowledge gaps in the literature 
are identified with regard to epidemiology, risk factors and diagnostic opportunities. 
Lastly, it’s indicated for each chapter how conducted studies contributed to closing these 
gaps. 
 
Chapter 2 aims to determine the current state of awareness, knowledge, and use of 
evidence-based medicine with regard to IAH and ACS among Dutch surgeons. A literature-
based and expert consensus study was developed for this and completed by 60 
respondents. Intra-abdominal pressure (IAP) was measured by 59 (98%) respondents using 
intra-vesical methods. Diuretics (38 respondents, 63%) and laparotomy (33 respondents, 
55%) were considered as useful treatments for IAH as prevention of ACS by the majority. 
Only 16 (27%) respondents used the evidence-based guideline (from the WSACS - 
Abdominal Compartment Society) in daily practice, yet another 37 (62%) were willing to 
do so. Mesh assisted techniques for temporary abdominal closure (TAC) following 
decompressive laparotomy was preferred by Dutch surgeons, while literature previously 
showed that vacuum assisted techniques should be favored. Fifty-nine (98%) respondents 
believed that open abdominal treatment improved the outcome of patients with 















  Definitions of the WSACS guidelines were well known among respondents, the 
guidelines themselves however were implemented poorly in Dutch hospitals. 
  Mesh assisted techniques for temporary abdominal closure (TAC) following 
decompressive laparotomy was preferred by Dutch surgeons. 
  Respondents supported open abdomen treatment following decompressive 
laparotomy, even though they were aware of the high associated morbidity and 
mortality. 
 
Chapter 3 compares the characteristics of patients who developed high-grade intra-
abdominal hypertension (IAH) after trauma laparotomy (i.e., grade III of IV IAH; IAP> 20 
mmHg) with those of patients who developed low-grade IAH (grade I or II; IAP ≤20 mmHg). 
The retrospective study was performed among 567 consecutive trauma patients admitted 
to a level 1 trauma center (specialized hospital for severely injured patients) in Australia. 
Of the included patients, 10.2% developed high-grade IAH of which 52% (30/58) 
developed ACS. Open abdomen did not necessarily prevent ACS from re-occurring. 
Patients with high-grade IAH were older (p<0.001), had a higher Injury Severity Score (ISS, 
p<0.001), larger base deficit (p<0.001), and lower body temperature at admission 
(p=0.011). In the first 24 hours of admission, patients with high-grade IAH received larger 
volumes of crystalloid resuscitation fluids (p<0.001), larger volumes of colloid resuscitation 
fluids (p<0.001), and more units of packed red blood cells (p<0.001). Following surgery, 
prolonged prothrombin time (PT, p<0.001) and activated partial thromboplastin times 
(aPTT, p<0.001) were seen. Patients with high-grade IAH had higher mortality rates than 




  Development of high-grade IAH is associated with acidosis, coagulopathy, and 
hypothermia (also known as the triad of death). 
  Patients with high-grade IAH after a trauma laparotomy received significantly 
larger volumes of crystalloid and colloid resuscitation fluids. 
240 CHAPTER 11
 Open abdomen treatment does not necessarily prevent ACS from re-occurring
(recurrent ACS).
Chapter 4 aims to determine the prevalence and mortality of ACS among severely injured 
patients, and to compare these before and after January 1, 2005, the date of introduction 
of WSACS guidelines. This was done by means of a systematic literature review and meta-
analysis. After pooling data of the 81 included publications, the study demonstrated a 
prevalence of ACS among trauma patients ranged from 0.0% to 36.4% (N=33,455 patients) 
with a weighted average prevalence of 5.2% and 3.7% before and after January, 2005, 
respectively. ACS prevalence was 1.1% in seriously injured patients admitted to the ICU, 
2.8% in patients with visceral injuries, and 5.0% in patients who had undergone trauma 
laparotomy. The mortality rate varied from 0.0% to 100.0% with a weighted average of 
47.1% before January 1, 2005 and 53.1% after that date. These values should be 
interpreted with caution due to the high statistical and clinical heterogeneity across the 
included studies. Therefore, a causal relationship could not be concluded with improved 
trauma care or the introduction of the WSACS guidelines. 
Conclusions: 
 The prevalence of ACS among trauma patients ranges from 0.0% to 36.4% with a
pooled average of 4.5%.
 Mortality of trauma patients with ACS ranges from ranges from 0.0% to 100.0%
with a pooled average of 48.3%.
 No decrease of ACS prevalence and mortality after introduction of the WSACS
guidelines could be demonstrated.
 The supposed elimination of ACS (among severely injured patients) has not yet
become a reality.
 Uniform handling of internationally used definitions and cut-off points is crucial
for the researching the relatively rare syndromes of IAH and ACS.
Chapter 5 provides an overview of literature regarding IAH and ACS in severe burn 
patients with a focus on epidemiology and management strategies. A systematic literature 
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severe burn patients was 4.1-16.6 % and 64.7-74.5%, respectively. The mean mortality 
rate of burn patients with ACS was 74.8%. The use of plasma and hypertonic lactated 
resuscitation fluids could prevent IAH or ACS. Despite that the use of colloid fluids 
decreased the total needed volume of resuscitation fluids, no benefit of this in preventing 
IAH was proven. Escharotomy, peritoneal catheter drainage, and decompression 
laparotomy demonstrated to be effective IAP diminishing treatments in burn patients. 
Lastly, it showed that markers for IAP-related organ damage or organ failure might be 
superior to IAP measurements itself. 
Conclusions: 
 A systematic literature search demonstrated prevalence of ACS and IAH in severe
burn patients to be 4.1-16.6 % and 64.7-74.5%, respectively.
 The mean mortality rate of ACS in severe burn patients is estimated as high as
74.8% based on available literature.
 IAH or ACS can be prevented by decreasing resuscitation volume.
 Truncal burns in patients with ACS require immediate escharotomy and should
be followed by increasingly invasive decompression measures if no pressure
relieve is achieved.
 Diagnostic tools for early recognition of IAH-related adverse outcomes might be
more important than the measurement of IAP or APP.
Chapter 6 is a prospective study that focused primarily on determining the prevalence of 
IAH among severe burn patients. Secondarily, it aimed to determine the value of urinary 
intestinal fatty acid binding protein (I-FABP) as early marker for IAH-associated 
complications. I-FABP is a protein that occurs exclusively in the small intestine, an organ in 
the abdomen that is sensitive to ischemia (oxygen deficiency). With slight ischemic 
changes in the small intestine, elevated concentrations of this protein can already be 
measured in blood and urine. The theory is that ischemia of the small intestine is one of 
the first adverse effects of IAH and may play a central role in the development of 
inflammation in the rest of the body. 
The patients included for this study (N=58, prospectively included in two Dutch burn 




patients developed IAH, 17 (29%) patients developed new organ failure, but none of the 
patients developed ACS. Maximal urinary I-FABP levels per patient had a fair 
discriminatory ability for distinguishing patients with IAH from patients without IAH. 
Despite this result, no predictive value of urinary I-FABP levels on IAH or new organ failure 
could be demonstrated.  
 
Conclusions: 
  In a population of 58 severe burn patients, IAH was very common, but no cases of 
ACS were seen. 
  Urinary I-FABP levels showed to have no significant diagnostic or predictive value 
for IAH and related organ failure in a patient population with severe burns. 
 
Chapters 7 and 8 describe the design and outcomes of the I-Fabulous study. This study is 
the largest prospective cohort study of ICU patients with two or more risk factors for IAH 
up to date. This study determined the value of urinary and serum intestinal fatty acid 
binding protein (I-FABP) levels as early marker for IAH-associated complications. Of 198 
included patients, 74 (37%) developed new organ failure and 15 (8%) developed ACS. I-
FABP and IAP were positively correlated. Patients who developed ACS had higher median 
baseline levels of urinary I-FABP (235 µg/g creat, corrected for renal function) than 
patients who only developed IAH but not ACS (87 µg/g, p=0.037). I-FABP had no 
discriminatory ability between patients with and without ACS as the area under the 
receiver operating characteristic curve (AUC) was 0.53 for urinary I-FABP and 0.65 for 
serum I-FABP. An AUC value of 1.0 would be the perfect test, and a value of 0.5 is 
comparable to tossing a coin). With an odds ratio of 1.00, neither urinary nor serum I-
FABP indicated clinically relevant increased risk for developing new organ failure or ACS. 
 
Conclusions: 
  The results of this study showed a prevalence of ACS among patients admitted in 
the ICU with two or more risk factors for IAH of 8%. 
  The results of Chapter 8 (and Chapter 6) unequivocally show that intestinal 
ischemia or mucosal disruption (as measured by I-FABP) are no early signs of IAH-











  I-FABP has no value for prediction or early detection of IAH-related adverse 
outcomes in daily clinical practice. 
 
Chapter 9 determines the relation between IAP (at subclinical levels of IAP under 20 
mmHg) on one hand, and respiratory parameters, hemodynamic parameters, and the 
development of early (intestinal) ischemia on the other hand in an experimental model. 
Although the relevance of subclinical levels of IAP below 20 mmHg with no evidence of 
organ failure is unclear in the literature, this study demonstrated that these intra-
abdominal pressure levels are inversely associated with mean arterial pressure (Spearman 
correlation coefficient; Rs= -0.466, p=0.019), oxygen saturation (Rs= -0.882, p<0.001), 
partial oxygen pressure (pO2) (Rs= -0.752, p<0.001), and pH-value (Rs= -0.934, p<0.001). 
In addition, IAP was positively associated with central venous pressure (Rs= 0.581, 
p=0.002). No associations were found between IAP and lactate level or albumin-cobalt 
binding (ACB) capacity, an experimental marker for systemic ischemia. Histological signs 
for intestinal ischemia were not found. 
 
Conclusions: 
  Subclinical levels of intra-abdominal pressure (up to 20 mmHg) were correlated 
with increasing respiratory and hemodynamic problems in an experimental rat 
model. 
  In the first three hours after onset, abdominal pressures up to levels of 20 mmHg 
were not associated with significant ischemic complications in rats. 
  The results of this first research into the performance of the albumin-cobalt 
binding (ACB) assay, as easily determined marker for IAH-related adverse 
outcome, were not encouraging to perform larger scale studies. 
 
Chapter 10 is the general discussion of this thesis and provides future perspectives 











Hoofdstuk 1 is de introductie van dit proefschrift. Het geeft een overzicht van definities, 
epidemiologie, etiologie, risicofactoren, fysiologie, klinische presentatie, diagnostiek, 
management en uitkomst of van intra-abdominale hypertensie (IAH) en abdominaal 
compartimentsyndroom (ACS). Verder werden enkele in de literatuur bestaande 
kennislacunes geïdentificeerd met betrekking tot epidemiologie, risicofactoren en 
diagnostische mogelijkheden voor IAH en ACS. Tot slot werd er voor elk hoofdstuk van dit 
proefschrift aangegeven hoe de uitgevoerde studies bijdroegen om deze lacunes te 
dichten. 
 
Hoofdstuk 2 heeft als doel om de huidige bewustwording, kennis en gebruik van evidence-
based medicine met betrekking tot IAH en ACS bij Nederlandse chirurgen te bepalen. 
Daarvoor is een op literatuur gebaseerd en expertconsensus vragenlijst ontwikkeld, welke 
werd ingevuld door 60 respondenten. Intra-abdominale druk (IAP) werd door 59 (98%) 
respondenten gemeten met behulp van intra-vesicale methoden. Diuretica (38 
respondenten, 63%) en laparotomie (33 respondenten, 55%) werden door de 
meerderheid beschouwd als nuttige behandelingen voor IAH ter preventie van ACS. Mesh-
geassisteerde technieken voor tijdelijke abdominale sluiting (TAC) na decompressieve 
laparotomie hadden de voorkeur van de Nederlandse chirurgen, terwijl uit literatuur een 
voorkeur voor vacuümondersteunde technieken blijkt. Slechts 16 (27%) respondenten 
gebruikten de evidence-based richtlijn van de WSACS (The Abdominal Compartment 
Society) in de dagelijkse praktijk en nog eens 37 (62%) waren bereid om dit alsnog te 
doen. Negenenvijftig (98%) respondenten geloofden dat open buikbehandeling de 
uitkomsten van de patiënt met (dreigend) ACS verbetert, terwijl 46 (77%) zich bewust 
waren van het hoge risico op complicaties van deze behandeling. 
 
Conclusies: 
  Definities uit de WSACS richtlijn waren goed bekend onder de respondenten, de 
richtlijn zelf was echter slecht geïmplementeerd in Nederlandse ziekenhuizen. 
  Mesh-geassisteerde technieken voor tijdelijke abdominale sluiting (TAC) na 






Nederlandse samenvatting en conclusies 247
 Respondenten ondersteunden een open buikbehandeling na een decompressie
laparotomie, ook al waren ze zich bewust van de hoge gerelateerde morbiditeit
en mortaliteit.
Hoofdstuk 3 vergelijkt de kenmerken van patiënten die na een traumalaparotomie 
hooggradige intra-abdominale hypertensie (IAH) ontwikkelden (d.w.z. graad III of IV IAH, 
IAP > 20 mmHg) met die van patiënten waarbij dat niet gebeurde (graad I of II, IAP ≤ 20 
mmHg). De retrospectieve studie uit dit hoofdstuk, werd uitgevoerd onder 567 
opeenvolgende traumapatiënten die werden opgenomen in een level 1 traumacentrum 
(gespecialiseerd ziekenhuis voor de ernstig gewonde patiënten) in Australië. Van de 
geïncludeerde patiënten ontwikkelde 10,2% hooggradige IAH, waarvan 52% (30/58) ACS 
ontwikkelde. Een aanatl patiënten ontwikkelde ACS zelfs nadat er een open 
buikbehandeling was gestart. Patiënten met hooggradige IAH waren ouder (p < 0,001), 
hadden een hogere ISS (score voor ernst van letsel, p < 0,001), groter base tekort of ‘base 
deficit’ (p < 0,001) en lagere lichaamstemperatuur bij opname (p = 0,011). In de eerste 24 
uur na opname ontvingen patiënten met hooggradige IAH een hoger volume cristalloïde 
resuscitatievloeistoffen (p <0,001), grotere volumes colloïde resuscitatievloeistoffen (p < 
0,001) en meer eenheden van rode bloedcellen (p <0,001) ). Na de operatie werden een 
verlengde PT (protrombine tijd, p <0,001) en aPTT (geactiveerde partiële thromboplastine 
tijd, p <0,001) waargenomen. Patiënten met hooggradige IAH hadden een hoger risico op 
overlijden dan degenen die geen hooggradige IAH ontwikkelden (respectievelijk 25,9% vs. 
12,2%, p = 0,012). 
Conclusies: 
 Ontwikkeling van hooggradige IAH is geassocieerd met acidose, coagulopathie en
hypothermie (ook bekend als de “triad of death”).
 Patiënten met hooggradige IAH na een traumalaparotomie ontvingen significant
grotere volumes van cristalloïde en colloïde resuscitatievloeistoffen.





Hoofdstuk 4 heeft als doel om vast te stellen wat de prevalentie en mortaliteit is van ACS 
onder ernstig gewonde patiënten en deze te vergelijken voor en na 1 januari 2005 
(introductie van WSACS richtlijn). Dit werd gedaan met behulp van een systematisch 
literatuuronderzoek en meta-analyse. Na pooling van de data van de 81 geïncludeerde 
publicaties, toonde de studie een ACS prevalentie onder traumapatiënten van 0,0% tot 
36,4% (N = 33.455 patiënten), met een gewogen gemiddelde van 5,2% en 3,7% vóór en na 
januari 2005 respectievelijk. Bij ernstig gewonde IC patiënten was dit 1,1%, 2,8% onder 
patiënten met visceraal letsel en 5,0% bij patiënten die een traumalaparotomie hadden 
ondergaan. De mortaliteit varieerde van 0,0% tot 100,0% met een gewogen gemiddelde 
van 47,1% vóór en 53,1% na 1 januari 2005. Deze waarden moeten met de nodige 
voorzichtigheid worden geïnterpreteerd gezien de grote statistische en klinische 
heterogeniteit van de geïncludeerde studies. Daarom kon geen causaal verband worden 
geconcludeerd met verbeterde traumazorg of de introductie van WSACS richtlijn. 
 
Conclusies: 
  De prevalentie van ACS bij traumapatiënten varieert van 0,0% tot 36,4% met een 
gepoolde prevalentie van 4,5%. 
  De mortaliteit van traumapatiënten met ACS varieert van 0,0% tot 100,0% met 
een gepoolde waarde van 48,3%. 
  Geen afname van ACS prevalentie en mortaliteit na introductie van de WSACS 
richtlijn kon worden aangetoond. 
  De veronderstelde eliminatie van ACS (bij ernstig gewonde patiënten) is nog geen 
realiteit geworden. 
  Uniform gebruik van internationaal gebruikte definities en afkappunten is 
cruciaal voor het onderzoek naar de relatief zeldzame syndromen van IAH en 
ACS. 
 
Hoofdstuk 5 geeft een overzicht van literatuur met betrekking tot IAH en ACS bij patiënten 
met ernstige brandwonden met een focus op epidemiologie en managementstrategieën. 
Er werd systematisch literatuuronderzoek gedaan dat 50 publicaties opleverde welke in 
totaal 1616 patiënten rapporteerde. De prevalentie van ACS en IAH bij patiënten met 
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mortaliteit van brandwonden patiënten met ACS was 74,8%. Het gebruik van plasma en 
hypertone resuscitatievloeistoffen kan IAH of ACS voorkomen. Ondanks het feit dat het 
gebruik van colloïde vloeistoffen het totale benodigde volume aan ruscitatie vloeistoffen 
verminderen, is er niet aangetoond dat dit bijdraagt aan het optreden van IAH. 
Escharotomie, peritoneale catheter drainage en decompressielaparotomie bleken 
effectieve IAP verlagende behandelingen te zijn bij patiënten met brandwonden. Ten 
slotte bleek dat markers voor IAP-gerelateerde orgaanschade of orgaanfalen mogelijk 
superieur zijn aan de IAP metingen zelf. 
Conclusies: 
 Systematisch literatuuronderzoek toonde aan dat de prevalentie van ACS en IAH
bij patiënten met ernstige brandwonden respectievelijk 4,1-16,6% en 64,7-74,5%
was.
 De gemiddelde mortaliteit van ACS bij patiënten met ernstige brandwonden
wordt geschat op 74,8% op basis van beschikbare literatuur.
 IAH of ACS kunnen worden voorkomen door het resuscitatievolume te
verminderen.
 Brandwonden van de romp bij patiënten met ACS vereisen onmiddellijke
escharotomie en moeten worden opgevolgd door toenemend invasieve
decompressiemaatregelen als geen drukverlaging wordt bereikt.
 Diagnostische middelen voor vroege herkenning van aan IAH gerelateerde
nadelige uitkomsten kunnen belangrijker zijn dan de meting van IAP of APP.
Hoofdstuk 6 is er primair gericht op het bepalen van de prevalentie van IAH bij patiënten 
met ernstige brandwonden. Secundair had het als doel om te bepalen wat de waarde van 
het eiwit intestinal fatty acid binding protein (I-FABP) in urine was als vroege marker voor 
IAH-geassocieerde complicaties. I-FABP is een eiwit dat exclusief voorkomt in de dunne 
darm, een orgaan in de buik dat gevoelig is voor ischemie (zuurstof tekort). Bij lichte 
ischemische veranderingen in de dunne darm kan het eiwit al in verhoogde concentraties 
van zowel bloed als urine gemeten worden. De theorie is dat ischemie van de dunne darm 
één van de eerste ongewenste effecten is van IAH en mogelijk een centrale rol speelt in 
het ontwikkelen van inflammatie in de rest van het lichaam.  
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De patiënten in deze studie (N=58, geïncludeerd in twee Nederlandse 
brandwondencentra) hadden een mediaan totaal verbrand lichaamsoppervlak (TVLO) van 
29%. Eenendertig (53%) patiënten ontwikkelden IAH, zeventien (29%) patiënten 
ontwikkelden nieuw orgaanfalen, maar geen enkele patiënt ontwikkelde ACS. De 
maximale I-FABP waarde in urine per patiënt hadden een redelijk discriminerend 
vermogen tussen patiënten met en zonder IAH. Helaas bleken de individuele I-FABP 
waarden in urine geen voorspellende waarde te hebben voor IAH of nieuw orgaanfalen in 
deze populatie patiënten met ernstige brandwonden. 
Conclusies: 
 De 58 geïncludeerde patiënten met ernstige brandwonden hadden vaak IAH zeer
vaak voor, echter werden bij geen van de patiënten ACS waargenomen.
 I-FABP concentraties in de urine bleken geen significante diagnostische of
voorspellende waarde te hebben voor IAH en gerelateerd orgaanfalen in een
patiëntenpopulatie met ernstige brandwonden.
Hoofdstukken 7 en 8 beschrijven het ontwerp en de resultaten van de I-Fabulous studie. 
Deze studie was de grootste prospectieve cohortstudie van IC patiënten met twee of meer 
risicofactoren voor IAH tot nu toe. Het doel van deze studie was om de waarde te bepalen 
van intestinal fatty acid binding protein (I-FABP) spiegels in urine en serum als vroege 
marker voor IAH-geassocieerde complicaties. Van 198 geïnjecteerde patiënten 
ontwikkelden 15 (8%) ACS en 74 (37%) ontwikkelden nieuw orgaanfalen. I-FABP en IAP 
waren positief gecorreleerd. Patiënten die ACS ontwikkelden, hadden hogere mediane 
baseline niveaus van I-FABP in de urine (235 µg/g creat, gecorrigeerd voor nierfunctie) dan 
patiënten die alleen IAH, maar geen ACS ontwikkelden (87 µg/g, p=0,037). I-FABP had 
geen discriminerend vermogen voor het al dan niet ontwikkelen van ACS gezien de 
oppervlakte onder de receiver operating characteristic curve (AUC) 0,53 was voor I-FABP 
in urine, en 0,65 voor I-FABP in serum. Een AUC van 1,0 zou de perfecte test zijn en een 
waarde van 0,5 is vergelijkbaar met het opgooien van een muntje). Met een odds ratio van 
1,00 duidden noch I-FABP in urine noch in serum op een klinisch relevant verhoogd risico 












  De resultaten van deze studie lieten een prevalentie van ACS bij IC patiënten met 
twee of meer risicofactoren voor IAH zien van 8%. 
  De resultaten van de hoofdstukken 6 tot 8 tonen ondubbelzinnig aan dat 
intestinale ischemie of mucosa beschadiging (zoals gemeten met I-FABP) geen 
vroege tekenen zijn van IAH gerelateerd orgaanfalen of ACS. 
  I-FABP heeft geen waarde bij de voorspelling of vroege detectie van IAH 
gerelateerde negatieve uitkomsten in de dagelijkse klinische praktijk. 
 
Hoofdstuk 9 bepaalt de relatie tussen IAP (op subklinische niveaus van IAP onder d 20 
mmHg) enerzijds, en ademhalingsparameters, hemodynamische parameters en de 
ontwikkeling van ischemie in de vroege darm anderzijds in een proefdier experiment. 
Hoewel in de literatuur de klinische relevantie van subklinische niveaus van IAP onder de 
20 mmHg zonder tekenen van orgaanfalen onduidelijk is, toonde deze studie aan dat dit 
soort intra-abdominale drukken wél negatief geassocieerd zijn met gemiddelde arteriële 
druk (Spearman correlatiecoëfficiënt; Rs = -0,466, p = 0,019), zuurstofverzadiging (Rs = -
0,882, p <0,001), partiële zuurstofdruk (pO2) (Rs = -0,752, p <0,001) en pH-waarde (Rs = -
0,934, p <0,001). Daarnaast was IAP positief geassocieerd met centrale veneuze druk (Rs = 
0,581, p = 0,002). Intra-abdominale druk was niet geassocieerd met lactaatniveau of 
“albumine-cobalt bindingscapaciteit” (ACB), een experimentele marker voor systemische 
ischemie. Er werden geen histologische tekenen voor intestinale ischemie gevonden. 
 
Conclusies: 
  Subklinische niveaus van IAP (tot de 20 mmHg) waren gecorreleerd met 
toenemende ademhalings- en hemodynamische problemen in een experimenteel 
rattenmodel. 
  In de eerste drie uur na ontstaan, zijn buikdrukken tot en met een niveau van 20 
mmHg niet geassocieerd met significante ischemische complicaties bij ratten. 
  De resultaten van dit eerste onderzoek naar de prestaties van de albumine-cobalt 
binding (ACB) test als gemakkelijk te bepalen marker voor IAH-gerelateerde 
negatieve uitkomsten, waren niet bemoedigend om grootschaliger studies uit te 
voeren. 
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Hoofdstuk 10 is de algemene discussie van dit proefschrift en biedt 
toekomstperspectieven met betrekking tot verdere verbetering van IAH en ACS 
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